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CHAPTER 1 
INTRODUCTION 
1.1 The cholinergic hypothesis 
Alzheimer's disease (AD) was first described by Alois 
Alzheimer, who identified the cortical senile plaques and 
neurofibrillary tangles which are its classical neuropathological 
hallmarks [2]. The functional importance of these cortical 
abnormalities was indicated by a report that showed a correlation 
between cortical plaque counts and scores upon both a functional 
rating scale of dementia and a short information-memory-concen-
tration test [8]. Further progress was made when three indepen-
dent research groups showed that AD brains had consistently low 
levels of cholinergic markers, especially the synthetising enzyme 
choline acetyltransferase (ChAT) [10, 17, 40]. The reduced 
cortical ChAT activity in AD was inversely related to cortical 
plaque densities and paralleled the degree of cognitive impair-
ment [41]. Other indices of cholinergic function such as 
measurements of acetylcholinesterase (AChE) levels which are 
relatively specific to cholinergic cells [42], the very specific 
high-affinity choline uptake system [43], and the capability of 
cerebral biopsy samples to synthétise acetylcholine [il] have all 
confirmed a true loss of cholinergic function in AD. 
The fact that the decreased ChAT activity in AD brains was 
greater than the degree of cortical cell loss [50] suggested that 
the cholinergic cell bodies might reside in a subcortical 
location, as was already indicated by earlier work, that showed a 
pronounced decrease in cortical AChE and ChAT levels by undercut-
ting the overlying cortex [28]. With the use of antibodies to 
the specific cholinergic marker ChAT, it has been firmly 
established that most large neurons in the subcortical nucleus 
basalis of Meynert, the diagonal band of Broca and the medial 
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septal nucleus are cholinergic [29, 39, 47, 48]. These choliner-
gic neurons send projections directly to the cerebral cortex and 
hippocampus [33, 34, 39] and are selectively lost in AD, whereas 
no consistent reduction in neurons was observed in adjacent 
structures [3, 52, 53]. This loss of cholinergic neurons in AD 
is correlated with the number of cortical senile plaques [4] and 
is inversely related with cortical ChAT levels [23]. Furthermo-
re, the distended neurites of primitive and mature senile plaques 
in the cerebral cortex show immunoreactivity against (axons and 
axonal endings of) cholinergic neurons [5]. These observations 
strengthened the association between cholinergic dysfunction, 
neuropathological findings, and the intellectual impairments in 
patients with AD. These biochemical, neuropathological and 
behavioural studies have been repeated extensively confirming the 
cholinergic dysfunction in AD. Moreover, early psychopharmacolo-
gical studies showed that suppression of cholinergic function in 
normal subjects can produce learning and memory disturbances [21, 
24]. In humans, the centrally acting anticholinergic drug, 
scopolamine, produced disturbances in the memory for recent 
events. These effects could be reversed by enhancing the 
cholinergic activity with the anticholinesterase agent physostig-
mine, but not by enhancing the noradrenergic activity with D-
amphetamine [25]. In the early stages of Alzheimer's disease 
small improvements in cognitive functioning have been reported by 
administering anticholinesterase agents as physostigmine [51] and 
tetrahydroaminoacridine [49]. 
In its commonest form the cholinergic hypothesis states that 
loss of cholinergic function causes or contributes to some of the 
intellectual impairments particularly the memory deficits of AD 
[6, 14, 13, 43]. More than a decade after its formulation the 
cholinergic hypothesis is still subject to critical evaluation. 
Until now, it is largely based on evidence of neurochemical and 
neuropathological disturbances in affected brain tissue, but 
still awaits an effective therapy for its ultimate validation. 
The pattern of memory failure induced in normal people by 
scopolamine (which blocks muscarinic receptor sites) is said to 
be distinct from that seen in AD [7]. The effect of THA is not 
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only due to acetylcholinesterase-blocking, but probably also to 
activation of cortical monaminergic systems [1]. Moreover, 
certain neuroactive peptides are hydrolysed or actually produced 
as a result of acetylcholinesterase action [32], and its 
inhibition by THA may thus be associated with functional 
alterations of cerebral neuropeptides rather than enhancing the 
availability of acetylcholine [45]. 
The cholinergic deficit is unlikely to be specific to AD in 
view of the many diverse disorders associated with cortical 
cholinergic degeneration and/or reductions in neuron numbers in 
the nucleus basalis of Meynert: Parkinson's disease, Parkinson's 
disease with dementia, Parkinsonism-dementia of Guam, Down's 
syndrome, Gerstmann-Straussler syndrome, hereditary olivopontine 
cerebellar degeneration, progressive supranuclear palsy, dementia 
pugulistica, and Korsakoff's psychosis [43]. In the Parkinsonian 
group over 70% of cortical ChAT loss has been measured, and yet 
only a mild form of dementia which is not typical of AD is 
present. This suggest that the cholinergic system is unlikely to 
be involved in all aspects of cognitive function affected in AD, 
and that other neuronal systems may also be involved. This 
difference in cognitive profiles between Parkinson's disease and 
AD has been ascribed to a compensating denervation-induced 
muscarinic-receptor supersensitivity evident in important 
projection areas as the hippocampus in Parkinson's disease but 
not in AD [44]. 
As in most neurodegenerative diseases numerous different 
neurotransmitter systems are affected to a greater or lesser 
extent. The noradrenergic deficit in AD (reduced locus coeruleus 
neuron numbers [9] and/or cortical dopamine-ß-hydroxylase 
deficiency [15]) does not relate closely to cognitive impairment, 
but to a diminishing general arousal and emotional response, as 
recently has been demonstrated by a remarkable case of congenital 
dopamine-3-hydroxylase deficiency with apparently normal 
intellectual function, but a tendency to "be apathetic and avoid 
physical exercise" [37]. The clinical significance of serotoner-
gic deficit has not been demonstrated yet [11]. Several lines of 
evidence implicate reductions of excitatory amino-acid abnormali-
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ties e.g. glutamate in AD [38], but not in Parkinson's disease 
[16]. The clinical significance of the cortical glutamate 
reduction in AD remains to be established. Cortical reductions 
of the neuropeptides somatostatin [18, 46] and substance-P [19] 
have been reported. It is unlikely that all of these neurochemi-
cal disturbances are of equal importance in relation to the core 
symptoms of AD, and most of them are probably not clinically 
relevant due to the compensatory mechanisms of the human brain. 
The role of acetylcholine in memory processing is still 
obscure. At the molecular level stimulation of the nicotinic 
cholinergic receptor by nicotine or acetylcholine induces 
transcription of the actin gene and a proto-oncogêne [27]. 
Nicotinic-receptor binding is substantially reduced in AD, 
Parkinson's disease and Down's syndrome [44, 54], but it is not 
established yet whether this is reflected by altered protein 
transcriptions. At the cellular level, cholinergic neurons of 
the nucleus basalis of Meynert (nbM) could be involved in memory 
processing because animal lesion studies of this nucleus 
generally result in learning deficits [for review: 6, 13, 20]. 
The trophic state of cholinergic neurons depends on the cortical 
production of nerve growth factor (NGF) that promotes the 
survival and recovery of these neurons in the mammalian brain. 
Immunocytochemical studies have shown extensive loss of nbM 
neurons in AD positive for nerve growth factor-receptors (NGF-r) 
[30, 35]. It was recently demonstrated that NGF-r gene expressi-
on is extensively decreased in the nbM [31]. Other studies 
suggest that NGF itself regulates the expression of its own NGF-
receptor in the central nervous system [26, 36]. Therefore, the 
decrease in NGF-r gene expression in nbM neurons in AD may result 
from a lack of NGF support due to general cortical atrophy in AD. 
The latter suggests a secondary rather than a primary degenerati-
on of the cholinergic system in AD. It is at the systematic or 
multicellular level, however, that learning and other cognitive 
functions must eventually be understood. Hippocampus and 
temporal neocortex are considered as areas associated with 
learning and memory. These areas receive major cholinergic 
inputs from the nucleus basalis of Meynert, the diagonal band of 
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Broca and the medial septal nucleus [39]. In AD, the hippocampus 
and temporal neocortex show severe atrophy and cell loss [12, 
22]. However, whether this degeneration of hippocampus and 
temporal neocortex is the primary event in AD with subsequent 
retrograde degeneration of the cholinergic system, or whether it 
is secondary to a primary degenerating cholinergic system, 
remains to be established. 
Undoubtedly, the cholinergic hypothesis of dementia in 
Alzheimer's disease has been the single greatest impetus to 
research into AD. However, whether the cholinergic deficiency 
can provide any clues regarding the pathogenesis depends on the 
extent to which it is a major ana early involvement, and the 
extent to which it is specific to the Alzheimer's disease 
process. Rather, it would seem that cell loss of cholinergic 
neurons is a common feature of a variety of distinct disease 
processes. This vulnerability may well be related to the 
dependency on nerve growth factor, indicated by the selective 
NGF-receptor localisation on the cholinergic neurons, as opposed 
to most other neurons in the brain. 
1.2 Aim of the study 
With regard to the cholinergic hypothesis the loss of large 
cholinergic neurons in the nucleus basalis Meynert complex (NBMC, 
i.e., the nucleus basalis Meynert, the diagonal band of Broca, 
and the medial septal nucleus) is a central issue. This cell 
loss correlates with the degree of dementia, the number of senile 
plaques and neurofibrillary tangles in the neocortex and 
hippocampus, and the amounts of choline acetyltransferase in 
these structures (see 1.1). However, a closer look at these 
neuropathological and morphometric studies reveals several 
methodological errors especially in the counting procedures 
applied. Moreover, most studies considered only magnocellular 
neurons and excluded shrunken neurons from being counted. The 
neuropathological parameters investigated in this thesis include 
total neuron number, neuron size, the number of senile plaques 
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and n e u r o f i b r i l l a r y t a n g l e s , and the d i s t r i b u t i o n of congophilic 
angiopathy and l i p o f u s c i n o s i s . The following quest ions wi l l be 
considered in t h i s t h e s i s : 
1. What are the neuroanatomical boundaries of the NBMC and i t s 
subdiv is ions (Chapter 2)? 
2. What a r e the most appropiate morphometric counting and 
sampling methods (Chapters 3 and 4)? 
3. Do t h e neuropathological parameters of ( the subdivis ions of) 
t h e NBMC change in normal aging (Chapters 5 and 7)? 
4. Do the neuropathological parameters of ( the subdivis ions of) 
t h e NBMC in Alzheimer's d isease d i f f e r from normal aging 
(Chapters 5 and 7)? 
5. With regard to the s p e c i f i c i t y of the changes of the NBMC in 
normal aging and AD, do the supraopt ic and paraventr icu lar 
n u c l e i show s i m i l a r changes in normal aging and AD (Chapters 6 
and 1)7 
6. Are t h e r e l e f t - r i g h t di f ferences in the neuropathological 
parameters ; are t h e r e di f ferences between the subdivis ions of 
the NBMC (Chapters 5, б and 7)? 
7. With regard t o the r o l e of interneurons in the NBMC, does the 
Galanin- l ike immunoreactivity change in AD (Chapter 8)? 
8. Does the degeneration of the NBMC r e f l e c t s a primary or a 
secondary process in the pathogenesis of AD; consequently, 
does the degenerat ion of the NBMC in AD c o r r e l a t e with 
changes found in i t s pro jec t ion a r e a s , the neocortex and 
hippocampus, and with changes in the brainstem (Chapter 9)? 
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CHAPTER 2 
NEUROANATOMY OF THE HUMAN NUCLEUS BASALIS MEYNERT COMPLEX, 
THE SUPRAOPTIC AND PARAVENTRICULAR NUCLEI, 
AND THE ORGANUM VASCULOSUM OF THE LAMINA TERMINALIS 
2.1 Neuroanatomy of the human nucleus basalis of Meynert 
2.1.1 Topography of the human nucleus basalis Meynert complex 
The nucleus basalis of Meynert was first identified in passing 
in 1872 by Meynert [84], who described the nucleus as a populati-
on of large, hyperchromatic neurons in the basal forebrain (Kern 
der Linsenkernschlinge). His description was confined to the 
sublenticular part of the nucleus basalis. Later on the nucleus 
basalis was described in toto and in more detail by Kölliker 
[60]. He located the main body of this nucleus between the optic 
tract and the anterior commissure. Foix and Nicolesco [33] 
identified loosely scattered neurons outside the main body which 
were cytologically identical to those in the nucleus basalis. 
These neurons were present in the internal capsule, and the 
medial and lateral medullary laminae of the globus pallidus. 
Brockhaus [16] termed the main body "the pars compacta" and the 
regions with scattered neurons "the pars diffusa". Moreover, he 
considered the nucleus basalis of Meynert, together with the 
nuclei of the diagonal band of Broca, the medial septal nucleus, 
and with loosely arranged similarly appearing neurons in the 
olfactory tubercle, as one morphologic and functional entity, 
"the Basalkern-komplex". This entity-concept was elaborated by 
Divac [28], who postulated that the magnocellular neurons in the 
medial septal nucleus, the nuclei of the diagonal band of Broca 
and the nucleus basalis of Meynert all form part of a single 
system of neurons with projections to all parts of the pallium. 
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Abbreviations for all figures 
ace nucleus accumbens 
al ansa lenticularis 
amy amygdala 
ap ansa peduncularis 
bnst bed nucleus of the stria terminalis 
ca commissura anterior 
cdt caudate nucleus 
ce capsula externa 
egl corpus geniculatum laterale 
Chi medial septal nucleus 
Ch2 vertical limb nucleus of the diagonal band of Broca 
Ch3 horizontal limb nucleus of the diagonal band of Broca 
Ch4am anteromedial part of the nucleus basalis of Meynert 
Ch4al anterolateral part of the nucleus basalis of Meynert 
Ch4i intermediate part of the nucleus basalis of Meynert 
Ch4p posterior part of the nucleus basalis of Meynert 
ci capsula interna 
cl claustrum 
cm corpus marni Ilare 
co chiasma opticum 
fx fornix 
gpe globus pallidus, external segment 
gpi globus pallidus, internal segment 
hip hippocampus 
hy hypothalamus 
ins insular cortex 
isC islands of Calleja 
Ime lamina medullaris externa (nuclei lentiformis) 
Imi lamina medullaris interna (nuclei lentiformis) 
npv nucleus paraventricularis 
ns nucleus subthalamicus 
nsm nucleus septi medialis 
nso nucleus supraopticus 
ovlt Organum vasculosum of the lamina terminalis 
pc pedunculus cerebri 
put putamen 
ro recessus opticus 
rub nucleus ruber 
sa subcallosal area 
sn substantia nigra 
sol stria olfactoria lateralis 
som stria olfactoria medialis 
spe septum pellueidum 
tha thalamus 
tol tuberculum olfactorium 
topt tractus opticus 
vi ventriculus lateralis 
vp ventral pallidum 
vt ventriculus tertius 
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Confirmation came from several studies [53, 56, 76]. The latter 
study combined retrograde horseradish peroxidase techniques with 
histochemistry (acetylcholinesterase) and immunochemistry 
(choline acetyltransferase) in the rhesus monkey, demonstrating 
widespread projections to the entire cortical surface, hippocam-
pus, olfactory bulb and amygdala. The continuum of the choliner-
gic perikarya in the basal forebrain extended from the medial 
septal nucleus rostrally to the lateral geniculate body caudally, 
and its neurons were in close contact with fiber bundles of the 
diagonal band of Broca, the anterior commissure, the medial 
forebrain bundle, the ansa lenticularis, the ansa peduncularis, 
the internal and external capsules, the medullary laminae, the 
fornix, the stria terminalis and the inferior thalamic peduncle. 
Four subdivisions could be distinguished on behalf of their 
topology and projection patterns. These subdivisions were 
designated as Chl-Ch4, and were also readily identifiable in a 
series of Nissl-stained sections through a single human basal 
forebrain [76]. The Chi group in the rhesus monkey corresponded 
to the medial septal nucleus (10% of its neurons are choliner-
gic); the Ch2 group corresponded to the vertical limb nucleus of 
the diagonal band of Broca (about 70% of its neurons are 
cholinergic); the Ch3 group most closely corresponded to the 
horizontal limb nucleus of the diagonal band of Broca (only 1% is 
cholinergic); the Ch4 group corresponded to the nucleus basalis 
of Meynert (at least 90% of the neurons are cholinergic), that 
could be further subdivided into an anteromedial (Ch4am), an 
anterolateral (Ch4al), an intermediate (Ch4i) and a posterior 
part (Ch4p). 
The same topography of the Chl-Ch4 groups was demonstrated in 
the human brain and maps of these cell masses were provided using 
Nissl-staining [45], using combined acetylcholinesterase 
histochemistry with thionin-staining [113] or with Nissl-staining 
[97], or using lipofuscin-pigment-staining [135]. Although these 
maps of the nucleus basalis Meynert complex (NBMC) provide 
already sufficient insight into its topography, a new series of 
sections will be presented here in order to get a distinct 
definition of the different subdivisions of the NBMC (Chl-Ch4) in 
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Fig. 2.1 Diagram showing level and plane of sections in Fig. 2.2 
rostrocaudal direction in relation to its surrounding structures. 
The most rostrally located J part of the NBMC is localized in 
the medial part of the septum verum. Its boundaries are as 
follows (Fig. 2.2a): 
- medial: the median plane of both hemispheres; 
- dorsal: nuclei with small-sized neurons in the septum verum; 
lateral: nuclei with small-sized neurons in the septum verum; 
ventral: the diagonal band of Broca. 
The septum verum is well developed in the human brain contrary 
to the dorsally located septuirt pellucldum [4], and contains 
several small, rather poorly individualized cell groups. Due to 
the presence of these ill-defined nuclei no generally accepted 
nomenclature is available, although the subdivision proposed by 
Stephan and Andy [127] into a dorsal, ventral, caudal and medial 
group seems to be acceptable. This medial group can be further 
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Fig. 2.2a Section through head of caudate nucleus and putamen 
subdivided into "the septal component", a small-celled dorsal 
extension of the most dorsal part of the nucleus of the diagonal 
band of Broca, and the nucleus septalis medialis consisting of 
even smaller sized neurons. Only "the septal component" forms 
part of the NBMC. The parvocellular nucleus septalis medialis 
has multiple, confusing synonyms in different species in the 
literature: 
- noyeau hyperchromatique du septum [33]; 
nucleus diagonalis septalis [16]; 
- nucleus medialis septi [68, 92]; 
- nucleus parolfactorius medialis [105]; 
- nucleus septalis medialis [4, 39]; 
nucleus septi medialis [6]; 
- nucleus substantiae innominatae rostralis ascendens [42]; Chi 
[76], the cholinergic neurons in the medial septal nucleus. 
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Flg. 2.2b Section through main body of Ch2 and rostral Ch4 
The subsequent subdivision of the NBMC is the nucleus of the 
diagonal band of Broca. This nucleus has a ventrocaudal course, 
and is delimited by the following structures (Fig. 2.2b): 
dorsal: the medial septal nucleus (Chi). Its rostrodorsal 
boundary is rather arbitrarily located at the level of the 
anterior commissure [27]; 
- medial: subcallosal area and the subarachnoidal space; 
lateral: nucleus accumbens; 
the ventrocaudal boundary of the nucleus of the diagonal band 
of Broca has been disputed on as well as on the division in 
subnuclei. Brockhaus [16] distinguished parvocellular and 
magnocellular nuclei. Other studies subdivided the diagonal band 
nucleus into a vertical limb nucleus and a horizontal limb 
nucleus [2, 92]. The horizontal limb nucleus is described as a 
small band beneath the vertical limb nucleus, extending 
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Fig. 2.2c Section through the anterior commissure and Ch4a 
caudolaterally and having its greatest expansion between the 
preoptic region and the amygdaloid region [27, 34, 101]. Meibach 
and Siegel [72], however, considered the ventral part of the 
vertical limb nucleus as belonging to the horizontal limb 
nucleus, whereas De Olmos [27] defined this area as the pars 
ventralis of the vertical limb nucleus. Mesulam [76] designated 
the group of cholinergic neurons in the vertical limb nucleus 
(without the ventral part of this vertical limb nucleus) as Ch2 
(Fig. 2.2b), and the cholinergic neurons in the horizontal limb 
nucleus (defined as a small band without the ventral part of the 
vertical limb nucleus) as Ch3. This Ch3 group extends caudolate-
rally to the amygdaloid region (Figs. 2.2c and 2.2d). 
The pars ventralis of the vertical limb nucleus of the 
diagonal band of Broca [27] has been given several synonyms in 
the literature: 
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Fig. 2.2ä Section through caudal Ch4a 
nucleus diagonalis angularis [16]; 
nucleus substantiae innominatae rostralis angularis [42]; 
segment interstitiel de la bande diagonale de Broca [109]; 
- Ch4am [76], the group of cholinergic neurons in the 
anteromedial part of the nucleus basalis of Meynert (Ch4). 
The Ch4aiii region extends caudally to the ansa lenticularis and 
is bordered by the following structures: 
caudal: ansa lenticularis and the Ch4i region (see below); 
lateral rostral: the olfactory tubercle; 
lateral caudal: the Ch4al region (see below); 
dorsal: ventral pallidum (beneath the anterior commissure); 
medial: lateral preoptic nucleus (lateral hypothalamus); 
ventral: basal olfactory area and Ch3 region. 
Following the rostrocaudal direction, the rostral part of the 
Ch4am region borders initially on the olfactory tubercle, but 
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Fig. 2.2e Section through ansa lenticularis and rostral Ch4i 
immediately behind the tubercle it extends laterally to the 
amygdaloid region. This lateral extension of the cholinergic 
neurons in the the Ch4am region is known as the Ch4al region, the 
anterolateral part of the nucleus basalis of Meynert [76]. 
The Ch4al region borders on the following structures: 
rostral: the olfactory tubercle and the basal olfactory area; 
caudal: ansa lenticularis and the Ch4i region (see below); 
lateral: amygdaloid region; 
dorsal: ventral pallidum (beneath the anterior commissure); 
medial: Ch4am group; 
ventral: basal olfactory area and the Ch3 region. 
The subdivision of the anterior part of the nucleus basalis of 
Meynert (Ch4a) into an anteromedial and anterolateral part is 
rather arbitrarily based upon the presence of a large-sized 
vessel or a vertically orientated small zone with lower neuron 
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Fig. 2.2f Section through ansa pecluncularis and caudal Ch4i 
density (Fig. 2.2c). The main characteristic of Ch4a is the high 
neuron density in the "pars compacta" located in the centre, and 
the decreasing density towards the periphery of Ch4a, the "pars 
diffusa" [16, 137]. The most important synonyms for the Ch4a 
region are: 
nucleus basalis [16]; 
- nucleus praeopticus magnocellularis [68]; 
- nucleus substantiae innominatae basalis [42]. 
The subcommissural part of the substantia innominata (i.e., 
the ventral pallidum + anterior perforated substance + Ch4a; 
Figs. 2.2c and 2.2d) extends caudally into the sublenticular part 
of the substantia innominata (Figs. 2.2e and 2.2f), in which a 
new subdivision of the NBMC appears extending into caudalateral 
direction. Again a "pars compacta" and "pars diffusa" can be 
distinguished (Fig. 2.2e). In the caudal part of this 
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Fig. 2.2g Section through pedunculus cerebri and rostral Ch4p 
subdivision the "pars compacta" is being subdivided by the 
presence of the ansa peduncularis into a ventromedial and a 
dorsolateral subnucleus (Fig. 2.2f). The boundaries of the 
sublenticular part of the NBMC are as follows: 
- dorsal: globus pallidus (internal and external segment) and 
the putamen; 
- mediorostral: lateral hypothalamic region (Fig. 2.2e),· 
- mediocaudal: optic tract (Fig. 2.2f); 
ventral: amygdaloid region and amygdala; 
lateral: anterior commissure; 
rostral: Ch4a group; 
- caudal: Ch4p group; 
This sublenticular part of the NBMC has several synonyms: 
- Kern der Linsenkernschlinge [84]; 
- nucleus ansae peduncularis [9, 92]; 
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Fig. 2.2h Section through lateral geniculate body and caudal Ch4p 
nucleus substantiae innominatae sublenticularis [42]; 
Ch4i [76], the group of cholinergic neurons in the 
intermediate part of the nucleus basalis of Meynert (Ch4). 
The most caudal part of the NBMC is extending caudally from 
behind the ansa peduncularis to the rostral part of the lateral 
geniculate body. Even more caudally, small cell clusters are 
present in the external medullary lamina (Fig. 2.2h). Only 
Mesulam [76] regarded this posterior part of the NBMC as a 
separate subdivision and called it the Ch4p group, the group of 
cholinergic neurons in the posterior part of the nucleus basalis 
of Meynert (Ch4). Others considered this posterior ending of the 
NBMC as part of respectively the "Kern der Linsenkernschlinge" 
[84], the "nucleus substantiae innominatae sublenticularis" [42], 
or the "nucleus ansae peduncularis" [92]. 
The more-or-less continuous band of cholinergic neurons of 
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the nucleus basalis Meynert complex (NBMC) has several extensi-
ons: 
the most prominent extension is located lateral from the 
Ch4al and extends rostrally beneath the putamen to the frontal 
plane that shows the rostral beginning of the Ch2 group (Fig. 
2.2a). Ayala [10] regarded this extension as a separate 
nucleus, the subputaminal nucleus. 
another extension from the Ch4a group crosses through the 
ventral pallidum in a caudodorsal direction, passing the 
anterior commissure posteriorly to end at the medial edge of 
the internal capsule (Fig. 2.2c). 
several small extensions of the Ch4 group can be distin-
guished: the external capsule (Fig. 2.2c), the internal and 
external medullary laminae (Figs. 2.2c-h) and ventral to the 
lateral anterior commissure (Figs. 2.2e-f). 
Solitary magnocellular neurons showing similar cytology can 
be demonstrated in the olfactory tubercle (Fig. 2.2b) and the 
islands of Calleja within the olfactory tubercle [132], the 
fornix (Fig. 2.2c-d), the internal capsule (Figs. 2.2c-e) and the 
nucleus accumbens [45] (Fig. 2.2b). 
After several initial reports on cholinergic properties of 
the magnocellular neurons of the human NBMC [36, 86, 95, 98, 
113], it was recently demonstrated that 80-90% of the magnocellu-
lar neurons in this complex stain positively for choline 
acetyltransferase in the human brain [82]. In the present study 
the nomenclature of Mesulam [76] will be adopted. However, it 
should be explicitly mentioned that, whenever the Ch-prefix is 
used, not only cholinergic neurons but also noncholinergic 
neurons are included. 
2.1.2 Cytology of the human NBMC 
In cresyl-fast violet-staining the characteristic neurons of 
the Chl-Ch4 system stand out sharply from their surroundings 
because of their large size and the intense (hyperchromatic) 
staining of their Nissl material. Many small neurons are 
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intermingled between the magnocellular neurons, especially in the 
Chi and Ch2 region. 
The Chi region (medial septal nucleus) is composed primarily 
of small to medium sized (10-25 цт in diameter), mostly round 
neurons. It contains relatively few magnocelluar neurons. Many 
of the smaller neurons are so hyperchromatic in Nissl-stain that 
their nuclei (and nucleolus) are difficult to distinguish. Only 
few, large and fusiform neurons, show a clear nucleus with a 
prominent nucleolus. 
The Ch2 region (vertical limb nucleus of the diagonal band of 
Broca) is also composed primarily of hyperchromatic, but larger 
neurons with a clearly visible, ellipsoid, eccentric nucleus with 
a prominent dark nucleolus. The neurons tend to be orientated 
parallel to the ventrolaterally sweeping fibers of the diagonal 
band. 
Contrary to the Ch4 region, the Ch3 region (horizontal limb 
nucleus of the diagonal band of Broca) consists of smaller (10-
20цт), more fusiform, relatively hypochromatic, and less densely 
packed neurons. These neurons are irregularly scattered among 
the fibers of the diagonal band, which run along the floor of the 
basal forebrain underlying the Ch4a region. 
Both the Ch4a and Ch4i region are cytologically characterized 
by large and very large (25-50 цт), hyperchromatic neurons with a 
clearly visible, large (10-15 цт) and eccentric nucleus contai­
ning a conspicuous nucleolus. Also small neurons are present. 
Neuronal shape is distinctly heterogeneous, varying from fusiform 
and polygonal to predominantly ellipsoid. Aggregates of Nissl 
material are often located in one or more foci at the periphery 
of the perikaryon, while smaller deposits occur throughout the 
rest of the cytoplasm. From the centre of the Ch4a and Ch4i 
region towards the periphery cell size gradually decreases. 
The Ch4p region is primarily composed of hyperchromatic, 
medium-sized neurons (10-25цт), that show almost equally intense 
staining of the cytoplasm and nucleus, among several magnocellu­
lar neurons with a clearly visible nucleus and nucleolus. 
Using Golgi material, two main classes of neurons have been 
distinguished within the NBMC, namely medium-sized reticular 
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neurons and large multipolar neurons [7]). The reticular type 
was found to be the most predominant. In combined pigment-Nissl 
preparation, three types of neurons could be defined on behalf of 
lipofuscin content and cell size [136]. Large neurons with a 
moderate number of small, faintly stained lipofuscin granules 
predominated above almost evenly large neurons with dense 
accumulations of intensely stained lipofuscin granules. The 
third type showed a small soma size, small amounts of basophilic 
material, and a few faintly stained lipofuscin granules. The 
possible importance of morphologic studies [7, 136] describing 
different neuronal types and their ratios to each other, still 
have to be evaluated in neurodegenerative diseases such as 
Alzheimer's and Parkinson's disease associated with dementia. 
2.1.3 Chemoarchitecture of the primate and human NBMC 
With the use of antibodies to the specific cholinergic marker 
choline acetyltransferase (ChAT), it has been firmly established 
that most large neurons in the NBMC are cholinergic [44, 76, 114, 
115]. Many large neurons of the NBMC also show galanin-like 
immunoreactivity [23, 73, 138, 143]. The majority of the 
cholinergic neurons stain with antibodies for nerve growth 
factor receptor (NGF-r) in the NBMC in the monkey [61, 119] and 
human CNS [47, 63, 83]. Intermingled among the cholinergic 
magnocellular neurons of the NBMC, smaller neurons are present 
[45, 53, 139], most of which are not cholinergic [76, 143]. In 
the NBMC of primates it has been shown, that fibers and/or 
putative nerve terminals on cholinergic neurons, and/or small 
noncholinergic neurons may demonstrate immunoreactivity against: 
cholecystokinin octapeptide [20]; 
- enkephalin [20, 40, 41, 143]; 
- neuropeptide Y [125, 143]; 
- neurotensin [71, 131, 143]; 
oxytocin [20]; 
proopiomelanocortin peptides [20, 55]; 
- somatostatin [12, 20, 143]; 
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- substance Ρ [20, 41]; 
vasoactive intestinal polypeptide [20]. 
τ-Aininobutyric acid (GABA) containing neurons have been 
demonstrated in the rat [15] and cat basal forebrain [32], but 
not in the primate or human NBMC. 
No information is yet available on the coexistence of peptides 
with one another in small neurons of the basal forebrain, as has 
been demonstrated e.g. for somatostatin and neuropeptide Y in 
neurons of the hippocampus and cortex [22]. The function of 
small peptidergic neurons in the NBMC is unclear. The presence 
of peptidergic axonal "boutons" on cholinergic neurons suggests 
that small cells could act as local-circuit neurons to possibly 
regulate the cholinergic activity. The neuropeptidergic fibers 
in the NBMC could be part of fiber tracts passing through or 
terminating in the NBMC. These fiber tracts appear to be largely 
derived from the bed nucleus of the stria terminalis and the 
amygdala, two centres where many neuropeptide containing cell 
bodies have been demonstrated [89, 145]. 
In Alzheimer's disease significant reductions in ChAT enzyme 
activity in the NBMC correlate with cell counts and reduced cell 
size in the NBMC [19, 95, 97]. Moreover, a down regulation of 
cholinergic function of Ch4 has been suggested by galanin 
hyperinnervâtion of the remaining cholinergic neurons [24], 
whereas decreased galanin innervation has been proposed in Ch2 
[138]. A further decrease in cholinergic activity in Alzheimer's 
disease is suggested by selectively reduced gene expression for 
nerve growth factor receptors within cholinergic neurons of the 
NBMC [48], nerve growth factor being known to promote growth of 
NBMC cholinergic neurons and to prevent their atrophy and death 
[46]. The possible pathogenic role of the small peptidergic, 
noncholinergic neurons in the NBMC in Alzheimer's disease has 
been speculated on, but still needs clarification, and remains an 
important area for future research. 
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2.1.4 Connections of the nonhuman primate NBMC 
Visualization of cholinergic pathways in the brain became 
possible using histochemical staining methods for acetylcholines-
terase (AChE) [54, 58]. For instance, undercutting of the cat 
cerebral cortex resulted in loss of cortical AChE-positive fibers 
in the overlying cortex, suggesting the existence of cholinergic 
neurons extrinsic to the neocortex and probably within the basal 
forebrain [43, 67, 122]. However, the specificity of AChE as a 
marker of cholinergic neurons was seriously questioned by the 
demonstration that catecholaminergic neurons also stained 
intensely for this enzyme [17]. Direct visualization of 
cholinergic pathways in the brain by immunocytochemical staining 
methods for the acetylcholine synthetizing enzyme choline 
acetyltransferase (ChAT) was hindered by difficulties in 
obtaining a sufficiently purified preparation of ChAT in order to 
raise specific monoclonal antibodies. In most mammals ChAT 
represents only between one millionth and one hundred thousandth 
of the total brain protein content [107, 108]. Nevertheless, 
several research groups were able to generate monoclonal 
antibodies to ChAT [25, 29, 85, 141] and a wealth of information 
on cholinergic pathways in the brain has now become available in 
the mammalian brain. In this section the efferent and afferent 
pathways of the nonhuman primate NBMC will be reviewed, since 
they are believed to reflect most closely the putative pathways 
in the human brain. 
2.1.4.1 Efferent connections of the nonhuman primate NBMC 
In primates, magnocellular AChE-rich and ChAT-immunoreactive 
neurons are located in the NBMC [44, 76, 77, 114, lis]. Lesions 
of the NBMC in primates cause significant reductions in ChAT and 
AChE activities in the cortex [128]. Using retrograde and 
anterograde transport tracing techniques, anatomical studies in 
monkeys have shown that the large NBMC neurons project to 
amygdala [53, 59, 62], hippocampus [2, 53, 59, 76], thalamus [50, 
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93], caudate nucleus [8], brainstem [93], and in a crudely 
topographical fashion to the entire neocortex [28, 51, 56, 57, 
74, 76, 91, 94, 133, 134, 142, 144]. 
The subdivisions of the NBMC, the contiguous cell groups Chl-
Ch4, give rise to the following cholinergic projections: 
1. Chi provides a substantial projection to the hippocampus, 
especially the Ammon's horn, the dentate gyrus, the subicular 
complex and the entorhinal cortex [2, 51, 59, 76]. The fibers 
pass via the fimbria/fornix [57]. Contrary to rats [31], no 
cholinergic pathway has yet been demonstrated in nonhuman 
primates via the stria terminalis and the habenulointerpeduncular 
tract to the interpeduncular nucleus and ventral tegmental area. 
2. Ch2 is the major source of cholinergic innervation that the 
hippocampal formation (Ammon's horn, dentate gyrus, subicular 
complex, entorhinal cortex) receives from the NBMC [2, 51, 57, 
59, 76]. Fibers enter the hippocampus mainly via the ventral 
pathway, coursing through the entorhinal cortex and subiculum 
prior to entering the prosubiculum and the hippocampus proper 
[2, 57, 146]. Ch2 projects heavily to the lateral hypothalamus 
[76] and several cortical areas [53] as the cingulate cortex [57, 
59, 76], the subcallosal area, the parahippocampal gyrus [76] and 
the visual cortex [134, 144]. Moreover, Ch2 projects to the head 
of the caudate nucleus [8], to the reticular, mediodorsal, 
anteroventral/anteromedial and ventromedial (RE, MD, AV/AM, VM) 
thalamic nuclei [50, 93], and to the pedunculopontine region in 
the brainstem [93]. 
3. Ch3 is the major source of cholinergic innervation of the 
olfactory bulb [76]. Moreover, it has a substantial projection 
to the magnocellular basal nucleus of the amygdala [3] and minor 
projections to the head of the caudate nucleus [8], to the 
hippocampus [59], to the hypothalamus [76], to the reticular and 
mediodorsal thalamic nucleus [50, 93], and to the pedunculoponti-
ne region in the brainstem [93]. 
4. Ch4am, the anteromedial part of the nucleus basalis of 
Meynert, projects mainly to the medial surface of the hemisphe-
res, including the cingulate cortex [59, 76]. Lesser, but 
substantial projections were directed to the hypothalamus, 
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hippocampal formation, ventral part of somatosensory cortex, 
ventrolateral orbital, middle insular, peristriate, and parahip-
pocampal regions as well as the inferior parietal lobule [76]. A 
prominent projection to the amygdala (magnocellular part of the 
basal nucleus) has been demonstrated [3, 62, 76] as well as minor 
projections to RE, MD, AV/AM and VM thalamic nuclei [50, 93], the 
head of the caudate nucleus [8] and to the pedunculopontine 
region in the brainstem [93]. 
5. Ch4al, the anterolateral part of the nucleus basalis of 
Meynert, is the principal source of cholinergic projections to 
frontoparietal opercular regions and to the amygdala [3, 59, 62, 
76]. Additional substantial projections were directed to the 
olfactory bulb, medial frontal pole, dorsomedial motor cortex, 
ventrolateral orbital cortex, insula, inferotemporal area, and 
the parahippocampal gyrus [59, 76]. Small projections were 
directed to RE, MD, AV/AM and VM thalamic nuclei [50, 93], the 
head of the caudate nucleus [8] and to the pedunculopontine 
region in the brainstem [93]. 
6. Ch4i, the intermediate part of the nucleus basalis of Meynert, 
provides prominent cholinergic inputs to ventrolateral orbital, 
insular, dorsal prefrontal, peristriate, inferotemporal, 
parahippocampal areas as well as the the inferior parietal lobule 
[57, 76]. Substantial projections were directed to medial 
frontal pole, dorsomedial motor cortex, frontoparietal opercular 
areas, the amygdala, anterior auditory cortex, and the temporal 
pole [59, 62, 76]. 
7. Ch4p, the posterior part of the nucleus basalis of Meynert, 
demonstrates rather circumscript projection patterns to the 
auditory association areas in the superior temporal gyrus, to the 
temporal pole, and to the entorhinal cortex [76, 80, 82], 
entering the hippocampal formation via the ventral cholinergic 
pathway [146]. Substantial projections were directed to 
inferotemporal and posterior insular regions [76], and minor 
projections to the amygdala [59]. 
8. Projections to the contralateral hemisphere are very rare 
[57, 76, 77, 94, 142]. Only occasional AChE-positive, ChAT-
immunoreactive fibers or autoradiographically labeled axons were 
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demonstrable in the anterior commissure and corpus callosum [57]. 
The cholinergic efferent projections course through five 
major pathways to reach their neuronal targets within monkey 
amygdala, hippocampus and neocortex [57]: 
- medial pathway: axons directed rostrally pass through the Ch2 
and Chi region, bend around the rostrum and genu of the corpus 
callosum to enter the cingulate bundle, innervating cingulate 
cortex and medial parts of frontal and parietal cortices. 
lateral pathway: at Ch4a and Ch4i, many fibers assemble 
laterally beneath the globus pallidus and putamen, transverse 
the external and extreme capsules, spread out within the 
corona radiata and innervate parts of the insular and 
dorsolateral segments of the temporal, parietal and occipital 
cortices. The medial and lateral pathways have also been 
described in human brain [113]. 
ventral pathway: at Ch4a and Ch4i, axons project ventrally 
beneath the lateral parts of the anterior commissure to the 
temporal lobe to innervate the hippocampus and amygdala. 
rostral pathway: via the orbitofrontal fibers cholinergic 
axons appear in the fasciculus and tractus olfactorius to 
innervate rostral frontal and olfactory cortices. 
fimbria/fornix pathway: via this pathway NBMC neurons project 
to the hippocampal formation. The ventral pathway seems to be 
the major source of cholinergic input to the primate 
hippocampus [2, 57, 76], whereas in rodents the fimbria/fornix 
pathway seems to be the most important input pathway [112]. 
The topographical arrangement of Ch4 connectivity is complex 
and shows considerable overlap [53, 57, 59, 74, 76, 94, 142]. As 
compared to the thalamocortical connections, the boundaries of 
the subdivisions of the NBMC are not as sharply delineated as in 
the thalamic nuclei, nor does the organization of projection of 
the Ch4 follow a functional delineation as is the case in 
thalamocortical projections, where a segregation exists of 
sensory, motor, association, and limbic connections [88]. The 
intermingling of NBMC neurons projecting to different cortical 
areas suggests collateralization. However, no double labeling of 
cholinergic neurons in the NBMC was observed after tracer 
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injections in different cortical areas [76, 142]. Nevertheless, 
double labeled neurons have been demonstrated in the monkey Ch4a, 
projecting to both the thalamus and pedunculopontine region [93], 
or projecting to both orbitofrontal cortex and thalamus [50]. In 
rat, it has been demonstrated that individual NBMC neurons 
project to very restricted areas of 1-2 mm within the cortex [13, 
64, 103, 112] and that these neurons show small clusters of short 
axon collaterals originating near the perikaryon [64]. This 
local type of coordination could also be carried out by basal 
forebrain interneurons [23, 24, 143]. 
In primates, regional variations in cortical cholinergic 
innervation are apparent, with the hippocampus, amygdala and 
piriform regions showing the highest levels of cortical AChE-
fibers. The paralimbic regions such as the insula, caudal 
orbitofrontal cortex, the temporal pole, and the parahippocampal 
gyrus receive heavier cholinergic innervation than the adjacent 
association cortical areas [65, 78, 81]. The same AChE-distribu-
tions have been demonstrated in the human except for the 
paralimbic region of the cingulate cortex, that contained high 
levels of cholinergic markers in the human but not in the monkey 
[82]. Laminar variations of cortical cholinergic innervation 
exists among different regions within and across species, but no 
conclusive remarks can yet be made on this issue [for review: 
49]. For instance, in the rat cerebral cortex 13 different 
laminar patterns of ChAT-staining can be found [70]. 
In human controls, the ChAT-activity is highest at the level 
of layers II and IV of the temporal and frontal cortex, whereas 
in Alzheimer's disease the topographical laminar distribution of 
ChAT-activity seems completely lost [96, 126]. No data of 
laminar distribution of ChAT-activity in the parietal and 
occipital human cortex are available. 
2.1.4.2 Afferent connections of the nonhuman primate NBMC 
The subdivisions of the NBMC, the contiguous cell groups Chl-
Ch4, receive the following neuronal inputs: 
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1. In rat, the Chi and Ch2 subdivisions, i.e., the medial septal 
complex comprised of the medial septal nucleus and the vertical 
limb nucleus of the diagonal band of Broca, receive a massive 
projection from the lateral septal nucleus [129] and a further 
wide variety of afférents, including the anterior hippocampus, 
the hypothalamus, ventral tegmental area, the median raphe, the 
locus coeruleus, and the dorsal tegmental nucleus [121]. In 
primates and man, studies of the septal nuclei have been scarce 
and almost exclusively limited to cytoarchitectonic analyses. In 
the macaque, hippocampal efferente terminate densely in the 
medial (Chi), lateral and dorsal septum, and in the Ch2 region 
[1]; moreover, innervating amygdalofugal fibers have been 
demonstrated [1, 110]. In man, the Chi and Ch2 region show 
noradrenergic terminals on cholinergic neurons [35]. 
2. Ch3, the horizontal limb nucleus of the diagonal band of 
Broca, receives neuronal input from the central nucleus of the 
amygdala [38, 102, 110]. Whether the Ch3 region receives 
substantial input from other structures than the amygdala, is not 
clear: most studies concerning afferent connections of the 
cholinergic basal forebrain system are either restricted to the 
Ch4 region proper or do not differentiate between the Ch4 region 
and the underlying Ch3 cell group. 
3. In primates, the Ch4 region receives neuronal input from a 
variety of cortical and subcortical sources [52, 53, 66, 79, 90, 
102, 110, 111]. The cortical input arises from the orbitofrontal 
cortex, entorhinal area and perirhinal cortex, the temporopolar 
and temporosuperior cortex, the prepiriform cortex, and the 
anterior insula. The subcortical afférents of the Ch4 region 
originate from the lateral and medial septum complex (Chi and 
Ch2), nucleus accumbens and ventral pallidum, the medial 
hypothalamus, the thalamus (especially the central and midline 
thalamic nuclei), the amygdala (particularly the basal nuclei), 
the peripeduncular nucleus, the pars compacta of the substantia 
nigra, the mesencephalic raphe nuclei, the parabrachial nuclei, 
and the locus coeruleus. 
4. concerning the subdivisions of the Ch4 region (Ch4am, Ch4al, 
Ch4i and Ch4p) the cortical neuronal input patterns to Ch4al and 
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Ch4i are broadly similar. From the prefrontal and orbitofrontal 
areas Ch4al and Ch4i receive the highest neuronal input, Ch4am 
receives less, and Ch4p lacks frontal afférents. From the 
entorhinal and perirhinal cortex Ch4al and Ch4i receive dense 
innervation, but the Ch4am and Ch4p lack neuronal input. From 
temporopolar and superior temporal areas Ch4p receives the 
highest input, Ch4i less, Ch4al the least, and Ch4am nothing at 
all. The prepiriform cortex innervates all Ch4 subdivisions 
except the Ch4p region. The anterior insula innervates all Ch4 
subdivisions except the Ch4am region [52, 79]. The subcortical 
neuronal input to the Ch4 subdivisions is almost similar, except 
for the medial septal complex (Chi and Ch2) that does not 
innervate the Ch4p region [52, 79]. 
2.1.5 Functional considerations of the NBMC 
From the efferents and the afférents of Chi and Ch2, it 
appears that the septal nuclei (medial and lateral septal 
nucleus, vertical limb nucleus of the diagonal band of Broca) 
form part of a number of neuronal loops which also include the 
hippocampal formation, the hypothalamus and some monoaminergic 
brain stem nuclei as nodal points [52, 79]. The amygdala, which 
projects heavily on the Ch4 region, receives itself substantial 
neuronal input from the Ch4 region [1]. Although the hippocampus 
sends only very few direct projections to Ch4, it may neverthe-
less exert considerable indirect effects upon this area, either 
via the amygdala [100] or via the lateral septum, both of which 
project heavily throughout the Ch4 [79]. Although the Ch4 
complex projects to all parts of the neocortical mantle, the 
great majority of the Ch4 connections with the neocortex is not 
reciprocal [52, 79]. The cortical projections into Ch4 arise 
from orbitofrontal, temporal, prepiriform, anterior insular and 
entorhinal areas. Additional subcortical projections originate 
in the amygdala, medial hypothalamus, the septal nuclei and the 
nucleus accumbens - ventral pallidum complex. The one common 
characteristic of these neuronal inputs into Ch4 is that they 
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originate in limbic and paralimbic structures. This connectivity 
pattern implicates, that the few cortical areas with reciprocal 
connections to Ch4 can potentially influence not only the level 
of cholinergic signals they receive but also the cholinergic 
innervation of other parts of the neocortex. 
The responsity of Ch4 neurons to the sight and taste of food 
[26, 106] implies that they must be receiving complex sensory 
information in several modalities. Several potential routes can 
be indicated for this sensory input. Olfactory information can 
reach Ch4 neurons from the primary olfactory cortex in the 
prepiriform region. Gustatory and visceral information might be 
relayed through projection from the anterior insula into Ch4 
[75]. Auditory input could reach Ch4 from the anterior portions 
of the superior temporal region, and visual information via the 
medial inferotemporal region. Additional sensory information 
could be relayed by the amygdala. All the structures that 
project to the Ch4 region are integrative regions of extensive 
sensory preprocessing or regions of polysensory convergence [79, 
110]. The hodologic organization of the Ch4 complex suggests 
that it is in a position to act as a cholinergic relay for 
transmitting predominantly limbic and paralimbic information to 
the neocortex in a fashion that may influence complex behaviour 
(integrated motor or emotional responses, learning and memory) 
according to the prevailing emotional and motivational states 
encoded by the limbic and paralimbic regions of the brain. 
The supposed correlation of the Ch4 complex with higher 
mental functions is supported by its phylogenesis. From 
comparative anatomy it is known that the Chl-Ch4 complex becomes 
progressively larger and more complex with increasing cerebrali-
zation, reaching maximum volume and differentiation in species 
with the greatest neocortical development such as primates and 
man [37, 120]. Additionally, pharmacological studies and animal 
lesion studies of the Ch4 complex support the role of the Ch4 
region in higher cognitive function and have led to the formula-
tion of "the cholinergic hypothesis of dementia". Moreover, 
neuropathological studies demonstrate the involvement of the Ch4 
complex in dementing diseases such as Alzheimer's disease. 
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2.2 Neuroanatomy of the human supraoptic nucleus 
In man the supraoptic nucleus (SON) is made up of three 
parts: a dorsolateral, a dorsomedial and a ventromedial part [16, 
30]. The dorsolateral part is the largest of the three, and it 
is situated most rostrally. Throughout its entire length [5-10 
mm, 104, 140] the SON is closely associated with the posterior 
portions of the optic chiasm and adjacent portions of the optic 
tract (Figs. 2.2b-e). The SON consists of densely packed 
multipolar neurons that are evenly dispersed within the limits of 
the nuclear gray. The SON is extremely vascular. The large SON 
neurons possess a light, large and eccentric positioned nucleus 
containing a conspicuous nucleolus. Flocks of Nissl material are 
often located in one or more foci at the periphery of the 
perikaryon. Vacuoles of varying size often are present in 
peripheral portions of the cell body. 
The SON projects exclusively along the supraoptico-hypophyseal 
tract to the posterior pituitary [130], where its neurohormones 
vasopressin and oxytocin are released into the blood vessels of 
the neurohypophysis [11]. 
The afférents to the SON originate from: 
bed nucleus of the stria terminalis [130]; 
some catecholaminergic centres in the brain stem (including 
the noradrenergic locus coeruleus, Al and Ά2 cell groups, and 
the adrenergic CI and C2 cell groups [117, 118]); 
the hypothalamic dorsomedial nucleus and median preoptic 
nucleus [116] ; 
the preoptic region, including the Organum vasculosum of the 
lamina terminalis and the subfornical organ [69, 123]. 
In summary, it appears that a rather smalm number of cell 
groups in the limbic regions of the telencephalon, the brain stem 
and the hypothalamus provide most of the neural inputs to the 
SON. The evidence that humoral factors, except in the case for 
gonadal steroids, directly influence cells in the SON is not so 
strong [130]. 
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2.3 Neuroanatomy of the human paraventricular nucleus 
In man the paraventricular nucleus (PVN) lies closely to the 
inner surface of the third ventricle as an elongated plate of 
cells. The rostrocaudal axis of this nucleus is orientated 
infero-superiorly, extending from the wall of the recessus 
opticus to the latitude of the interventricular foramen of Monro 
[16, 30, 87]. Its lateral border is relatively ill-defined. 
While the SON is made up of uniformly large neurons, the PVN is a 
composite nucleus composed of cells of diverse size and shape 
[14]. Cytologically, the Nissl-substance is distributed 
peripherally in a compact manner. In the cytoplasm vacuoles of 
varying diameter can be present, giving the neurons an irregular, 
bulging appearance. The relatively dark nucleus is rather 
difficult to distinguish, but a large round nucleolus is 
prominently present in the centre. 
In addition to the magnocellular neurosecretory neurons 
(projecting along the paraventriculo-hypophyseal tract to the 
posterior pituitary [130], where the neurohormones vasopressin 
and oxytocin are released into the blood vessels of the neurohy-
pophysis [11]), the PVN contains numerous smaller peptidergic 
elements, that can be subdivided into: 
a parvocellular neurosecretory system, the fibers of which 
pass to the external lamina of the median eminence, where 
their terminals contact the hypophyseal portal capillaries 
[5]. This subpopulation comprises vasopressinergic neurons 
and elements containing corticotrophin releasing factor [69]; 
and a parvocellular descending projecting system, consisting 
of thin unmyelinated, mainly oxitocinergic fibers, which 
innervate a number of autonomic centres in the brain stem and 
the spinal cord [130]. 
The afférents to the PVN closely correspond to those to the 
SON, however, the PVN has additional sources of local hypothala-
mic input from the suprachiasmatic nucleus, the anterior 
hypothalamic area, from parts of the lateral hypothalamic area, 
and from the anterior and ventromedial hypothalamic nuclei [88, 
130]. 
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In summary, the primary functions of the SON and PVN are 
probably best viewed in relation to the magnocellular neurosecre-
tory projections to the posterior lobe of the pituitary: 
vasopressin is responsible for antidiuresis, promoting reabsorp-
tion of water by the kidney, and oxytocin stimulates uterus 
smooth muscle and mammary glands to contract. In addition, 
however, the PVN has a second component, which is part of the 
parvocellular neurosecretory system, that regulates the output of 
the anterior pituitary, and a third component that modulates 
autonomic reflexes, which are mediated by circuitry in the brain 
stem and spinal cord. 
2.4 Neuroanatomy of the human Organum vasculosum of the lamina 
tenninalis 
The Organum vasculosum of the lamina terminalis (OVLT) is an 
unpaired structure situated immediately dorsal to the optic 
chiasm (Fig. 2.2a). Like the other circumventricular organs as 
the subfornical organ, the median eminence of the hypothalamus, 
the neurohypophysis, the pineal body and the area postrema, the 
OVLT is higly vascularized and lacks a blood-brain barrier [21, 
88]. Capillary fenestrations provide specific sites for the 
transfer of proteins and solutes, irrespective of molecular size 
and lipid solubility. The neurons in the OVLT are therefore 
influenced by neuronal afférents, and by substances of the 
cerebrospinal fluid and plasma-derived substances as well. The 
OVLT has a role in the control of gonadotrophin secretion [99] 
and of water-electrolyte balance and blood-pressure regulation 
[124]. In rats the OVLT receives substantial afférents from the 
subfornical organ, several hypothalamic nuclei and the locus 
coeruleus [18, 69]; the OVLT has projections to the dorsomedial, 
supraoptic and paraventricular hypothalamic nuclei [69, 123]. 
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CHAPTER 3 
MATERIAL AND METHODS 
3.1 Brain material 
3.1.1 Cases 
Twelve cases of Alzheimer's disease (AD) were selected, one 
case of Parkinson's disease (PD), and ten nondemented controls. 
The twelve AD cases could be subdivided in five early-onset AD 
cases (first symptoms of the disease manifestated before 65 years 
of age) and seven late-onset AD cases. 
The clinical diagnosis of probable Alzheimer's disease was 
confirmed neuropathologically using Khachaturian's criteria [11], 
that include minimum numbers of senile plaques and neurofibrilla-
ry tangles per age category in hippocampal and cortical brain 
areas. The clinical diagnosis of Parkinson's disease was 
neuropathologically confirmed by the characteristic lesions in 
the substantia nigra consisting of cell loss, degenerative cell 
changes, gliosis and the presence of Lewy inclusion bodies [12]. 
The control patients showed clinically and neuropathologically no 
evidence of neurological or psychiatric disease. Data on the 
available brain material are summarized in Table 3.1. 
3.1.2 Brain regions of interest 
The whole nucleus basalis Meynert complex (NBMC) and its 
surrounding structures were removed in toto from both hemispheres 
using the polus temporalis and the corpus geniculatum laterale as 
borders for the rostral and caudal cutting plane, respectively. 
These cutting planes were orientated perpendicularly to the 
hippocampal axis and to the imaginary plane throughout the 
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TABLE 3 . 1 
C h a r a c t e r i s t i c s o f b r a i n m a t e r i a l 
dia- brain fix. p.m. cause of duration 
case gnosis sex age weight NBMC SON PVN OVLT time delay death dementia 
(y) (g) (m) [ìiì (y) 
22 
23 
С 
С 
С 
С 
С 
С 
с 
с 
с 
с 
AD 
AD 
AD 
AD 
AD 
AD 
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AD 
AD 
AD 
PD 
Г 
N 
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H 
F 
M 
F 
H 
N 
N 
F 
H 
F 
M 
F 
F 
F 
И 
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H 
F 
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60 
62 
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70 
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75 
80 
86 
91 
65 
66 
69 
69 
76 
76 
76 
77 
82 
90 
90 
93 
74 
1162 
1351 
1570 
1200 
1185 
1346 
1250 
1475 
1290 
1288 
865 
1136 
1105 
1077 
970 
1275 
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985 
1353 
1100 
1160 
842 
1370 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
- R 
L+R 
- R 
-R 
L+R 
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- R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
- R 
L+R 
L+R 
L+R 
L+R 
- R 
-R 
L+R 
- R 
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- R 
L+R 
L+R 
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-R 
L-
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L+R 
--
L+R 
L+R 
- R 
L+R 
L+R 
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+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
5.5 
<1 
<1 
<1 
12 
<1 
14 
<24 
36 
50 
40 
<24 
36 
48 
36 
36 
<12 
<24 
<12 
<12 
6 
4 
5 
2.5 
<14 
<12 
<12 
<12 
8 
sepsis 
aorta rupture 
pneumonia 
trauma 
sepsis 
cardiac arrest 
carcinoma 
cardiac arrest 
cachexia 
carcinoma 
sepsis 
sepsis 
sepsis 
cachexia 
cachexia 
status epilepticus 
renal failure 
pleumonia 
cardiac failure 
pneumonia 
sepsis 
pleumonia 
cardiac arrest 
12 
14 
11 
16 
Neuropathological diagnosis, sex, age, brain weight, fixation time, postmortem 
delay, cause of death, and duration of dementia. AD, Alzheimer's disease; c, 
control ; F, female; L, left hemisphere; M, male; PD, Parkinson's disease; R, 
r ight hemisphere; h, hours; m, months; y, years; g, grams; ?, unknown; - , not 
available or incomplete; +, present; cases 11-15, early onset AD; cases 16-22, 
la te onset AD. 
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rostrocaudal extent of both tractus optici, which resulted in an 
approximate 20-25 degrees difference with respect to the coronal 
plane. 
The following subdivisions of the NBMC were investigated: 
Chi and Ch2 were considered as one subdivision, because their 
adjacent boundaries are not readily identifiable and because 
both regions project to the hippocampus [14]; 
- Ch3 as recently delineated [15]; 
Ch4 as a whole (nucleus basalis of Meynert); 
the three Ch4 subdivisions: Ch4 anterior (Ch4a), Ch4 interme-
diate (Ch4i), and Ch4 posterior (Ch4p). 
both Ch4a subdivisions: Ch4 anteromedial (Ch4am) and Ch4 
anterolateral (Ch4al). 
Moreover, to verify if the NBMC is selectively affected in 
AD, two more nuclei in the immediate vicinity of the NBMC were 
investigated: the entire supraoptic nucleus (SON) and the whole 
paraventricular nucleus (PVN). 
In addition, the orgamum vasculosum of the lamina terminalis 
was studied because this region is devoid of a blood-brain 
barrier, and could therefore serve as a "natural model" to 
verify whether amyloid deposits in AD are of systemic origin or 
whether amyloid is produced in the brain itself. 
3.1.3 Histological procedure 
All 23 brains were fixed in toto in 4% formaldehyde for at 
least 5 months except for six brains that were processed earlier 
(Table 3.1). A fixation time of 5 months has been recommended, 
because after this time, variation in tissue swelling and 
shrinkage due to fixation has ceased and a stable volume has been 
obtained [8, 9, 18]. Different tissue processing may result in 
different tissue shrinkage and different volumes of brain 
structures. Moreover, the pathological process itself can also 
affect volume. As a consequence, for determination of total 
neuron numbers only those brain structures of interest (NBMC, SON 
and PVN) that were present in toto in the available brain 
59 
material, were processed. It needs to be stressed that the 
parameter of total neuron number (instead of neuron number per 
unit volume) is not susceptible to any volume shrinkage (or 
expansion) of the NBMC, SON and PVN. Although a fixation time 
less than 5 months may bias neuron size (less shrinkage), no 
corrections have been made, while it is not known whether, and to 
what extent neuron size is really affected. 
Postmortem delays varied from 2.5 to 50 hours. The postmortem 
interval between death and fixation or freezing of brain tissue 
is not only important for neurochemistry (compound levels quickly 
drop in a few hours and some even in a few seconds), but may also 
affect morphological parameters. For instance, autolysis is a 
common artefact from delayed fixation in Nissl-stained sections, 
and leads to the more confusing microscopic sponginess as a 
result of cellular désintégration. All brains listed in Table 
3.1 showed no autolysis in Nissl and Klüver-Barrera-staining and 
were suitable for examination. Only one brain (not listed) 
showed severe autolysis after a postmortem delay of 72 hours. 
After embedding in paraffin serial sections with a thickness 
of 10 or 20 цт were cut using a Jung 2050 microtome. Sections 
were stained at regular intervals throughout the entire rostro-
caudal extent of the NBMC, SON and PVN. The Klüver-Barrera-
stained sections were used for identification of the NBMC and its 
subdivisions Chl-Ch4, and the adjacent Nissl-stain was used for 
counting and measuring purposes. If the brain structures of 
interest (NBMC, SON, PVN) were not entirely present in the 
available brain material, they were not included in the analysis 
(see Table 3.1), because availability of the whole structure is 
an absolute requirement to a sound determination of total neuron 
numbers. 
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3.2 Quantitative methods 
3.2.1 The nucleolus as sampling item 
Nucleoli are regarded as the traditional markers of neurons 
[22]. Unbiased quantification of neuron numbers using the 
nucleolus as sampling item can be ascertained under the following 
assumptions: 
1. The neurons of interest contain only one nucleolus; 
2. The nucleolus has a spherical shape and therefore the 
orientation in space is random and independent of the plane 
of sectioning; 
3. The nucleolus is not being transected by the microtome knife 
and, consequently, does not appear in more than one section. 
In the NBMC no neurons were found with more than one nucleo-
lus; however, in the PVN and SON very rarely binucleolated 
neurons could be demonstrated (+1 per 1000 neurons. Fig. 3.1). 
This number of binucleolated neurons is so small, that the 
generated bias due to this phenomenon is negligible. 
To verify whether nucleoli are spherically shaped, 200 
J 
Él 
<*! 
к 
4ff, 
rig. 3.1 A binucleated and binucleolated neuron in the paraventricular 
nucleus (xlOOO magnification). 
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nucleoli of NBMC neurons were morphometrically analyzed using a 
semi-automatic image analysis system (Mopp Videoplan, Kontron): 
the maximum diameter of the nucleoli was measured at a xlOOO 
magnification (3.72+0.07 |im; mean + standard error of the mean, 
n=200) and compared to the mean circular diameter (i.e., the 
diameter belonging to a virtual circle with an area of the same 
size as the outlined, actual area occupied by the nucleolus) of 
the same nucleoli: 3.69+0.06 цт. The close similarity between 
the maximum diameter and the circular diameter demonstrates a 
spherical shape for the nucleolus. 
It has recently been shown, that the nucleolus is not 
transected but pushed aside by the microtome knife and' remains 
uncut in paraffin sections with a thickness >10 μιη [20]. 
Moreover, when the nucleolus is the particle to be sampled, 
numerical data do not differ between the conventional counting 
method (sampling all visible nucleoli throughout the entire 
thickness of the section) and the unbiased optical disector 
method [23, 24] provided that paraffin sections >10 цт are used 
(Chapter 4 of this thesis). 
In conclusion, the nucleolus can be used as the sample item 
without introducing major biases, even when the conventional 
counting method is applied [20]. 
All nucleolus counts in the NBMC, SON and PVN were performed 
at a x400 magnification using an ocular grid with a quadrant 
sampling field of 250x250 цт 2, subdivided into 100 squares of 
25x25 цт2 each. The nucleoli hitting the boundaries of the 
sampling grid were dealt with according to the exclusion 
principle of Gundersen [5] (Fig. 3.2). 
Neuron size was defined as the maximum diameter (а
т в ж
). 
Focussing at the level of the nucleolus, the âmax of each 
nucleolated neuron within the sampling field was measured. Four 
size categories (0-12.5; 12.5-25.0; 25.0-37.5 and >37.5 \im) were 
deliberately chosen: firstly, the sampling grid with squares of 
25x25 цт2 could serve as a quick measuring scale, and secondly, 
mapping studies demonstrated the NBMC-neurons with a d
m M >25 цт 
to be the putative cholinergic neurons [13, 14] and therefore 
cholinergic and noncholinergic neurons of the NBMC could be 
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t 
Fig. 3.2 The ocular sampling field with the exclusion principle of 
Gundersen [5]: all nucleoli (no. 1) that hit the forbidden 
(solid) line are not counted; the nucleoli entirely inside the 
sampling frame as well as those hitting the dotted line are 
counted (nos. 2, 3 and 4). The side length of the frame 
corresponds to 250 цт at a x400 magnification or to 100 \m at 
xlOOO magnification. 
roughly d i f f e r e n t i a t e d . However, the use of the äm=L3i as a 
measure for neuron s i ze with the nucleolus being in focus, i s 
biased in two ways. F i r s t l y , the а
тшх
 depends on t h e o r i e n t a t i o n 
of the neuron in space and t h e r e f o r e on the angle of the sect ion 
plane. Secondly, the p o s s i b i l i t y of nucleolus displacement from 
the cent re of the soma i s far from t h e o r e t i c a l [ 1 ] , because both 
the accumulation of l ipofuscin in-normal aging and the presence 
of n e u r o f i b r i l l a r y tangle formations in AD do in fact d i splace 
the nucleus and nucleolus towards an e c c e n t r i c p o s i t i o n . 
However, in order t o maintain the p o s s i b i l i t y of comparison with 
data from t h e l i t e r a t u r e , t h i s b i a s has not been c o r r e c t e d for. 
63 
3.2.2 The sampling design 
Taking the nucleolus as the particle to be sampled, the 
question arises in which way and how many nucleoli have to be 
sampled to accomplish reliable estimations on total nucleolus 
numbers in the structures of interest and to minimize the 
observed variance (variance is defined as s 2; s=standard 
deviation). It should be emphasized that the observed variance 
(0s?) in any biological system depends on several variables each 
contributing to the observed total variance between the subjects. 
This is particularly true for a multiple stage sampling, 
consisting of several hierarchical sampling levels, each wi.th its 
own variance. The sampling strategy of this study consists of 
three hierarchical levels: 
1. population sample (i.e., the subjects used in one population); 
2. tissue sample (i.e., the sections used in one structure); 
3. field sample (i.e., the fields used in one section); 
The observed total variance between subjects (0з2
яи1эі) may be 
regarded as the sum of the true biological variance (5 2
я и Ь Ь
) 
plus the observed variance of the mean of the number η sections 
at the second lower level (Os2
se<=
t / n
sec
.t) ; similarly, the 
observed variance of the sections (Os 2
s e < = t) may be regarded as 
the sum of the true variance of the sections (s2
sect..) plus the 
variance of the mean of the number m sampling fields at the 
third lowest level (s2* / m,). This will result in the following 
formula: 
1 1 
O S ^ a ^ b j = S 2 e u ö J + * S ^ e c z t + * S z t 
n e e c t Пае.-,-. * m* 
Os^ciucj being the observed total variance of the subjects; 
s
2
s
^,j is the true (biological) variance of the subjects; 
s
2
ee<=
t is the true variance of the sections; 
s
2
,- is the true variance of the sampling fields; 
Heect is the number of η sections; 
m,- is the number of m fields. 
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From this formula it can be deduced, that major reductions in 
the observed total variance can be most efficiently accomplished 
by increasing the number of subjects and sections but not by 
increasing the number of fields per section. For instance, it is 
appropiate to investigate more subjects (10 instead of 5 
subjects) and less sections per subject (5 instead of 10 
sections) than vice versa; it is also worthwhile to study more 
sections and less fields per section than vice versa. Alternati-
vely speaking, by "doing more less well" it is possible to 
optimize the sampling design and to reduce the observed total 
variance [6], whereas the workload remains the same (for example, 
10 fields in each of the 5 sections per subject instead of 50 
fields in only one section per subject). 
In order to obtain a representative sample of the structure 
of interest and to prevent any bias, the sampling of sections and 
fields within sections should be basically randomized. This 
procedure, that postulates that the samples should be taken 
independently from each other, is called "simple random sampling" 
[22]. However, independent samples are proned to cluster in 
certain regions, whereas other regions are undersampled (Fig. 
3.3a: so-called O-dimensional-sampling design). This disadvanta-
ge of simple random sampling can be overcome by spacing 
the samples in a more or less regular fashion in order to get a 
more representative sample of the entire structure. This 
systematic approach with a random start is called the "systematic 
random sampling" method, that is both theoretically [3] and 
experimentally [4] proven to be superior to simple random 
sampling. These studies have shown that the standard error of of 
the number of nucleoli within one section is nearly ten times as 
large when the microscope fields are obtained by simple random 
(Fig. 3.3a) rather than systematic sampling (Fig. 3.3b). A 
further decrease in the standard error can be effectuated by 
investigating equidistant systematic sections (Fig. 3.4a). The 
most representative sample of the entire structure can be 
obtained when all samples are positioned systematically along 
three perpendicular directions (Fig. 3.4b). In such a sampling 
system all the samples are dependent on each other: the first 
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Fig. 3.3а O-dimensional simple random sampling design 
b 1-dimensional systematic random sampling design 
black squares represent sample fields; numbers indicate sections 
sample, that is randomly choosen somewhere in the structure, 
automatically defines the positions of all other samples 
throughout the eptire specimen. The whole structure of interest 
is now evenly appreciated and bias to clustering of sample fields 
is fully absent. However, if the structure itself contains a 
certain periodicity which coincides with that of the sampling 
fields, variance may be dramatically increased. The three 
structures of interest in this study (NBMC, SON and PVN) do not 
have such periodicities, like, for instance, a layered structure 
as the neocortex, or the parallel bundling of elongated elements 
like myofibrils in skeletal muscle and nerve fibers in nerve 
tracts. Therefore, periodicity bias is unlikely to occur. 
Considering all the sampling pitfalls mentioned above, 
efficient and reliable sampling schemes for the NBMC, SON and PVN 
could be designed. Equidistant sections were sampled at 
intervals of 800 μπι, with a random start of the first section 
somewhere between 0 and 800 μπι. For the rostrocaudal extent of 
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Fig. 3.4a 2-dimensional systematic random sampling design 
b 3-dimensional systematic random sampling design 
black squares represent sample fields; numbers indicate sections 
both the entire SON and PVN, this resulted in an amount of 9.5 
sections, and for the NBMC as a whole in approximately 25 
sections. This is an amply sufficient large amount of sections 
to accomplish reliable results with a low variance [7]. The 
latter study proved experimentally and theoretically, that each 
systematic randomly performed count in any structure will have an 
estimated coefficient of error (CE) below 5% provided that at 
least eight equidistant sections are used (the CE is a measure of 
the reliability of the count; a CE of 0.05 or 5% corresponds to a 
95% reliability of the count; this means that the true number is 
somewhere in between the counted number +5% and -5%). Conside-
ring the magnitude of variation among subjects in most stereolo-
gical studies a CE of 10% or better is nearly always sufficient. 
Gundersen and Jensen [7] developed formulae to predict the 
validity of 2-äimensional (Fig. 3.4a) and 3-dimensional (Fig. 
3.4b) systematic sampling designs. Using these formulae, it 
became possible to optimize the sampling scheme of the NBMC, SON 
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and PVN, and to co-relate the CE with the minimum number of 
nucleoli, that had to be sampled. For both the SON and PVN this 
resulted in a 2-dimensional-sampling scheme, in which 4 sampling 
fields per mm' were taken systematically; at a x400 magnification 
the area of 1 sampling field corresponds to 250x250 цт^. Using 
this design, it could be shown for both the SON and PVN, that an 
amount of >200 sampled nucleoli always resulted in a CE of less 
than 10%, or alternatively speaking in a reliability of >90% 
(Figs. 3.5a and b). 
The NBMC as a whole has sufficient sections for a 2-dimensio­
nal-sampling scheme, even when only l sampling field per тт^ is 
taken. However, its subdivisions Ch3, Ch4i and sometimes also 
Ch4a and Ch4p span less than 8 sections, resulting in an increase 
of the CE (Fig. 3.6a). Therefore, the 3-dimensional- sampling 
system was applied on the subdivisions of the NBMC as 
well as on the NBMC as a whole, in order to reduce the CE. Using 
this 3-dimensional-sampling system and taking only 1 sampling 
field per mm2, an amount of >200 systematically sampled nucleoli 
always resulted in a CE less than 5%, or a reliability of >95%. 
Already 50 nucleoli ensure a reliability of >90% (Fig. 3.6b). 
Because the whole procedure of sampling is in fact nothing 
else than fractionating the total structure of interest, total 
nucleolus number can be easily calculated. At first, 20 цт 
sections are investigated at regular distances of 800 цт, the 
section fraction being l/40th (only 1 out of every 40 sections is 
sampled). Secondly, taking only 1 sampling field of 250x250 цтг 
per mm2 throughout the entire structure area of the section, 
only l/16th of the area is sampled, the area fraction being 
l/16th. Therefore, the total sampling fraction of the entire 
structure is 1/40*1/16=1/640. Total nucleolus number is obtained 
by multiplying the sampled nucleolus number (e.g. , 1800 for a 
NBMC) with the inverse of the sampling fraction (640) resulting 
in a total number of 1.800 χ 640 = 1.152.000 nucleoli. 
For the SON and PVN the section fraction is the same (1/40), 
but the area fraction is smaller (1/4). The sampled nucleolus 
number (e.g. 350 for a SON) must now be multiplied with 160 (40 * 
4) to a total number of 350 χ 160 = 56.000 nucleoli. 
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3 .3 Q u a l i t a t i v e methods 
The q u a l i t a t i v e methods concern c l a s s i c a l s t a i n i n g methods 
and i i ranunohistochemical s t a i n i n g methods . 
As r e g a r d s t h e s t a i n i n g methods Congored [16 , 17] and 
t h i o f l a v i n e - S [19] were chosen t o d e s c r i b e t h e neu ropa tho logy in 
normal a g i n g and AD ( g r a n u l o v a c u o l a r d e g e n e r a t i o n , s e n i l e 
p l a q u e s , n e u r o f i b r i l l a r y t a n g l e s and c o n g o p h i l i c ang iopa thy ) as 
observed i n t h e NBMC, t h e SON and PVN and t h e OVLT. For d e t a i l s 
about t h e s e methods s e e Chapter 7 of t h i s t h e s i s . 
Concerning t h e i iranunohistochemical s t a i n i n g methods t h e 
a n t i b o d i e s t o g a l a n i n were used and v i s u a l i z e d wi th t h e a v i d i n -
b i o t i n - p e r o x i d a s e complex method [ 1 0 ] . The a n t i b o d y g a l a n i n was 
chosen b e c a u s e of i t s c o - l o c a l i z a t i o n w i t h c h o l i n e a c e t y l t r a n s f e -
r a s e i n t h e c h o l i n e r g i c neurons of t h e b a s a l f o r e b r a i n in monkey 
[21] and human [ 2 ] . Ga lan in could t h e r e f o r e s e r v e as a marker 
for c h o l i n e r g i c n e u r o n s . For d e t a i l s about t h e g a l a n i n immuno-
h i s t o c h e m i s t r y s e e Chapter 8 of t h i s t h e s i s . 
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CHAPTER 4 
THE NUCLEOLUS IN QUANTITATIVE MORPHOLOGY 
O.J.M. Vogels, H.J. ter Laak and C.A.J. Broere 
(submitted for publication) 
4.1 Abstract 
This study compares numerical data obtained from biased 
conventional counting methods with unbiased numerical data 
obtained from the disector. Three lines of evidence (conventio­
nal counting, physical disector and optical disector) indicate 
that the nucleolus is not transected but pushed aside by the 
microtome knife and remains uncut in paraffin sections with a 
thickness >10 цт. As a consequence, when the nucleolus is the 
particle to be quantified, numerical data do not differ between 
biased conventional counting methods and the unbiased disector. 
This study shows, that the conventional counting methods in the 
past have not led to seriously false results with regard to 
numerical data, provided that the nucleolus was quantified in 
paraffin sections with a thickness of at least 10 цт. 
4.2 Introduction 
Estimates of total numbers of particles (e.g. nucleoli, 
nuclei and nerve cell somata) in various regions of the human 
brain have been carried out for many decades using a variety of 
indirect and biased methods. Recently developed stereological 
tools as the physical disector [17], the optical disector [7, 12, 
19, 20], the selector [4], and the fractionator [7] have enabled 
morphologists to quantify total numbers of particles in an 
unbiased way without assumptions upon shape, size, and orientati-
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on of the investigated particles and without assumptions upon 
overprojection and capping. Because this chapter deals with the 
physical and optical disector and not with the selector and 
fractionator, readers interested on the latter subjects are 
referred to three review articles by Gundersen et al. [7, 9, 10]. 
The most frequently used conventional method for counting 
particles was developed by Abercrombie [1]: in a defined area of 
one single section with a certain section thickness (t) all 
particles are counted, including those particle fragments that 
are transected by the microtome knife in the upper and lower 
surfaces of the section; consequently, this counted particle 
number is too large and depends on the height of the particles 
(h) and the section thickness (t). The thinner the section and 
the larger the particle height, the larger the counting error. 
Abercrombie [1] postulated a formula (1) to correct for this 
overcount: 
t 
true particle number = counted particle number * (1) 
h + t 
However, Abercrombie's method [1] has five limitations: 
1. Particle size distribution, shape and orientation are not 
taken into account. 
2. To determine particle height, the particle diameter in 
sections cut precisely at a right angle to the remainder of 
the tissue, has to be measured [Abercrombie, l]; in practice 
this is almost impossible, and height will be easily mixed up 
with particle diameter. 
3. Actual section thickness varies considerably within one 
individual section [11]. 
4. Small particle fragments are difficult to be identified as 
such ("lost caps"). 
5. It is not known to what extent particles are indeed transected 
by the microtome knife and whether or not they are pushed 
aside by the knife and remain uncut. 
All these limitations are in fact the consequences of using 
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one single section, and can be overcome by the disector [17]. 
The central idea of the physical disector is that arbitrarily 
shaped particles with an arbitrarily orientation in space can be 
counted unambiguously by using two consecutive sections with 
thickness (t), which is smaller than the minimum particle height. 
Because large particles have an increased chance of being hit by 
the section plane in comparison to small particles, the number of 
particle profiles seen in one section has no known relationship 
to the number of particles in the 3-dimensional space or 
reference volume V(ref). However, the probability that a 
particle is hit by a section and at the same time is not hit by 
the parallel section is identical for both small and large 
particles. Therefore, total number of particles (N) can be 
estimated using the following equation (2): 
η 
Σ Qi 
i=l 
N = * V(ref) (2) 
η 
t * Σ atfraíi 
i=l 
- Qi is the number of particles that is counted in the first 
section minus the number of particles present in both secions; 
- a(fra)i is the area of the sampling frame (Fig. 4.1), in which 
particles are sampled according to the exclusion principle of 
Gundersen [6]; 
- Σ is the summation that is carried out over i=l,2,..., η 
systematic randomly positioned disectors (i.e., at equidistant 
positions with a random start) in the reference volume V(ref); 
t represents the section thickness. In this approach it is 
not necessary anymore to measure t, since: 
m 
V(ref) = t * Σ Aj (3) 
j=l 
Σ A 3 being the estimated total sectional area of all m sections. 
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substituting equation (3) into (2), the t in the numerator 
cancels the t in the denominator [16]. In practice, not all m 
sections but only a certain fraction (f) will be used (e.g. , 
every 50th section is measured, f being 1/50), resulting in the 
following equation: 
V(ref) = l/f * t * Σ Aj (4) 
The central idea of the optical disector [7, 12, 19, 20] is 
the use of one relatively thick section, in which two parallel 
thin optical sections can be indicated by moving the plane of 
focus up or down. Total particle number was obtained by using 
equation (2) in which t now represents the height of the optical 
disector (the distance between the two optical planes of focus, 
e.g. 10 \xm in a 20 \im thick section). For the purpose of optical 
disectioning a microcator was attached to the microscope to 
measure the movements of the stage in the z-axis. The smallest 
possible focal depth was reached by using high numerical aperture 
oil immersion lenses. As compared to the physical disector, the 
optical disector in one relatively thick physical section has one 
main advantage: the most time consuming step of aligning the two 
physically separate sections in order to obtain two coinciding 
fields of view in two identical microscopes, is eliminated. 
Moreover, densely packed cells like the dentate granule cells of 
the hippocampus are almost impossible to count in physical 
disectors (overprojection), whereas the optical disector solves 
this problem. 
The results of numerous quantification studies obtained in 
the past using conventional counting methods [like Abercrombie's 
method, 1] are biased to an unknown extent. The aim of this 
study is to investigate whether and to what extent these 
conventional data have led to seriously false conclusions in the 
past. The particle of interest in this study is the nucleolus, 
because it is regarded as the traditional marker for neurons 
[18]. Moreover, the nucleolus has a spherical shape, and 
therefore the orientation in space is independent of the plane of 
sectioning. To investigate to what extent nucleoli are indeed 
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Fig. 4.1 The ocular sampling grid with the exclusion principle of 
Gundersen [6]: all profiles (black nucleolus, no. 1) that hit the 
forbidden (solid) line are not counted; the profiles entirely in­
side the sampling frame as well as those hitting the dotted line 
are counted (open nucleoli, nos. 2, 3 and 4). The side length of 
the frame corresponds to 100 μιη at a xlOOO magnification. 
being t r a n s e c t e d by the microtome knife and whether or not they 
are pushed as ide by the knife and remain uncut, t h r e e d i f f e r e n t 
approaches are used: 
1. Comparison of the number of n u c l e o l i in 10 and 20 μιη s e c t i o n s , 
obtained with conventional methods; if t r a n s e c t i o n of nuc leo l i 
does occur, the counts in 10 \іщ s e c t i o n s w i l l be r e l a t i v e l y 
higher than those in 20 μιη s e c t i o n s . 
2. Using the physical d i s e c t o r , fragments of t h e same nucleolus 
in two phys ica l ly seperated 10 μιη s e c t i o n s can be t r a c e d . 
3. Comparison of the nucleolus count using the o p t i c a l d i s e c t o r 
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1 0 0 μ m 
Fig. 4.2 Schematic representation of the optical disector with height 
(h=10 μιη) in a nominal 20 \m section, with upper and lower guard 
zone (dotted/hatched areas; +2 μιη), and the upper (u) and lower 
(1) focus plane of the optical disector. Nucleoli (black, no. 5) 
hitting the upper focus plane are not counted, but those nucleoli 
entirely inside the optical disector (no. 7) or in the lower 
focus plane (no. 6) are sampled. 
with a height of 10 μη within a sec t ion of nominal thickness 
of 20 μιη, with the conventional nucleolus count in exact ly the 
same area throughout the e n t i r e sec t ion th ickness (both counts 
expressed as number per u n i t volume). 
4.3 Material and methods 
4.3.1 Histo logical methods 
The s t r u c t u r e of i n t e r e s t i s the human nucleus b a s a l i s of 
Meynert in t h e basa l forebrain because of i t s la rge c o n s t i t u e n t , 
p u t a t i v e c h o l i n e r g i c neurons (>25 μπ\) [14, 15] showing r e l a t i v e l y 
la rge n u c l e o l i (+3.5 μιη) t h a t can be e a s i l y recognized as 
prominent, round s t r u c t u r e s in the n u c l e i . After f i xa t ion in 4% 
formaldehyde and embedding in para f f in , 27 s e r i a l sec t ions were 
cut on a Jung 2050 microtome with varying th ickness r e s u l t i n g in 
6 s e r i e s of a t o t a l th ickness of 60 μιη, c o n s i s t i n g of a l t e r n a t e 
6x10 μιη s e c t i o n s and 3x20 μιη sec t ions ( t o t a l l y 18 sec t ions of 10 
μιη and 9 s e c t i o n s of 20 μιη t h i c k n e s s ) . Sections were s ta ined 
according t o N i s s l . 
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4.3.2 stereological methods 
The conventional counts were carried out on the 10 and 20 \m 
sections throughout the entire thickness of the sections at a 
x400 magnification using an ocular grid with a quadrant sampling 
area of 250x250 цт2, subdivided into 100 squares of 25x25 цт2 
each. The nucleoli hitting the boundaries of the grid were dealt 
with according to the exclusion principle of Gundersen [6] (Fig. 
4.1). All other visible nucleoli in the sampling grid were 
counted, whether they were transected or not. As counting of all 
nucleoli is a rather elaborate task, one sample of 250x250 цт2 
per each 1 mm2 was systematically taken throughout the whole 
area of each section. This sampling scheme provided a suffi­
ciently large amount of samples to ensure a high validity (>95%) 
of the counting data [8]. Only large, putative cholinergic 
neurons with a maximum diameter of >25 цт were considered because 
of their relatively large and prominent nucleoli. Because 
determination of nucleolus number can be influenced by the actual 
section thickness of nominal 10 \im and 20 цт sections (due to 
possible inaccuracy of the microtome, variation in temperature, 
and histological processing), the thickness of all sections was 
measured at 4 different positions within each section. These 
measurements were carried out at xlOOO magnification (oil 
immersion lens, numerical aperture of 1.4) using the microcator 
attached to the light microscope. 
The physical disector approach was not used to quantify 
nucleoli in an unbiased way [17] in this study, but to verify 
whether actual transectioning of nucleoli did occur. In two 
adjacent 10 цт sections 200 nuclei and nucleoli were investigated 
at a ХІ000 magnification (oil immersion lens, numerical aperture 
of 1.4) to determine the number of neurons showing nuclei and 
nucleoli in both sections. 
The optical disector approach was compared to the conventional 
counting method. Firstly, in an area of 1000x4500 цт2 in a 
section with nominal thickness of 20 цт, 72 samples of 250х250цт2 
were taken meanderlike (4 vertically versus 18 horizontally) at a 
x400 magnification and all visible nucleoli throughout the whole 
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section thickness were counted. Secondly, in each of the 72 
samples the actual section thickness was measured using the 
microcator at a xlOOO magnification. Thirdly, in exactly the 
same area of 1000x4500 цт2 of the same section 450 consecutive 
optical disectors (disector area: 100x100 цт 2; height disector: 
10 μπι) were taken meanderlike (10 vertically versus 45 horizon­
tally) at a xlOOO magnification. Because the cut-surface of the 
section is irregular, an upper guard zone of about 2μιη under the 
cut-surface was taken into account to ensure that the upper plane 
of the optical disector was fully present within the section. 
All nucleoli, that were sharply focused were not counted, and 
while focusing down along 10 μπι of the z-axis all new nucleoli 
coming into focus were being counted including those that were in 
focus in the lower plane of the optical disector (Fig. 4.2). 
The nucleoli that hit the boundaries of the sampling frame were 
dealt with according to the exclusion principle of Gundersen [6] 
(Fig. 4.1). 
4.4 Results 
Results include the conventional counts in 10 and 20 цт 
sections, the physical disector to verify actual transectioning 
of the nucleolus, and the comparison between the counting data 
obtained with the optical disector and the data obtained with 
conventional counting. 
The nominal 10 and 20 цт thick sections appeared to be 
actually 8.6+0.1 цт (mean + standard error of the mean; n=72) and 
17.1+0.2 цт (n=36), respectively. This change in section 
thickness did not significantly differ between 10 and 20 цт 
sections. Secondly, to exclude a possible change in nucleolus 
number along the extent of the 27 sections investigated, nucleoli 
counts of all eighteen 10 цт sections were added and compared 
with the total nucleolus number of all nine 20 цт sections. In 
the 10 цт sections a total of 944 nucleoli were sampled versus 
953 in the 20 цт sections (difference: <1%). This result 
suggests either the absence of nucleolar transectioning, or an 
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equal number of nucleolar splitting, that may be due to a more 
severe compression during the cutting of the 10 μιη sections. 
To verify whether actual transectioning of nucleoli and 
nuclei did occur, the physical disector was applied on a 10 μιη 
section pair. Only 21 nuclei from the 200 nuclei present in the 
first section only 21 nuclei could also be detected in the 
adjacent second section (10.5%). All of these 21 transected 
nuclei showed an intact nucleolus present in either of the two 
nucleus halves. Moreover, each of the 200 nuclei contained only 
1 nucleolus. These results indicate the absence of nucleolus 
transectioning in 10 μη thick paraffin sections. 
The approach of the optical disector (450 consecutive 
disectors of 100x100x10 μιη3 in an area of 1000x4500 \imz at a 
xlOOO magnification) resulted in an unbiased number of 259 
sampled nucleoli. The actual section thickness of this area was 
14.23+0.17 μιη (n=72). The biased conventional count (72 
consecutive samples of 250x250 μιη2 in exactly the same area of 
1000x4500 μιη2 throughout the whole thickness of the section, at 
a x400 magnification) resulted in a sampled number of 370 
nucleoli. If no nucleolus transectioning does occur, the number 
of nucleoli sampled in the biased manner should equal the number 
of nucleoli obtained from the optical disector (259) multiplied 
with the volume-fraction of the two sampling methods 
(1000x4500x14.23 μιη3 /1000x4500x10 μιη3), i.e., 259x1.423=368.55 
nucleoli. The conventional count mounted up to 370 nucleoli 
(difference: <1%). The latter finding indirectly points out to 
an absence of nucleolus transectioning. 
4.5 Discussion 
The results show three lines of evidence, that the nucleoli 
of neurons of the human nucleus basalis of Meynert are not 
transected but pushed aside by the microtome knife, and remain 
uncut in paraffin sections with a thickness >10 μιη. As a 
consequence, when the nucleolus is the particle to be quantita-
ted, the numerical data obtained from biased conventional 
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counting methods do not differ from the unbiased numerical data 
obtained from the optical disector. It is therefore tempting to 
extrapolate this finding on conventional biased data of the past, 
and to state cautiously that these former quantification studies 
have not led to seriously false conclusions, provided that 
paraffin sections with a thickness of >10 цт were used and that 
the nucleolus was being quantified. Larger particles like the 
nuclei or the neurons themselves would never give similar results 
in both the biased conventional counting methods and the unbiased 
stereological techniques, because several assumptions have to be 
made upon transectioning, shape, size-distribution and orientati­
on in space. While counting nerve cells (not nucleoli) in the 
neocortex, Bok en Van Erp Taalman Kip [2] previously faced this 
problem of overcounting due to transectioning of the cell soma, 
and developed a kind of predecessor of the physical disector. 
They performed cell counts in both 15 and 30 цт sections; 
subsequently, the difference between the two counts was reckoned 
to be the number of nerve cells present in an imaginary section 
the thickness of which was equal to the difference between the 
thicknesses of the two sections used. 
The small percentage of transected nuclei (10.5%) may be due 
to compression and (temporary, elastic) deformation of the 
nucleus during the cutting procedure. It can be hypothesized 
that nuclei are behaving like water balloons with a smooth 
surface and are pushed aside by the microtome knife into one or 
the other of the two sections. A splitting error of 10% for 
nuclei has already been reported previously [5], however, section 
thickness was not mentioned. Ά neglectable nucleolus splitting 
in 6 up to 12 цт thick sections has been demonstrated by Jones 
[13], who postulated that the nucleolus was harder than the 
surrounding tissues and the paraffin like intact peanuts in 
peanut-butter. This hypothesis was indirectly supported by the 
demonstration of artifactual displacement of intact nucleoli in 
the direction of cutting [3], sometimes even through the nuclear 
membrane into the cytoplasm. However, in the present study no 
nucleolar displacement was found, because of the small probabili­
ty for the nucleolus of being transected by the microtome as a 
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direct consequence of the low percentage of nucleus transectio-
ning. 
In conclusion, biased quantification studies in the past, that 
used the nucleolus as quantifiable particle in paraffin sections 
with a thickness >10 цт, have not led to seriously false 
conclusions. However, it can not be excluded that nucleoli of 
neurons in pathological conditions are indeed susceptible to 
transectioning. Therefore, the (optical) disector approach may 
turn out to be superior to any conventional counting method. 
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CHAPTER 5 
CELL LOSS AND SHRINKAGE IN THE NUCLEUS BASALIS MEYNERT COMPLEX IN 
ALZHEIMER'S DISEASE 
O.J.M. Vogels, C.A.J. Broere, H.J. ter Laak, H.J. ten Donkelaar, 
R. Nieuwenhuys and B.P.M. Schulte 
(Neurobiology of Aging 1990;12:1) 
5.1 Abstract 
Marked neuron loss in the nucleus basalis of Meynert complex 
(NBMC) in Alzheimer's disease has repeatedly been reported in the 
literature. However, most of these studies quantitated only 
magnocellular, hyperchromatic (putative cholinergic) neurons of 
just a small part of the NBMC, and counts were expressed as 
numerical density. Applying a 3-dimensional-sampling design 
throughout the entire rostrocaudal extent of the NBMC and 
sampling neurons regardless of their size and staining characte-
ristics, an overall neuron loss of only 15.5% was demonstrated 
for the whole NBMC. Neuron loss varied from 0% rostrally in the 
NBMC up to 36% in the most caudal part of the nucleus basalis of 
Meynert. Moreover, a significant increase in the number of 
small-sized neurons and a significant decrease in the number of 
large, putative cholinergic neurons could be detected, suggesting 
that apart from neuron loss neuron shrinkage appears to be 
another characteristic neuropathological feature of this 
degenerating cholinergic NBMC system. Preservation of these 
magnocellular cholinergic neurons in shrunken form renders it 
likely that cholinergic dysfunction, characteristic of Alzhei-
mer's disease, may be responsive to neurotrophic influences. 
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5.2 Introduction 
There has been considerable debate during the last years 
regarding the extent of neuronal loss during normal aging and in 
dementing diseases. This is particularly true for the nucleus 
basalis of Meynert complex (NBMC) in the basal forebrain (medial 
septal nucleus, nucleus of Broca's diagonal band, nucleus basalis 
of Meynert). Based on the distribution of choline acetyltransfe-
rase positive neurons and their respective fiber connections, the 
NBMC can be subdivided into four regions [33, 34]: the Chi region 
(corresponding to the medial septal nucleus), the Ch2 region 
(vertical limb nucleus of the diagonal band of Broca), the Ch3 
region (horizontal limb nucleus of the diagonal band of Broca) 
and the Ch4 region (nucleus basalis of Meynert), which latter can 
be further subdivided into an anteromedial (Ch4am), an anterola-
teral (Ch4al), an intermediate (Ch4i) and a posterior part 
(Ch4p), that ends at the rostral level of the corpus geniculatum 
laterale. 
In normal aging a linear decline in neuronal number of the 
NBMC starting shortly after birth has been reported, showing cell 
loss ranging from 23% [29] up to 70% [32]. However, other 
investigators claimed stability of neuronal number in this 
complex [5, 8] during normal aging (Table 5.1). 
In Alzheimer's disease (AD) and Senile Dementia of Alzheimer's 
Type (SDAT) the reported variation in cell loss is even greater, 
ranging from apparent persistence of cholinergic neurons [37] to 
a 90% cell loss in a patient with a familial form of AD [51]. 
This considerable variation in neuron number and cell loss of the 
NBMC does not result from different patient selection criteria 
and inconsistency in tissue processing, but is mainly due to 
counting procedures applied. 
Concerning tissue processing, an age-dependent embedding-
shrinkage of brain tissue could have influenced data on neuronal 
densities [42], although this is not a universal problem, and may 
even be isolated to the use of methylbenzoate for paraffin 
embedding. Together with a secular acceleration in body and 
brain size [21] both these variables may significantly affect 
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morphometric evaluation of neuronal densities (number per unit 
volume) during aging. 
A closer look at the counting procedures applied reveals 
three sources of bias (Table 5.1): 
1. Most studies [1, 7, 8, 10, 11, 30, 35, 37, 39, 41, 48, 51, 
52, 55, 56] examined only a small region of one or more of the 
subdivisions of the NBMC, especially the subcommissural region, 
Fig. 5.1 The subcommissural Ch4a region. Note the absence of sharply 
delineated boundaries. Abbreviations: CA = Commissura Anterior; 
Ch4a: anterior part of the nucleus basalis of Meynert. 
i.e., the anterior part of the nucleus basalis of Meynert (Ch4a,· 
see Fig. 5.1). However, the NBMC of the human brain is a large, 
complex, and highly differentiated structure that is characteri-
zed by a marked irregularity in arrangement and distribution of 
its constituent cholinergic and noncholinergic neurons. 
Therefore, an investigation of the entire rostrocaudal extent of 
the NBMC and its subdivisions is an inevitable requirement for a 
sound analysis. 
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2. Neuron number has usually been expressed as numerical density, 
i.e., neuron number per unit volume (or per unit area). This 
parameter can only be used appropriately under the assumption 
that the total volume of the brain structure of interest is not 
affected by pathological conditions nor by (differential) 
embedding shrinkage. Therefore, it seems more suitable to 
express neuron numbers as absolute total neuron numbers. 
3. Most studies [3, 4, 5, 7, 8, 10, 11, 13, 29, 30, 32, 35, 39, 
48, 51, 52, 55, 56] introduced two criteria for neurons to be 
counted: a minimum size criterion (magnocellular neurons, usually 
larger than 30 \im) and a subjective staining criterion (hyper-
chromatic neurons showing "abundance of Nissl substance"). 
Mapping studies demonstrated these hyperchromatic, magnocellular 
neurons to be the putative cholinergic neurons [32, 33]. It is 
not known whether neuronal loss is restricted to large neurons 
and whether shrinkage of cells prior to death might lead to 
inaccurate impressions of the loss of large neurons. The 
decreased functional state of the NBMC cholinergic neurons in 
Alzheimer's disease is reflected by strongly reduced levels of 
choline acetyltransferase in the NBMC itself [39, 7] and by 
dissolution of the Nissl substance in the cytoplasm of the NBMC 
neurons. Therefore, an immunohistochemical stain for choline 
acetyltransferase or the use of another staining criterion such 
as "abundance of Nissl substance" make these parameters less 
reliable as markers for the NBMC in Alzheimer's disease, because 
these parameters are subjected to the disease process itself. 
Moreover, absence of transmitter-associated enzyme staining 
(choline acetyltransferase and acetylcholinesterase) is not an 
absolute indicator of death of cholinergic neurons [27]. 
Consequently, it appears to be necessary to count all neurons 
irrespective of their size and staining characteristics, and thus 
irrespective of their cholinergic properties. Quantitative 
studies that did not use a minimum size criterion, but instead 
counted all neurons, showed an increase in small-sized neurons 
[1, 37, 41, 53], indeed indicating neuronal shrinkage. However, 
these studies were either restricted to a small part of the NBMC 
[l, 37, 41, 53], or used the perikaryon instead of the nucleolus 
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TABLE 5.1 
Neuron numbers of NBMC in normal aging and Alzheimer's disease 
Référence 
Chui ctal (8) 
Mann et al (30) 
McGeereíaf (32) 
Bigi el al (5) 
Lowes-Hummel eí al (29) 
Whitehouseetíí (51) 
Whilchouseere/ (52) 
Репу étal (39) 
Wilcockefa/ (55) 
Arendt étal (3) 
Candy étal CT) 
Nagaiefa/ (35) 
Peaison et al (37) 
Tagliavini and 
Pillen (48) 
Whitehouseeía/ (52) 
Mann et al (30) 
McGeerefa/ (32) 
Pegion 
Ch4a 
Ch4a 
Ch4 
Ol l , d û 
Ch4 
Ort 
Ch4 
CM 
Ch4 
Ch4 
Chi, Ch2 
αι4 
CM 
CM 
O l a 
Ch4 
CM 
a i 4 a 
Ch4 
N 
17 
20 
10 
8 
16 
14 
22 
6 
Technique Cntena 
Normal Aging 
histology 
(CV) 
histology 
(CV) 
imiDunochem. 
( O i A T + C V ) 
histology 
(CV) 
histology 
(CV + HE) 
>25 μα 
nucleolus 
> 3 0 ц т 
hyperchromatic 
nucleolus 
>35 μιη 
penkaiyon 
nucleolus 
>20 and >30 μιη 
hypeichmnatic 
nucleolus 
>35 μτα 
nucleo! us 
Alzheimer's Disease 
histology 
(CV + HE) 
histology 
(CV) 
hi sloe hem 
(AChE) 
histology 
(CV) 
histology 
(CV) 
histology 
(CV) 
immunochem. 
(ChAT) 
immunochem. 
histochem 
(ChAT + AChE) 
histology 
(CV) 
histology 
(CV) 
histology 
(CV) 
immunochem 
histology 
(ChAT+ CV) 
large neurons 
hypeichromaoc 
nucleolus 
>30μιη 
hyperchromatic 
nucleolus 
large neurons 
>30μιη 
hypeichiomahc 
nucleolus 
>20 μιη 
hypeichicmanc 
nucleolus 
laige neurons 
nucleolus 
>30μιη 
penkaiyon 
all sizes 
penkajyon 
laige neurons 
nucleolus 
all sizes 
penkaiyon or 
nucleolus' 
> 30 μιη 
hypeichromabc 
nucleolus 
>35 μm 
pcnlcuyon 
nucleolus 
Etpressed As 
maximum 
density 
mean density 
total neuron 
number 
total neuron 
number 
total neuron 
number 
maximum 
density 
maximum 
density 
density 
maximum 
densit> 
maximum 
density 
mean density 
mean density 
mean density 
mean density 
mean density 
mean density 
total neuron 
number 
Results 
cell density ** (25-87 y) 
cell density J. 35% (40-90 y) 
ChAT cell Ν α | 70% (1-95 y) 
(475,000 - 150,000) 
cell No « · (36-85 y) 
(Chl+2+4 Î. 225,000) 
cell No i 23% (0-90 y) 
(150,000 - 114,000) 
cell density I 90% 
cell density 4 73% 
cell density | 33% 
cell density I 50% 
cell density | 70% 
mean density I 35% 
density OiAT I 66% 
density ChAT | 18% (as . ) 
densilyAChEl 14% (n.s ) 
soma area i 26% 
cell density J. 44-76% 
large neurons I 
small neurons t 
cell density I 59% 
nucleolis diam. 4- 33% 
ChAT cell Να 4 75% 
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TABLE 5.1 
Continued 
Reference 
Arendt étal (4) 
Doucette eí al (10) 
Eüenne étal (11) 
Gertz et al (13) 
Rinne ef al (41) 
Allenerà/ (1) 
Wilcockeraí (56) 
Region 
Chi, Ch2, 
CMam, CMi 
CMal, CMp 
CMa, Ch4i 
02, a i4a 
CMi 
Chi, Ch2 
CMa 
CMi 
Ch2, a i4a 
CWi, Ch4p 
N 
5 
β 
10 
7 
7 
7 
13 
Technique 
histology 
(CV) 
histology 
(CV) 
histology 
(CV) 
hutdogy 
(CV) 
histology 
(CV) 
immunochem. 
(NSE) 
histology 
(CV) 
Cntena 
>20 and >30 μ,ιη 
hypeichromatic 
nucleolus 
medium and 
laige neurons 
nucleolus 
>30μπι 
hypeichromatic 
nucleolus 
>20 and >30 /un 
nucleus 
all sizes 
nucleolus 
all sizes 
penkaiyon 
>20 and >30 μια 
hypeichromatic 
nucleolus 
bpressed As 
total neuron 
number 
mean density 
mean densty 
total neuron 
number 
mean density 
mean density 
maximum 
density 
Results 
cell N a i 5 7 % Ch4p 
most affecloJ 
cell density Ch4a 4. ± 60% 
C h 4 i | ± 5 5 % C h 4 p J . ± 6 0 % 
cell density Ch2 I 70% 
Ch4a I 7 3 % Ch4i i 87% 
soma sue** 
cell Ν α Chi + CM | 46% 
cell density CMa i 22% 
mean cell size CMa I 25% 
cell density i 2 9 % 
small Î 59% laige I 61% 
cell density Ch2 I 39% 
Cli4am I 13% CMal I 52% 
CMi I 4 1 % CMp i 57% 
Ν, number of subjects; n.s., not significant; y, years; CV, cresyl violet; HE, 
hematoxylin eosin; ChAT, choline acetyltrans ferase; AChE, acetylcholine este­
rase; NSE, neuron specific enolase. 
as the counting item [1, 37, 53] and were therefore biased by 
overcounting due to splitting error. 
As Table 5.1 shows, no quantitative studies on the NBMC in 
normal aging and in Alzheimer's disease have yet appeared in the 
literature that at once made allowance for all three methodologi­
cal sources of bias as mentioned cibove by: in toto analysis of 
the NBMC (or of its subdivisions), determination of total neuron 
numbers, absence of size or staining restrictions. 
This paper deals with an efficient and reliable sampling 
scheme for the NBMC as a whole, as well as for its subdivisions 
(Chl-4), in order to determine total neuron numbers. Neurons to 
be counted were not subjected to any size or staining criterion; 
thus cholinergic and noncholinergic neurons were included. 
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Moreover, the NBMC-neurons were subdivided into four size 
categories, in order to detect a possible shift from large 
neurons into shrunken ones. To our knowledge no study has 
appeared in the literature that accounts for estimation of total 
neuron number regardless of size and staining properties and of 
neuron number per size category throughout the entire rostrocau-
dal extent of the NBMC and of its subdivisions in age-matched 
controls and Alzheimer's disease. 
5.3 Material and methods 
Five cases of early onset Alzheimer's disease, five cases of 
late onset Alzheimer's disease, one case of Parkinson's disease 
without cognitive impairment, and eight nondemented controls were 
obtained. The clinical diagnosis of probable Alzheimer's disease 
was confirmed neuropathologically using Khachaturian's criteria 
[25]. The clinical diagnosis of Parkinson's disease was 
neuropathologically confirmed by the characteristic lesions in 
the substantia nigra consisting of cell loss, degenerative cell 
changes, gliosis and the presence of Lewy inclusion bodies. The 
control patients showed no evidence of neurological or psychiat-
ric disease. Clinical and pathological data are summarized in 
Table 5.2. 
The whole NBMC was removed from both hemispheres using the 
polus temporalis and the corpus geniculatum laterale as borders 
for the rostral and caudal cutting plane, respectively. These 
cutting planes were orientated perpendicularly to the hippocampal 
axis, which resulted in an approximate 20-25 degree difference 
with respect to the coronal plane. The following subdivisions of 
the NBMC were investigated: 
- Chi and Ch2 were taken together, because the boundaries 
between them are rather arbitrary and because both regions 
project to the hippocampus [33]; 
- Ch3 as recently delineated [34]; 
Ch4 as a whole (nucleus basalis of Meynert); 
- the three Ch4 subdivisions: Ch4 anterior (Ch4a), Ch4 interme-
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case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
dia­
gnosis 
С 
С 
с 
С 
С 
С 
С 
с 
AD 
AD 
AD 
AD 
AD 
AD 
AD 
AD 
AD 
AD 
PD 
sex 
F 
M 
M 
M 
M 
F 
M 
M 
F 
M 
F 
M 
F 
F 
M 
F 
M 
F 
F 
age 
(y) 
60 
62 
65 
69 
71 
75 
80 
91 
65 
66 
69 
69 
76 
76 
77 
90 
90 
93 
74 
brain 
weight 
(g) 
1162 
1351 
1570 
1200 
1346 
1250 
1475 
1288 
865 
1136 
1105 
1077 
970 
1275 
985 
1100 
1160 
842 
1370 
TABLE 5. 
Brain 
hemi­
sphere 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
L+R 
- R 
L+R 
- R 
- R 
L+R 
L+R 
2 
material 
fix. 
time 
(m) 
5 
5 
2 
9 
7 
6 
7 
5.5 
9 
5 
5 
<1 
<1 
5 
<1 
12 
6 
7 
<1 
p.m. 
delay 
(h) 
14 
<24 
36 
50 
<24 
36 
48 
36 
<12 
<24 
<12 
<12 
6 
4 
2.5 
<12 
<12 
<12 
8 
cause of 
death 
sepsis 
aorta rupture 
pneumonia 
trauma 
cardiac arrest 
carcinoma 
cardiac arrest 
carcinoma 
sepsis 
sepsis 
sepsis 
cachexia 
cachexia 
duration 
dementia 
(y) 
3 
4 
? 
12 
14 
status epilepticus 5 
pneumonia 
pneumonia 
sepsis 
pneumonia 
cardiac arrest 
11 
6 
3 
16 
Characteristics of brain material with neuropathological diagnosis, sex, age, 
brain weight, hemispheres available, fixation time, postmortem delay, cause of 
death, and duration of dementia. AD, Alzheimer's disease; C, control; F, 
female; L, left hemisphere; M, male; PD, Parkinson's disease; R, right hemi­
sphere; h, hours; m, months; y, years; g, grams; ?, unknown; -, not available. 
P.M.: cases 9-13, early onset AD; cases 14-18, late onset AD. 
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diate (Ch4i), and Ch4 posterior (Ch4p); 
both Ch4a subdivisions: anteromedial (Ch4am) and anterolateral 
(Ch4al). 
5.3.1 Histological methods 
Brains were fixed in toto in 4% formaldehyde. Postmortem 
delays varied from 2.5 to 50 hours. After embedding in paraffin 
serial sections with a thickness of 10 or 20 цт were cut using a 
Jung 2050 microtome. Sections were stained at regular intervals 
of 800 цт throughout the entire rostrocaudal extent of the NBMC. 
The Nissl-stain was used for counting and measuring purposes and 
the adjacent Kliiver-Barrera-stained sections were used for 
identification of the NBMC and its subdivisions Chl-Ch4. 
5.3.2 stereological methods 
Morphometric analysis was carried out by counting the 
nucleoli, the traditional markers of neurons [50], and by 
measuring the maximum diameter of neurons that contained a 
nucleolus. Nucleolus counts were made at a 400x magnification 
using an ocular grid with a quadrant area of 250x250 цт2, 
subdivided into 100 squares of 25x25 цт2 each. The nucleoli 
hitting the boundaries of the grid were dealt with according to 
the exclusion principle of Gundersen [18]. Focussing at the 
level of the nucleolus the maximum diameter of every nucleolated 
neuron (regardless of size or staining property) was measured. 
Four size categories (0-12.5; 12.5-25.0; 25.0-37.5 and over 37.5 
цт) were chosen and the squared eyepiece graticule served as 
measuring scale. Medium- and large-sized neurons could easily be 
identified by their cytoplasm (with or without abundant Nissl 
substance) and their relatively pale, large, round or oval 
nucleus with a prominent nucleolus. In Nissl-stain small-sized 
neurons (<12.5 цт) could be distinguished from oligodendrocytes 
and astrocytes on their distribution pattern and on the morpholo-
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gy of their nuclei [14]: 
macroglia, especially the Oligodendroglia, are often grouped 
together in small clusters or chains; 
the nuclei of Oligodendroglia are round or oval and small 
(<5цт), relatively darker stained, and with many deep-blue 
spots ; 
the nuclei of astrocytes are larger (4-10 цт) , irregular and 
lighter stained, and with many light-blue spots, some of which 
(>l) are prominent, resembling nucleoli; 
apart from their somewhat Nissl-positive cytoplasm small-sized 
neurons contain large (5-10 цт), regular nuclei with fewer 
light-blue spots and with precisely one prominent nucleolus. 
Small-sized neurons were always larger than +7 цт in their 
largest diameter. 
A 3-dimensional-sampling scheme was used throughout the whole 
NBMC and its surroundings. Samples were taken systematically 
along three mutually perpendicular directions at intervals of 1.0 
mm within the sections and 0.8 mm between the sections (see Fig. 
5.2a). These three directions corresponded to three mutually 
perpendicular planes: the median plane, the plane through both 
"hippocampal axes" and the plane at an angle of 25 degrees to the 
frontal plane perpendicular to both former planes. For the NBMC 
this means about 25 equidistant sections at regular intervals of 
800 цт throughout its entire rostrocaudal extent. In this 3-
dimensional-sampling scheme the sampling fraction is either 1/640 
(only 1 out of 40 serial 20 цт sections is considered, the 
section fraction = 1:40; each sample of 250x250 цт2 represents 
1/16 part of 1 mm2, the area fraction = 1:16) or 1/1280 (when 
only l out of 80 serial 10 цт sections is considered, the section 
fraction being 1:80; the area fraction remaining 1:16). Actual 
nucleolus number was obtained by multiplication of the number of 
counted nucleoli with the inverse of the sampling fraction, i.e., 
X640 or ХІ280. 
The rostrocaudal length of the NBMC and its subdivisions in 
age-matched controls and AD was defined as the mean number of 
sections transecting the NBMC (or each of its subdivisions) 
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multiplied by the distance between the sections, i.e., x0.8 
millimeters. 
5.3.3 Sampling design and statistical methods 
In general statistics the coefficient of error (CE) is a 
measure of accuracy of the average of several independent 
observations. The CE is statistically defined as С / п 1 / 2 , in 
which CV is defined as SD/mean (abbreviations: CV = coefficient 
of variation; η = number of independent observations; SD = 
standard deviation; mean = the mean or average of η observations; 
n>l). The lower this calculated CE, the more accurate is the 
average of several independent observations. From the definition 
of the CE it can be deduced that the accuracy (or reliability) 
does not depend on the standard deviation (SD remains constant in 
a given distribution) but on the number, n, of observations: the 
higher the number n, the lower the CE. 
In a strict 3-dimensional-sampling scheme the position of 1 
sample automatically defines the position of all other samples 
(see Fig. 5.2a); this first sample is the only randomly chosen 
sample. This dependency between all samples makes it theoreti­
cally possible to estimate the coefficient of error (CE) of each 
total nucleolar count (n=l), that is in fact a summation of 
several samples. CE estimation formulae have been developed 
[20] that can give an impression of the reliability of just 1 
nucleolar count (and not of η independent counts) of a certain 
brain region based on the strict dependent position of all 
samples taken 3-dimensionally throughout the whole extent of 
that particular brain structure. This opens the opportunity to 
detect a relationship between nucleolar counts and their 
respective estimated CE's, and to optimize the sampling scheme. 
Differences in neuron counts in AD and age-matched controls 
were all statistically analyzed applying the distribution-free, 
nonparametric Mann-Whitney U-test. Comparisons were made at the 
hemisphere level: 
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Fig. 5.2a 3-Dimensional-sampling design with section fraction of 1:40 and 
area fraction of 1:16. The black squares represent the counting 
fields of 250x250 цт2. The numbers indicate sections 
reliability in % 
600 1000 1500 
number of saTiplod nucleoli 
Fig. 5.2b Relation between number of neurons sampled in a 3-äimensional-
sampling design and reliability expressed as % {[l-CE]*100%) 
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- left hemisphere : 5 young (cases 1-5) versus 
3 old age-matched controls (cases 6-8); 
5 early onset AD versus 2 late onset AD; 
7 AD versus 8 age-matched controls; 
- right hemisphere: 5 young versus 3 old age-matched controls; 
5 early onset AD versus 5 late onset AD; 
10 AD versus 8 age-matched controls; 
- left-right : 8 left versus 8 right age-matched controls; 
7 left versus 7 right AD. 
In both early and late onset AD correlations were made 
between the duration of dementia and the total numbers of 
putative cholinergic neurons (>37.5 μιη and >25.0 μιη) and smaller 
neurons (<25.0 μιη). 
5.4 Results 
Results concern the efficiency of the 3-dimensional-sampling 
method, total neuron numbers of the NBMC and its subdivisions, 
total neuron numbers as a function of neuron size, left-right 
comparisons, the rostrocaudal length of the NBMC and its 
subdivisions in age-matched controls and in AD, and correlations 
between total numbers of putative cholinergic neurons and 
duration of dementia. Neuron counts of the left and right 
hemisphere of one Parkinson's disease brain will be shown. 
5.4.1 The efficiency of the З-âimensional-sampiing method 
For the counts of the whole NBMC, its subdivisions and of 
size categories each time the coefficient of error (CE) is 
determined, using CE estimation formulae [20]. Concerning the 3-
dimensional-sampling design (sampling fraction: 1/640; see Figs. 
5.2a and 5.2b) a strict relationship between number of neurons 
sampled and reliability (expressed as (1-CE)*100%) can be 
indicated: it seems not necessary to count more than 200 neurons 
in order to ensure a reliability of 95% ; if a reliability of 90% 
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suffices, not more than 50 neurons have to be sampled systemati-
cally (Fig. 5.2b). For the NBMC as a whole this 3-d-sajnpling 
scheme resulted in a mean number of 1897 sampled neurons in 
normal aging versus 1604 in AD; for the Chl+Ch2 region a mean of 
350 neurons was sampled in age-matched controls versus 348 in AD; 
for the Ch3 subdivision 100 versus 85 neurons in AD; for the 
Ch4al subdivision 262 versus 221; for Ch4am 487 neurons in age-
matched controls versus 409 in AD; for Ch4i 503 versus 413 and 
for Ch4p 195 sampled neurons versus 124 in AD. 
5.4.2 Neuron numbers of the NBMC in young and old controls 
No significant differences in mean neuron numbers between 
young (case 1-5) and old age-matched controls (case 6-8) could be 
demonstrated. Therefore all age-matched controls were considered 
as one homogeneous group for further statistical analysis. 
5.4.3 Neuron numbers of the NBMC in early and late onset AD 
No significant differences in mean neuron numbers between 
early (case 9-13) and late onset AD (case 14-18) could be 
indicated. Therefore the early and late onset AD cases were 
considered as one group for further statistical analysis. 
5.4.4 Neuron numbers of the NBMC and its subdivisions in 
age-matched controls and AD 
Total neuron numbers in age-matched controls (young and old 
taken together) and AD (early and late onset together) indicated 
neuron loss for the NBMC as a whole and for all its subdivisions 
in AD except for the Chl+Ch2 region, in which stability of 
neuron number was found (see Figs. 5.3a and 5.3b). Applying the 
Mann-Whitney U-test, significant neuron loss was demonstrated 
for the left (L) and right (R) NBMC as a whole (15 and 16%, L+R: 
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Fig. 5.3a Total number of neurons (χ 1000) of the whole NBMC and subdivi­
sions in normal aging (black bars) and Alzheimer's disease 
(hatched bars) of the left hemisphere. *, p<0.05; **, p<0.01; 
***, p<0.001, according to Mann-Whitney U-test. 
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Fig. 5.3b Total number of neurons (x 1000) of the whole NBMC and subdivi­
sions in normal aging (black bars) and Alzheimer's disease 
(hatched bars) of the right hemisphere. *, p<0.05; **, p<0.01; 
***, p<0.001, according to Mann-Whitney U-test. 
99 
p<0.01), the nucleus basalis of Meynert as a whole (Ch4-L, 20%: 
p<0.01; R, 19%: p<0.05), the anterior part of the nucleus basalis 
of Meynert (Ch4a-L, 16%: p<0.05; Ch4a-R, 14%: p<0.01), the 
intermediate part (Ch4i-L, 18%: p<0.05; Ch4i-R, 17%: p<0.01) and 
the posterior part (Ch4p-L, 35%: p<0.01; Ch4p-R, 37%: p<0.001). 
5.4.5 Neuron number as a function of neuron size 
In AD the whole NBMC and all subdivisions showed a considera­
ble loss of absolute neuron numbers of large, putative choliner­
gic neurons (>25 μιη) and an increase of neurons of the smallest 
size category (<12.5 μιη). Applying the Mann-Whitney U-test, a 
significant increase in absolute neuron numbers of the smallest 
size category (<12.5 μιη) was demonstrated for the NBMC as a whole 
and for almost all its subdivisions: left hemisphere, ranging 
from 38 to 79% increase (p<0.05, or p<0.01); right hemisphere, 
ranging from 9 to 48% (p>0.05, or p<0.05). Neuron loss in the 
size categories 25-37.5 μιη and >37.5 μιη proved to be significant 
for the whole left and right NBMC as well as for all left and 
right subdivisions (probability ranging from p<0.05 to p<0.001), 
except for R-Ch3 in size class 25-37.5 μιη (p=0.09). 
5.4.6 Left and right hemispheric counts 
Comparisons between neuron numbers of 8 left and 8 right 
hemispheres of age-matched controls showed no statistical 
difference at all; comparisons between 7 left and 7 right AD 
hemispheres were also not significantly different. Neuron 
numbers and p-values are given in Table 5.4. 
5.4.7 Rostrocaudal length of the NBMC and its subdivisions 
In AD the length of both the left and right NBMC was signifi­
cantly reduced: p<0.001. The subdivision that accounted for this 
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TABLE 5.3 
Mean neuron numbers expressed in thousands (+ SEM) 
of the NBMC and its subdivisions as well as per size class 
in age matched controls (ЗА) 
12.5 \m 12.5-25.0 ρ 25.0-37.5 μη 37.5 μι« all cells 
NORMAL AGING 
ЗА 
(n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) 
NEMC 
- Chl+Ch2 
- C h 3 
- Oi4-t0tal 
- Ch4a 
- mm 
- Cii4al 
- Ch4i 
- Ch4p 
164+20 
39+4 
12+2 
113+15 
53+10 
36+8 
17+2 
44+6 
16+2 
172+16 
44+5 
15+2 
113+12 
54+7 
35+6 
19+3 
42+4 
17+2 
522+17 
110+9 
35+1 
377+18 
196+10 
130+8 
66+6 
132+10 
49+3 
511+25 
107+9 
34+1 
370+16 
183+9 
124+9 
59H5 
135+9 
52+3 
344+13 
59+2 
14+2 
271+12 
141+8 
90+5 
51+6 
93+5 
37+4 
339+14 
51+4 
12+1 
276+10 
140+7 
87+7 
53+5 
98+5 
38+4 
195+24 
21+2 
3+0.5 
171+22 
102+13 
66+9 
36+6 
50+7 
19+5 
179+16 
19+2 
3+0.3 
157+16 
90+9 
56+4 
34+6 
50+4 
17+3 
1225+17 
229+10 
64+2 
932+19 
492+14 
322+14 
170+16 
319+15 
121+9 
1201+31 
221+14 
64+3 
916+20 
467+17 
302+16 
165+15 
325+11 
124+8 
3B 
ALZHEIMER»S DISEASE 
NBMC 
- O1I+O12 
- 013 
- Ch4-t0tal 
-Ch4a 
- Ch4am 
- Ch4al 
- ai4i 
-Ch4p 
(n=7) 
1 6 0 " 
1 7 9 " 
138* 
156* 
158* 
150* 
175* 
150* 
164* 
(11=10) 
134* 
121 
109 
142* 
141* 
143* 
137 
148" 
134 
(n=7) 
102 
115 
83" 
100 
109 
107 
111 
98 
75* 
(n=10) 
100 
103 
90 
100 
107 
107 
108 
100 
75* 
(n=7) 
57" 
6 1 " 
48" 
57" 
62" 
6 3 " 
60* 
57** 
38" 
(n=10) 
6 0 * " 
73" 
69 
5 7 * " 
6 4 * " 
6 0 * " 
70* 
5 6 * " 
37— 
(n=7) 
26" 
4 1 " ! 
16** 
25" 
2 7 " ' 
27** ' 
2 7 " < 
26" 
9** ] 
n=10) 
8"* 
8* 
»9-" 
Г * * * 
1** 
1*** 
1 * * 
4*«* 
• 7 * * * 
(n=7) 
85" 
105 
83" 
80" 
84* 
83 
84 
82* 
65" 
(n= 
84* 
96 
88-
81* 
if," 
85* 
86 
83* 
63" 
3C 
PARKINSON'S DISEASE 
NBM: 
(n=l) 
109 
(n=l) 
114 
(n=l) 
103 
(n=l) 
115 
(n=l) 
95 
(n=l) 
97 
(n=l) 
97 
(n=l) 
94 
(n=l) 
100 
(П--1) 
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Mean neuron numbers in Alzheimer's disease (3B) and Parkinson's disease (3C) 
are expressed as percentage of age-matched controls (ЗА). L, left hemisphere, 
R, right hemisphere; SEM, standard error of the mean; *, p<0.05,· **, p<0.01; 
***, p<0.00l, according to Mann-Whitney U-test. 
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TABLE 5.4 
Mean neuron numbers of NBMC of left and right hemispheres 
expressed in thousands (+ SEM) in age-matched controls and 
Alzheimer's disease 
size class 
(μιη) 
<12.5 
12.5-25.0 
25.0-37.5 
>37.5 
all cells 
Normal 
L 
(n=8) 
164+20 
522+17 
344+13 
195+24 
1225+17 
aging 
R 
(n=8) 
172+16 
511+25 
339+14 
179+16 
1201+31 
Alzheimer1 
L 
(n=7) 
262+16 
534+30 
197+13 
51+5 
1044+38 
's disease 
R 
(n=7) 
249+12 
520+28 
204+12 
55 + 3 
1028+31 
L, left hemisphere; R, right hemisphere; SEM, standard error of the mean; 
p-values according to Mann-Whitney U-test ranged from 0.53 to 0.90. 
for this shortening, is the Ch4p (L:p<0.01; R:p<0.00l), whereas 
the other subdivisions Ch4i, Ch4a, Ch3 and Chl+Ch2 demonstrated 
no significant changes in length (Table 5.5). 
5.4.8 Correlations between neuron numbers and duration of 
dementia 
Although no differences were detected in both the mean neuron 
numbers and in the mean duration time of dementia between early 
(8.25 years +2.8 (SEM)) and late onset AD (8.2+2.4) applying the 
Mann-Whitney U-test , rather strong negative correlation 
coefficients could be demonstrated in late onset AD patients 
between duration of dementia and total numbers of putative 
cholinergic neurons (>37.5 μιη: r=-0.80, p=0.06; >25.0 μιη: r=-
0.61, p=0.l5), whereas weak correlations were found in early 
onset AD patients (>37.5 μιη: r=0.16, p=0.71; >25.0 μιη: r=0.19, 
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TABLE 5.5 
Rostrocaudal length (mm + SEM) of the NBMC and its subdivisions 
in normal aging and Alzheimer's disease 
structure 
NBMC 
- Chl+Ch2 
- Ch3 
- Ch4-total 
- Ch4a 
- Ch4am 
- Ch4al 
- Ch4i 
- Ch4p 
Normal 
L 
(n=8) 
19.6+0.6 
8.2+0.4 
4.0+0.3 
19.0+0.5 
7.2+0.3 
7.2+0.3 
6.5+0.3 
4.1+0.2 
7.7+0.2 
aging 
R 
(n=8) 
20.0+0.7 
8.8+0.4 
4.3+0.3 
18.9+0.6 
7.3+0.4 
7.3+0.4 
6.9+0.4 
4.1+0.2 
7.5+0.4 
Alzheimer's 
L 
(n=7) 
17.6+0.2*" 
7.9+0.4 
4.3+0.2 
17.0+0.3-
7.0+0.3 
7.0+0.3 
6.2+0.3 
4.1+0.2 
5.8+0. 2 " 
disease 
R 
(n=10) 
16.8+0.4-" 
8.3+0.4 
4.2+0.2 
16.3+0.5" 
7.5+0.2 
7.5+0.2 
6.6+0.2 
4.1+0.2 
4.8+0.3—-
L, left hemisphere; R, right hemisphere; mm, millimeter; SEM, standard error 
of the mean; ", ρ <0.05,· ", ρ <0.01; "-, ρ <0.001, according to Mann-
Whitney U-test. 
p=0.66). Small-sized neurons showed only weak correlations with 
duration of dementia (-0.29<r<0.33). However, none of these 
correlations was significant, probably due to the limited number 
of cases studied rather than to lack of a relationship. 
5.4.9 Neuron numbers and sizes in Parkinson's disease 
All neuron numbers per size category and per size class fell 
within the range of neuron numbers of age-matched controls. 
Because just one left and right hemisphere of the same Parkinson 
brain have been investigated, only the counting data of the whole 
NBMC are illustrated (Table 5.3c). 
103 
5.5 Discussion 
It is obvious that the large variation in neuron counts in 
the NBMC in AD as reported in the literature has to be attributed 
not only to differences in methodology (Table 5.1), but also to 
the disease process itself: variation exists in which subdivisi-
ons are affected [4, 11, 56, this paper]; additionally, increa-
sing age at onset of the AD cases is inversely related to the 
loss of large neurons [48]; and lastly, the duration of dementia 
may turn out to be another important variable affecting neuronal 
loss [this paper]. 
5.5.1 Discussion on methodology 
This paper points out that methodology has a major effect 
whether all neurons are counted irrespective of their size and 
staining characteristics, or whether only magnocellular, 
hyperchromatic (presumptive cholinergic) neurons are counted. 
Secondly, this paper shows that the subdivisions of the NBMC are 
differently affected in AD with respect to cell loss and cell 
shrinkage; therefore, it certainly does not suffice to investiga-
te only a small part of the NBMC, especially because the NBMC is 
a large, complex, and highly differentiated structure characteri-
zed by a marked irregularity in arrangement and distribution of 
its constituent neurons. Moreover, if neuron counts have not 
been performed systematically throughout the entire extent of the 
NBMC and its subdivisions, and therefore had to be expressed as 
numerical densities (i.e., neuron numbers per unit volume), 
possible changes in length or volume of the NBMC could not have 
been taken into account. As this paper demonstrates (Table 5.5), 
the length of the NBMC in AD is significantly shorter, and this 
finding itself makes the cell loss even more severe than is 
indicated by decreased density alone. 
Until now, only two studies [4, 5] performed neuron counts 
systematically throughout the entire rostrocaudal extent of the 
NBMC, as was done too for the nucleus basalis of Meynert [29, 
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32]; however, in these studies only large, hyperchromatic neurons 
were counted. Quantitative studies that did count all neurons 
irrespective of size and staining characteristics, showed an 
increase in small-sized neurons [1, 37, 41, 53], indicating 
neuronal shrinkage. However, these studies were possibly biased 
by either the use of mean densities instead of total neuron 
numbers [1, 37, 41, 53], or by overcounting due to splitting 
error of the perikaryon [1, 37, 53] that was used as counting 
item instead of the nucleolus (Table 5.1). 
All studies but those that performed systematic counts 
expressed neuron numbers as numerical densities i.e., number per 
unit volume. Use of this parameter is only permitted under the 
assumption of stability of total volume of the brain structure of 
interest under pathological conditions. However, recent studies 
[36, 47] clearly demonstrated changes in total volume of 
particular brain structures in various neurological and psychiat-
ric disorders. The present study revealed a significant decrease 
in the total length (and probably in volume, too) of the Ch4p 
region of the NBMC. Since neuropathologists so far have almost 
exclusively used numerical densities in their search for changes 
in the brain in relation to various neurological and psychiatric 
conditions, alterations in total neuron numbers may have been 
underestimated or exaggerated. Therefore, numerical densities 
are parameters to avoid. This bias generated by using numerical 
density and by investigating only a small part of the NBMC, can 
be avoided by applying the Cavalieri's principle [9, 20, 31, 49] 
upon the whole NBMC or any structure in general. The Cavalieri's 
principle can be used as a total volume estimator: the total 
volume of any arbitrary object can be estimated by summation of 
the cross-sectional areas of systematically taken (i.e., at 
regular intervals with a random start) equidistant sections, 
multiplied with the distance between two sections (see Fig. 5.4). 
If at least eight systematic sections are used, the total volume 
can be estimated with a coefficient of error (CE) less than five 
percent [20]. Total cell number can be obtained by multiplying 
the total volume by the mean numerical density. However, 
reliable determination of cross-sectional areas demands 
105 
et' 
I 
о [? 
О Q 
7 
PODO 
О о 
UGO 
V (total) = ^ Д.* d 
¿— I 
I - 1 
Fig. 5.4: Cavalieri's principle to estimate total volume of any arbitrary 
object on at least 8 systematical sections, resulting in a relia-
bility of >95%. 
sharply delineated boundaries of the structure of interest, a 
requirement the NBMC cannot fulfill because of its indistinct 
boundaries (see Fig. 5.1). We developed a 3-dimensional-sainpling 
scheme through a dissected part of the brain large enough to 
contain the whole NBMC, under the necessity that it is possible 
to identify unambiguously each neuron belonging to the NBMC [19]. 
Bias can then be eliminated by sampling neurons (regardless of 
their size and staining characteristics) systematically throug-
hout the length of the whole NBMC. Theoretically, such a 3-
dimensional-sampling design can be applied to any arbitrary 
object independent of its shape without homogeneity assumptions 
and without regard to distinct or indistinct boundaries [20]. 
Although the 3-d-sampling method seems to be elaborate because 
samples at several levels have to be taken through the whole 
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extent of the structure, it is not as time consuming and 
inefficient as expected at first glance: as Fig. 5.2b points out, 
it can be realized that counting more than 200 neurons is not 
worth the effort: a tenfold increase in workload (2000 neurons 
instead of 200) only enhances the reliability from 95 to 98%. It 
is the sampling step that is time consuming, but not the counting 
step since 200 neurons always suffice for a reliability of 95% 
in a 3-d-sampling design. The workload is largely dependent on 
the number of subdivisions and size categories investigated, 
since in each subdivision or size category per subdivision 200 
neurons have to be sampled to reach 95% reliability or 50 
neurons for 90% reliability. If one is only interested in total 
neuron numbers (not classified into size classes) of the whole 
NBMC, sampling and counting will take no more than 2 hours per 
hemisphere. However, for making statements about all subdivisi­
ons including size categories, two days workload are necessary to 
maintain a reliability of at least 90% for each of the 24 
constituting subsets in our analysis (four size categories per 
Chl+Ch2,· per СЬЗ; Ch4am; Ch4al ; Ch4i and Ch4p) . An exact 3-
dimensional-sampling scheme cannot strictly be realized in 
practice, but can at best be approximated. Therefore the value 
of the estimated CE of each neuron number will in fact be 
slightly higher. So, sampling more than 200 neurons does not per 
se imply a reliability of over 95%. However, this certainly does 
not mean any release from applying a 3-d-sampling scheme as 
carefully as possible. 
For determination of neuron size the maximum diameter was 
measured with the nucleolus being in focus. This approach is 
biased in two ways: firstly, maximum diameter is dependent on the 
orientation of the neuron in space and therefore on the angle of 
the section plane; secondly, focussing at the level of the 
nucleolus and measuring the maximum diameter does not ensure the 
real maximum diameter of the neuron [6]. The possibility of 
nucleolus displacement from the centre of the soma is far from 
theoretical, because accumulation of lipofuscin in normal aging 
and moreover presence of neurofibrillary tangle formations in 
Alzheimer's disease in fact do displace the nucleus and nucleolus 
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towards an eccentric position. However, to maintain the 
possibility of comparison with data from the literature, no 
correction for this bias has been made. 
The effect of different section thickness (10 or 20 цт) upon 
probable nucleolus splitting in paraffin sections [e.g. 10, 11] 
is of no significant influence [submitted, 1989]: using the 
disector [46] to trace actual splitting of nucleoli in two 
adjacent sections only 10.5% of 100 nuclei and none of the 
nucleoli were split in 10 цт sections. Therefore, it was 
justified to use both 10 цт and 20 цт serially sectioned brains 
in the same series, if the nucleolus is the counting item. 
5.5.2 Discussion of results 
The counting data obtained by this 3-dimensional-sampling 
method represent the first unbiased total neuron numbers of the 
NBMC and its subdivisions. For the nucleus basalis of Meynert 
(Ch4) the total neuron number per hemisphere was 164.000 neurons 
larger than 37.5 цт and 274.000 neurons sized between 25.0 and 
37.5 цт in the normal aged brain. This is not considerably 
different from the 200.000 neurons larger than 30 цт [4] and 
almost similar to the 150.000 [32] and 120.000 [29] neurons 
larger than 35 цт in control patients over the age of 65 years 
[32] and in the 9th decade respectively [29]. For the first time 
neuron numbers in Ch3 are determined: 3000 neurons larger than 
37.5 цт on a total of 64.000 neurons. 
In AD an overall neuron loss of only 15.5% for the whole NBMC 
and 19.5% for Ch4 was demonstrated. This is in full agreement 
with another study [37], in which antibodies to choline acetyl-
transferase were used and that reported an 18% neuron loss of the 
Ch4a in one AD brain without taking a minimum size criterion for 
neurons into account. Moreover, neuron numbers clearly reveal a 
differential involvement in the pathology of the subdivisions of 
the NBMC in AD: whereas the rostral Chl+Ch2 region shows no 
neuron loss at all, Ch3, Ch4a, Ch4i and especially Ch4p are 
significantly affected. Ch4p is the only subdivision with a 
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rather circumscript projection pattern to monkey temporopolar and 
superior temporal cortex [33] and therefore it would be interes­
ting to investigate cholinergic changes in these cortical areas 
in AD patients in order to indirectly verify anatomical connecti­
vity between Ch4p and these cortical structures in human. 
Total neuron numbers per size category unequivocally detect a 
shift from large into small neurons resulting in a significant 
increase of small-sized neurons (<12.5 \im) for the NBMC as a 
whole and for all the subdivisions, ranging from 9 to 48% for the 
right hemisphere, and from 38 to 79% for the left (no significant 
differences could be detected between neuron numbers of left and 
right hemispheres in both AD and age-matched controls). Many 
investigators (Table 5.1) reported a marked loss of magnocellular 
neurons in the NBMC in AD; our results support these reports: we 
found a 68% reduction in neurons with a maximum diameter >37.5 \im 
for the whole NBMC and a 70% reduction for Ch4. 
Subdividing the AD patients in early onset (n=5) and late 
onset AD patients (n=5) no significant differences were found in 
either mean total neuron numbers per size category nor in the 
mean duration of apparent dementia (8.25 years +2.8 (SEM) versus 
8.2+2.4)(Table 5.2). However, in late onset AD a rather strong 
correlation can be demonstrated between duration of dementia and 
numbers of large neurons 037.5 μπι: r=-0.80, p=0.06; >25.0 цт: 
r=-0.61, p=0.15), whereas no correlations can be indicated for 
early onset (r=0.16; p=0.71 and r=0.19; p=0.66, respectively). 
This finding suggests the possibility of a different disease 
process for late onset AD, although these data have to be 
interpreted with caution, because: 1) the validity of the start 
point of dementia and thus its duration time is difficult to 
ascertain, 2) the duration time is not necessarily correlated 
with the degree of dementia (not assessed in this study), 3) the 
number of brains in this study is limited, and 4) it is methodo­
logically wrong to quantitate only magnocellular neurons, as this 
paper demonstrates. 
Considering the loss of large neurons and the absolute 
increase in small neurons, our results suggest neuron death and 
neuron shrinkage as well. In the Chl+Ch2 region that projects 
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mainly to the hippocampus, which is heavily affected in AD, only 
shrinkage seems to occur, possibly suggesting a secondary 
retrograde degeneration process. In other NBMC subdivisions 
shrinkage combined with neuron death (to a limited extent) can be 
found. Whether neuron death has to be interpreted as the 
ultimate result of shrinkage due to secondary degeneration or as 
a possible primary degeneration process due to yet unknown 
factors has to await further future analysis. Atrophy of 
cholinergic neurons has been described in rat, monkey and man 
following cortical damage [38, 43, 44, 45], indicating retrograde 
degeneration. It has been hypothesized that lack of specific 
neurotrophic factors could be the cause of Alzheimer's' disease 
[2], such as lack of nerve growth factor (NGF) [22]. It is well 
known, that retrograde transport of NGF to basal forebrain 
cholinergic neurons occurs from their target zones in hippocampus 
and cerebral cortex, that NGF exerts a cytoprotective effect on 
cholinergic cells following fimbrial transection and that NGF 
elevates choline acetyltransferase activity in vitro and in vivo 
[54]. Immunocytochemical studies have shown extensive loss of 
NBMC neurons positive for nerve growth factor-receptors (NGF-r) 
[23, 26]. In contrast, no change in NGF-r mRNA levels in basal 
forebrain [17] nor in NGF mRNA levels in cerebral cortex [16] 
from patients with AD was found using RNA dot-blotting techni-
ques. However, using the more sensitive, quantitative in situ 
hybridization analysis, it was recently demonstrated that NGF-r 
gene expression is extensively decreased in the Ch4 region, but 
not in the Chl+Ch2 region in AD [24]. The reduction in NGF-r 
gene expression was most severe in Ch4p, the posterior part of 
the NBMC. This rostrocaudal decrease in NGF-r gene expression 
closely matches our findings of increasing cell loss and 
shrinkage from the anterior Chl+Ch2 region to the posterior Ch4p. 
Recent studies suggest that NGF regulates the expression of its 
own receptor in the central nervous system [12, 28]. Therefore, 
the decrease in NGF-r gene expression in NBMC neurons in AD may 
result from a lack of NGF support due to cortical atrophy. 
Moreover, insulin and insuline-like growth factors I and II (IGF) 
potentiate the response to NGF by increasing the number of NGF-
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r e c e p t o r s by an u p - r e g u l a t i o n of t h e NGF-r gene [ 4 0 ] . A p o s s i b l e 
d e f e c t i n IGF d i f f u s i o n from t h e p r o d u c t i o n s i t e s i n n e o c o r t e x 
and hippocampus t o t h e axona l e n d i n g s of t h e b a s a l f o r e b r a i n 
c h o l i n e r g i c n e u r o n s may c o n t r i b u t e t o t h e l a c k of NGF a s a 
consequence of m e c h a n i c a l b a r r i e r s due t o amyloid d e p o s i t i o n s i n 
AD; u s i n g i n s i t u h y b r i d i z a t i o n t e c h n i q u e s we were a b l e t o 
d e m o n s t r a t e t h a t IGF i s produced i n t h e e n d o t h e l i a l c e l l s of t h e 
v e s s e l w a l l [ B r o e r e and Vogels , u n p u b l i s h e d o b s e r v a t i o n s ] . I n 
AD, amyloid d e p o s i t i o n s known a s c o n g o p h i l i c a n g i o p a t h y may 
p r o v i d e such a b a r r i e r [ 1 5 ] . 
I n c o n c l u s i o n , our f i n d i n g s t h a t n e u r o n d e a t h i s l i m i t e d i n 
t h e NBMC and t h a t n e u r o n s h r i n k a g e i s a main n e u r o p a t h o l o g i c a l 
f e a t u r e i n AD may p r o v i d e a b a s i s on which t h e t h e r a p e u t i c 
a s p e c t s of n e u r o t r o p h i c f a c t o r ( s ) can be e x p l o r e d . 
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CHAPTER 6 
NEURONAL HYPERTROPHY IN THE HUMAN SUPRAOPTIC AND PARAVENTRICULAR 
NUCLEUS IN AGING AND ALZHEIMER'S DISEASE 
O.J.M. Vogels, C.A.J. Broere and R. Nieuwenhuys 
(Neuroscience Letters 1990: in press) 
6.1 Abstract 
In the literature activation of the hypothalamo-neurohypo-
physeal system (HNS) in normal aging has been demonstrated in rat 
and human. This activation might be secondary to an age-related 
decline in vasopressin binding sites in the kidney, or to cell 
loss in the supraoptic (SON) and paraventricular nuclei (PVN) 
and/or to an age-related decline in noradrenergic (NA) innervati-
on of the hypothalamus. This study shows neuronal hypertrophy in 
SON and PVN in normal aging and an additional hypertrophy in 
Alzheimer's disease. No cell loss could be demonstrated in both 
conditions. 
6.2 Introduction 
It has long been known that the neurohormones vasopressin 
(AVP) and oxytocin (OXT) are produced in the supraoptic (SON) and 
paraventricular nucleus (PVN), two centres situated in the 
anterior hypothalamus [2]. In the SON a predominance of AVP 
cells was found ranging from 90% [7] to 95% [5]. In the PVN 53% 
of the magnocellular neurons were shown to be AVP cells [7], 
whereas others reported 70-80% AVP cells in the PVN [5]. 
In the aging rat an increased activity of the AVP-cells has 
been reported [6], and cell numbers of SON and PVN were found to 
be unchanged [26]. Recently, an age-related increase of the 
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blood levels of AVP was demonstrated in humans [8,15,24], and an 
increase in nucleolar [12] and cellular size of human AVP-cells 
after 80 years of age [7] also indicated an activation of AVP-
cells; similar changes in nucleolar and cellular size were found 
in senile dementia of the Alzheimer type (SDAT) [7]. Three 
explanations for this activation of the hypothalamo-neurohypophy-
seal system (HNS) in aging have been indicated in the literature: 
1. The activation of the AVP cells could serve as a compensatory 
mechanism for cell loss in the SON and PVN (cf.[7,12]). 
2. The HNS-activation might be secondary to an age-related 
decline in AVP-binding sites in the kidney as has already been 
shown in rat [23]. 
3. Increased HNS-activity might be related to a reduction of 
noradrenergic (NA) innervation of magnocellular SON and PVN 
neurons, originating from the locus coeruleus [16]. Evidence 
for such a reduction has been provided for the aging rat 
[28,29]; in the aging human brain cell loss in the locus 
coeruleus has been demonstrated [21,32], and in Alzheimer's 
disease (AD) cell loss is even much greater [3,18,32], 
strongly suggesting a reduction in NA hypothalamic input. 
Total neuron number in the human PVN was recently found to 
remain constant in normal aging [11]. Until now, it is not known 
whether cell loss in the human PVN occurs in AD, nor whether cell 
loss in the human SON occurs in normal aging or in AD. The aim 
of this study is to determine total neuron numbers of the SON and 
PVN in both normal aging and AD, and to determine cell sizes of 
SON and PVN neurons in both conditions, regarding cell size as a 
rough measure for functional activity. 
6.3 Material and methods 
Fifteen normally aged (range 62-91y; mean age + SEM (standard 
error of the mean): 75.5+2.4γ) and 19 AD anterior hypothalami 
(range 65-93y; 77.3+2.2y) were processed (Table 3.1). Histologi­
cal examination showed all control brains (11 men, 4 women) to be 
essentially normal, and neuropathological study of all AD brains 
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(9 men, 10 women) confirmed the clinical diagnosis and excluded 
other structurally identifiable disorders [14]. The duration of 
illness varied between 3 and 16 years. The immediate cause of 
death was broadly similar, in +55% of both groups being associa­
ted with hypoxia and hypotension, both of which can influence 
peripheral release of AVP [1,27]. No conclusive data on 
medication known to affect AVP secretion were available. Mean 
postmortem delays (hrs) in age matched controls (AMC) were 
longer than in AD (33+2.7 versus 11+1.2), whereas fixation times 
(months) were similar (5.8+0.5 versus 5.2+0.8). In our brain 
material, the entire rostrocaudal extent of the SON was present 
in all of these anterior hypothalami; however, the PVN with its 
long dorsocaudal extension was entirely present in only 10 
normally aged (range 65-91y,· 76.0+2.8y) and 11 AD anterior 
hypothalami (69-93y; 79.2+3.0). 
After fixation in formaldehyde and embedding in paraffin, 
serial sections with a thickness of 20 μιη were cut and stained by 
cresyl-fast violet at regular intervals of 800 μιη. Morphometric 
analysis was carried out by counting the nucleoli, the traditio­
nal markers of neurons [33], and by measuring the maximum 
diameter (амл^) of the neurons. Approximately 1 out of 1000 
neurons showed double nucleoli, so no corrections were made for 
overcounting. Nucleolus counts were made at a x400 magnification 
using an ocular grid with a quadrant sampling area of 250x250 
цт
2
, subdivided into 100 small squares of 25x25 цт2 each. The 
nucleoli hitting the left and lower boundaries of the grid were 
dealt with according to the exclusion principle of Gundersen [9]. 
At a x400 magnification nucleoli were always distinct and clearly 
visible, and small neurons could be easily distinguished from 
glia. With the nucleolus in focus, the ам^х of the soma was 
determined, using the small squares of 25x25 цт2 as a measuring 
scale. The йм^х data were recorded in 4 size categories: <12.5 
μιη, 12.5-25 μιη, 25-37.5 μιη and >37.5 μιη in order to detect a 
possible shift from small-sized neurons to large-sized neurons 
indicative for hypertrophy. To determine total cell numbers and 
cell numbers per size category, we developed an efficient 
sampling design throughout the entire rostrocaudal extent of the 
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SON and PVN (1 out of every 40th section, and 1/4 of the section 
area was sampled systematically, i.e., 4 samples/1 mm7" ; sampling 
fraction: 1/160; total cell number = sampled cell number 
multiplied with 160). This systematic sampling design enabled us 
to estimate the reliability of each total number of sampled 
neurons in a particular structure [10]: sampling more than 200 
SON or PVN neurons always resulted in a sufficiently high 
reliability (>90%) (Figs 3.5a and b). Neuron numbers were 
statistically analyzed using the nonparametric Mann-Whitney li­
test. 
6.4 Results 
Total neuron numbers of PVN did not change after 65 years of 
age (mean + SEM in thousands: 122.3+4.5; n=10) nor did they 
differ from total neuron numbers in AD (123.2+3.6; n=ll). 
However, in AD neuron numbers per size category of the PVN showed 
a significant decrease (p<0.05) of small-sized neurons (<12.5 цт) 
and a significant increase (p<0.05) of large-sized neurons (>37.5 
цт; Table 6.1) as compared to AMC, indicating neuronal hypertrop­
hy of the PVN cells in AD. Although the same trend was present 
in normal aging after 65 years of age, no significant differences 
could be demonstrated between "young" (65-75y; n=6) and "old" AMC 
(76-91; n=4) (Table 6.1). 
Total neuron numbers of the SON did not change after 62 years 
of age (mean + SEM in thousands: 58.4+4.6; n=15) nor did they 
differ from total neuron numbers in AD (57.0+2.1; n=19) (Table 
6.1). However, in normal aging (after 62 years of age) neuron 
numbers of size class 25.0-37.5 цт in "old" AMC (76-91y; n=6) 
were significantly increased (p<0.05) as compared to "young" AMC 
(62-75γ; n=9), indicating neuronal hypertrophy (Table 6.1). 
Moreover, in AD neuron numbers per size category of the SON 
showed a significant decrease (p<0.05) of small-sized neurons 
(<12.5 цт) and a significant increase (p<0.0l) of large-sized 
neurons (>37.5 цт) as compared to AMC, indicating an additional 
neuronal hypertrophy of the SON in AD (Table 6.1.). 
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TABLE 6.1 
Mean neuron numbers + SEM per s i z e c l a s s of PVN and SON in 
young and o l d age-matclied c o n t r o l s and Alzhe imer 's d i s e a s e 
PVN 
UMAX (ЦШ) 
<12.5 
1 2 . 5 - 2 5 
2 5 - 3 7 . 5 
> 3 7 . 5 
a l l ce l l s 
SON 
c W x ( p i ) 
<12 .5 
1 2 . 5 - 2 5 
2 5 - 3 7 . 5 
> 3 7 . 5 
a l l ce l l s 
AMC-γ 
(n=6) 
1 9 . 0 + 3 . 0 
6 8 . 3 + 4 . 5 
2 4 . 4 + 2 . 1 
9 . 3 + 1 . 8 
1 2 1 . 0 + 4 . 6 
АМС-у 
(n=9) 
5 . 4 + 1 . 6 
2 2 . 5 + 3 . 3 
1 9 . 6 + 1 . 9 
8 . 5 + 1 . 2 
5 6 . 1 + 4 . 4 
АМС-0 
(n=4) 
1 8 . 8 + 1 . 6 
6 8 . 1 + 3 . 9 
2 8 . 1 + 2 . 9 
9 . 3 + 1 . 5 
1 2 4 . 3 + 4 . 0 
AMC-0 
(11=6) 
4 . 4 + 1 . 2 
2 2 . 0 + 2 . 9 
2 5 . 6 + 1 . 5 * 
9 . 8 + 2 . 1 
6 1 . 7 + 2 . 8 
AMC-t 
(n=10) 
1 8 . 9 + 2 . 5 
6 8 . 2 + 4 . 4 
2 5 . 9 + 2 . 7 
9 . 3 + 1 . 7 
1 2 2 . 3 + 4 . 5 
AMC-t 
(n=15) 
5 . 0 + 1 . 5 
2 2 . 3 + 3 . 3 
2 2 . 0 + 2 . 1 
9 . 1 + 1 . 6 
5 8 . 4 + 4 . 6 
AD 
( n = l l ) 
1 3 . 6 + 0 . 8 -
6 6 . 3 + 3 . 3 
3 1 . 4 + 2 . 2 
1 1 . 9 + 1 . 3 -
1 2 3 . 2 + 3 . 6 
AD 
(n=19) 
1 . 8 + 0 . 4 -
1 9 . 3 + 2 . 4 
2 2 . 6 + 1 . 5 
1 3 . 3 + 1 . 5 * -
5 7 . 0 + 2 . 1 
AD, Alzheimer's disease; AMC, age-matched controls; у, young; о, old; 
t , t o t a l ; PVN, paraventricular nucleus; SON, supraoptic nucleus; *, p<0.05; 
*-, p<0.01 according to Mann-Whitney U-test. 
No s i g n i f i c a n t c o r r e l a t i o n was p r e s e n t between n e u r o n numbers 
p e r s i z e c l a s s and e i t h e r postmortem d e l a y ( r = - 0 . 3 l , · p>0.2) or 
d u r a t i o n of i l l n e s s ( r = - 0 . 3 5 ; p > 0 . 3 ) . No d i f f e r e n c e s between men 
and women c o u l d be d e t e c t e d . No c y t o p a t h o l o g i c a l changes could 
be found i n t h e s e h y p e r t r o p h i e d c e l l s . 
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6.5 Discussion 
Our results confirm the activation of the human HNS in aging 
as reported by others [7,8,12,15,24 J. This activation is not due 
to a compensatory mechanism for cell loss in the PVN and SON 
since total neuron numbers remain constant during aging. 
Moreover, although the PVN and SON do not reveal any cell loss in 
AD, an additional activation of the HNS can be indicated in AD. 
Our results and those of others [7,12] are in contrast with a 
study reporting decreased nuclear and nucleolar volume of neurons 
in PVN and SON [17]. This difference may be due to the small 
number of subjects investigated and to the methodology used. We 
investigated several hundreds of neurons spread over approximate-
ly 9 different levels, whereas the other study [17] investigated 
40 neurons in 1 section, neglecting the changing distribution of 
AVP and OXT neurons in the PVN in rostrocaudal direction [7]. 
The total neuron number of the SON as reported here (58.400) 
is almost similar to that found in a previous study (52.600) in 5 
control persons over the age of 62 years [22], but the total 
neuron number of the PVN (122.000) is more than twice the number 
of 55.500 in the same study [22]. The discrepancy in PVN neuron 
number is probably due to the fact that the latter study 
quantitated only magnocellular cells in the PVN, that contains 
also numerous small sized neurons contrary to the SON (Table 
6.1). The less pronounced activation of the PVN as a whole in 
normal aging and in AD as compared to the SON in this study, is 
probably due to the smaller fraction of AVP cells in the PVN 
[5,7]: the effect of activation of the AVP cells is "diluted" by 
the presence of many small-sized, probably non-AVP cells in the 
PVN. Although OXT neurons in the SON and PVN are reported to be 
normal in AD [7], they are probably hypertrophied too but to a 
lesser extent than the AVP cells that might undergo an additional 
hypertrophy due to an age-related decline in AVP-binding sites in 
the human kidney as has been demonstrated in rat [23]. 
The HNS-activation in AD seems conflicting with the reported 
reduction in cerebrospinal fluid (CSF) AVP-levels in AD [19,31], 
the latter contrasting with the reported normal brain AVP-
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l eve l s (pg/mg pro te in ) in AD [20] . However, apar t from the HNS, 
AVP neurons are a lso located in the suprachiasmatic nucleus , the 
bed nucleus of the s t r i a t e rmina l i s and the medial amygdaloid 
nucleus [ 4 ] , a l l t h ree nuclei being affected in AD. Moreover, 
CSF AVP-levels are normal in d iabetes ins ip idus charac te r ized by 
decreased plasma AVP-levels [13] , suggesting two d i f f e ren t AVP-
systems. Addi t iona l ly , plasma AVP can not pass the blood-CSF 
b a r r i e r [30 ] , and l a s t l y the reported normal bra in AVP-levels in 
AD are expressed as concentra t ions [20] , leaving the p o s s i b i l i t y 
of t o t a l AVP amounts being decreased in the atrophied AD bra in . 
Fur ther , in AD the increased CSF volume may a l so a t t r i b u t e to the 
decreased AVP CSF-levels. 
7m age - r e l a t ed decl ine in AVP-binding s i t e s in the human 
kidney as has been demonstrated in r a t [23] can not be excluded 
as an explanat ion for the increased AVP-activity, and needs 
fur ther c l a r i f i c a t i o n . Also, the HNS-activation might be a 
secondary event due to changes within the c e n t r a l nervous system 
i t s e l f . A dec l ine in the NA innervat ion of the magnocellular SON 
and PVN neurons could play a ro l e in t h i s respect [3 ,18 ,21 ,28, 
29] , although no conclusive evidence e x i s t s for inh ib i to ry 
p rope r t i e s of the NA system upon the hypothalamus. Hypothalamic 
compensatory mechanisms have already been described in the 
dopaminergic pathways in Parkinson 's d isease [25] ; s i m i l a r l y , the 
a c t i v a t i o n of the HNS in AD could may as a compensatory mechanism 
for decreased noradrenergic inputs in the SON and PVN. 
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CHAPTER 7 
NEUROPATHOLOGY OF THE NUCLEUS BASALIS MEYNERT COMPLEX, THE 
SUPRAOPTIC AND PARAVENTRICULAR NUCLEI, AND THE ORGANUM VASCULOSUM 
OF THE LAMINA TERMINALIS IN AGING AND ALZHEIMER'S DISEASE 
7.1 Abstract 
A review of the recent literature concerning neuropathologic 
determinants in Alzheimer's disease is presented. Data are given 
on neurofibrillary tangles, senile plaques, congophilic angiopa­
thy, (granulo)vacuolar degeneration, lipofuscin accumulation and 
neuronophagia in the nucleus basalis Meynert complex, the 
supraoptic and paraventricular nuclei, and in the Organum 
vasculosum of the lamina terminalis. The results will be 
discussed in relation to the issue of primary and/or secondary 
degeneration of the cholinergic system in Alzheimer's disease. 
7.2 General introduction 
The main neuropathologic features of Alzheimer's disease (AD) 
consist of granulovacuolar degeneration, the presence of Hirano 
bodies, neurofibrillary degeneration, senile plaques, congophilic 
angiopathy, and loss and shrinkage of neurons [94, 121]. 
7.2.1 Granulovacuolar degeneration 
Granulovacuolar degeneration of Simchowicz [111] has been 
described in neurons of the pyramidal cell layer of the hippocam­
pus [56, 94, 121]. This neuronal change consists of one or more 
vacuoles with a diameter of 3-5 μπ» in the cytoplasm. Each 
vacuole contains a granule, immunohistochemically positive for 
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tubulin, abnormally phosphorylated neurofilaments and the 
microtubule-associated protein tau [29]. Sometimes the cytoplasm 
is completely filled with and distended by several (up to 20) 
vacuoles, giving the neuron a swollen appearance. The number of 
neurons showing granulovacuolar degeneration (GVD) in AD varies 
between 20 and 50% of the pyramidal neurons [119], and correlates 
with the duration of dementia [12]. The localization is mainly 
restricted to the ventrolateral quadrant of the hippocampus [13, 
135]. It needs to be stressed that GVD may be present also in 
nondemented subjects over the age of 65; in the ninth decade GVD 
can be demonstrated in 75% of the control cases [119]. However, 
the number of affected neurons does not exceed 9% 'of the 
pyramidal cells in the ventrolateral quadrant. Therefore, GVD is 
not pathognomonic for AD as it is present (to a limited extent) 
in normal aging too. In AD GVD has also been described in the 
nucleus basalis Meynert complex (NBMC) [60, 128] and, recently, 
in the cingulate and insular cortex [20]. Moreover, GVD has been 
reported in progressive supranuclear palsy [113], in amyotrophic 
lateral sclerosis, the Parkinsonism-dementia complex of Guam [52, 
54], and in Down's syndrome [71]. These findings constitute 
important exceptions to the rule that only pyramidal neurons in 
the hippocampus are subjected to GVD and that GVD is limited to 
AD and aging. In this study semi-quantitative data on GVD in the 
NBMC in aging and AD are presented. 
7.2.2 Hirano bodies 
Hirano bodies were originally described in the Parkinsonism­
dementia syndrome of Guam [53] and are mainly found adjacent to 
and within pyramidal neurons of the hippocampus. They are ovoid 
in shape, eosinophilic, and 10-30 цт long. They contain actin 
[38] and are immunohistochemically positive for microtubule-
associated protein-2 and tau [95]. They occur both in normal 
aging and in Alzheimer's disease [42], as well as in several 
other neurological disorders [54, 100, 108, 122]. Hirano bodies 
can not be considered as pathognomonic for AD, and their 
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pathogenesis and relevance is poorly understood. In the present 
study semi-quantitative data on Hirano bodies in the NBMC in 
aging and AD are given. 
7.2.3 Amyloid 
Neurofibrillary degeneration, the dystrophic neurites and the 
core of senile plaques, and the congophilic angiopathy are all 
composed of a protein that has been designated as amyloid by its 
staining characteristics [30, 31, 97] and its X-ray diffraction 
[33], demonstrating protein arrangements in a twisted ß-pleated 
sheet conformation [65]. The optical properties of amyloid as 
revealed by Congored-staining (yellowish-green birefringence 
under polarized light) depends on this ß-pleated sheet conforma-
tion [43]. 
The biochemical constitution of extraneuronal amyloid in 
senile plaque cores and congophilic angiopathy has recently been 
elucidated. in both AD and Down's syndrome (trisomy 21) the ß-
protein or A4-protein has been shown to be the major component of 
the congophilic angiopathy [46] and the senile plaques [79, 110, 
133]. This ß-protein consists of a sequence of 42 amino acids 
and is cleaved by proteolysis from a larger ß-protein precursor 
(BPP). The BPP consists of 695 amino acids and resembles a cell 
surface receptor [61]. The BPP-gene is located on chromosome 21 
[48, 61, 101, 114] in the same region of two loci that are linked 
to the genetic defect in familial AD (FAD)[112]. However, recent 
linkage analyses have shown that loci for the FAD are localized 
some distance from the BPP-gene and thus are not linked to it 
[107, 124]. 
An increased dosage of the gene coding for the BPP in both AD 
and Down's syndrome (trisomy 21) was postulated as the pathogenic 
mechanism [28], but this hypothesis could not be confirmed [114, 
124]. Moreover, (1) the absence of linkage between the FAD-gene 
and the BPP-gene [107, 124], (2) the ubiquity of BPP-mRNA in many 
organs in a variety of species, with the highest levels in brain 
tissue [11, 47], and (3) and the resemblance of BPP to a cell 
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surface receptor [61], all suggest a physiological rather than a 
pathological role in AD [93]. Instead, as p-pleated sheet 
fibrils can aggregate as amyloid [44] after partial proteolysis 
of several normal plasma and tissue proteins, such as prealbumin 
[32], it is more reasonable to suggest that the abnormal 
formation of ß-protein arises from posttranslational modification 
from either the BPP or the proteases responsible for the 
conversion of BPP into the (3-protein. For instance, due to 
alternative splicing the BPP-mRNA may contain an additional 
domain of 56 amino acids with a sequence homologous to serine 
protease inhibitors [66, 96, 115]. Moreover, the serine protease 
inhibitor «i-antichymotrypsin is tightly associated with the ß-
amyloid deposits in senile plaque cores and in the congophilic 
angiopathy [1]. These latter two unrelated protease inhibitors 
associated with the ß-protein may contribute to the resistance of 
amyloid deposits to clearing by further proteolytic cleavage. 
The intraneuronal neurofibrillary tangles (NFT) are intracel-
lular, perikaryal accumulations of fibrous material, ultrastruc-
turally composed of paired helical filaments (PHF) [64, 132]. 
From immunohistochemical studies it became clear that several 
proteins may participate in the composition of the PHF. However, 
it is still not certain which protein is actually involved in the 
PHF composition: neurofilament proteins [27], microtubule-
associated protein 2 (MAP2) [68], microtubule-associated protein 
tau (tau) [134], ubiquitin [73, 86] or ß-protein [50, 58]. In a 
recent study [49] the presence of ß-protein-immunoreactivity in 
PHF could not be confirmed. Although ß-protein was demonstrated 
in different types of neurons, including those with NFT, it was 
not present in the PHF itself [49]. Recently it has been shown, 
that the process of tangle formation is reflected by its changing 
immunoreactivity: accumulation of abnormally phosphorylated-tau 
proteins precedes the formation of intraneuronal NFT [14], and 
that the endstage is characterized by extraneuronal "ghost-
tangles" that are only immunoreactive to ubiquitin [23]. 
In conclusion, the ß-protein is the major component of 
amyloid fibrils of senile plaque cores, of congophilic angiopathy 
and perhaps of the PHF of the NFT. Additionally, the metabolism 
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of the BPP may be modified by altered proteolytic processing in 
AD, resulting in the deposition of the amyloid fibrils composed 
of ß-protein. 
7.2.4 Neurofibrillary degeneration 
The neurofibrillary degeneration or tangle (NFT) formation 
was first described by Alzheimer [3, 4] in the cerebral cortex of 
a 51-year old woman with a dementing illness. NFT's are easily 
seen in formalin-fixed tissue sections using silver impregnation 
methods [39, 40], fluorescence methods as thioflavine-S [109] and 
congored [98], the congored polarization method [97] and several 
immunohistochemical stainings against their composing proteins. 
Apart from AD NFT could also be demonstrated in normal aging 
[117], Down's syndrome [71], the Parkinsonism-dementia complex of 
Guam [52] and many other neurological disorders [121]. Recently, 
NFT were demonstrated in the NBMC ipsilateral to a massive 
cerebral infarct in the territory of the middle cerebral artery. 
Tangles were absent or rare in the contralateral NBMC and in 
other brain areas, suggesting that NFT can occur as a retrograde 
reaction in basalis neurons secondary to an old infarcation [62]. 
In AD NFT are abundantly present in the hippocampus, entorhi-
nal cortex and amygdala [63, 118], numerously in the neocortex 
[75, 129], and to a lesser extent in subcortical structures as 
the NBMC [7, 99, 103, 106], the thalamus and hypothalamus [81], 
and brainstem structures like the substantia nigra and locus 
coeruleus [59, 74]. In the neocortex the NFT occur in clusters 
in lamina III and V [91]. In the entorhinal cortex NFT has been 
shown to cluster in layer II [57]. It is still not clear whether 
NFT reflect lost neurons or represent degenerated (but not yet 
lost) neurons [77]. 
In the present study quantitative data are presented on the 
numbers of NFT in the subdivisions of the NBMC, the SON and the 
PVN; the numbers of NFT are compared to the number of neurons 
lost in these structures [125, 126]. 
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7.2.5 Senile plaques 
Senile plaques (SP), first described by Blocq and Marinesco 
[17], are discrete, roughly spherical structures within the 
neuropil with a diameter ranging from 10 to 200 цт across. SP 
are subdivided into three stages of increasing degeneration 
[131]: 
the primitive plaque (few swollen neurites and few astrocytic 
processes, without an amyloid plaque core); 
mature or diffuse plaque (many swollen neurites and astrocytic 
processes, microglial cells, with a dense central amyloid co­
re) ; 
burnt-out plaque (a dense central amyloid core, with many 
astrocytic and microglial cells). 
SP can be detected in formalin-fixed tissue sections using silver 
impregnation methods [39, 40], fluorescence methods as thioflavi-
ne-s [109] and congored [98], and the congored polarization 
method [97]. The distended neurites of primitive and mature 
plaques show immunoreactivity against axons and axonal endings of 
cholinergic neurons [9], noradrenergic neurons [67], somatostati-
nergic [87], GABA-ergic neurons [127], neuropeptide-Y containing 
neurons [24], substance-P neurons [8] and galaninergic neurons 
[21]. 
Apart from AD SP have been demonstrated in normal aging [117], 
Down's syndrome and Pick's disease [131], the ParXinsonism-
dementia complex of Guam [52], Creutzfeldt-Jacob disease [123] 
and other neurological disorders [121]. 
In AD SP are most abundantly present in the hippocampus, in 
the corticomedial nuclei of the amygdala [76] and in the 
association areas of the neocortex and less numerous in primary 
visual, auditory, somatosensory and motor areas [37, 91, 102]. 
The density of both SP and NFT in the cerebral cortex shows a 
significant correlation with the degree of dementia [16, 129]. 
In the neocortex a laminar [37, 91, 102] and columnar [10] 
distribution of SP has been demonstrated [10]. The site of the 
SP is often closely related to (degenerating) capillaries [15, 
84, 85, 90, 92]. This observation together with the fact that 
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the ß-protein was found to be the major component of both the SP-
core and the congophilic angiopathy, strongly suggest a hematoge-
nous origin of the amyloid in AD, although no real evidence is 
available of a dysfunction of the blood-brain barrier [2, 104]. 
In the NBMC the presence of SP has been demonstrated [7, 59, 
89, 105, 106]. Although it is commonly accepted that the number 
of NFT in the NBMC exceeds that of SP, no quantitative data on SP 
of the subdivisions of the NBMC are yet available. The present 
study shows quantitative data on SP in the NBMC, the SON and PVN; 
the number of SP are compared to the number of neurons lost in 
these structures [125, 126]. 
7.2.6 Congophilic angiopathy 
The congophilic angiopathy (CA) has been found in the great 
majority of AD patients [45, 84], affecting the small pial and 
intracortical arterioles, the leptomeningeal vessels and the 
intracortical capillaries [121]. In addition, CA has been 
demonstrated in the arterioles and arteries of the anterior 
perforated substance in the basal forebrain within the lateral 
part of the NBMC [7]. In the present study qualitative data are 
given on the presence of CA in the NBMC and the SON and PVN in 
the hypothalamus. 
The major chemical component of CA is the ß-protein [46], the 
same as for the amyloid core of SP [79, 110, 133]. This finding 
suggests a hematogeneous origin of the amyloid proteins due to 
possible damage of the blood-brain barrier in AD. This hypothe-
sis is strengthened by the presence of serum proteins in the 
extravascular compartment [130], the presence of immunoglobulins 
and complement factors in SP [34] and elevated cerebrospinal 
fluid/serum ratios of albumin and IgG in AD [35, 36]. However, 
these findings have to be interpreted with caution, because 1) 
postmortem leakage of serum proteins can occur, 2) areas with 
ischaemic necrosis contributing to the CSF compartiment cannot 
completely be excluded, 3) evidence of astrocytic production of 
complement factors C3 and Factor В has recently been found [72], 
131 
4) the distribution of СЛ is mainly restricted to the arterioles 
and the capillaries in the neocortex [121], whereas CA is hardly 
present in noncortical structures, and 5) the mRNA's of the ß-
protein precursor are found to be localized in the neurons [25, 
69, 80]. The postulated dysfunction of the blood-brain barrier 
is studied in a brain structure devoid of an intact blood-brain 
barrier, the Organum vasculosum of the lamina terminalis (OVLT). 
The OVLT is a highly vascular, unpaired structure located 
immediately dorsal to the optic chiasm. The capillary fenestra-
tions in the OVLT provide specific sites for the transfer of 
proteins and solutes, irrespective of molecular size and lipid 
solubility. Due to the absence of an intact blood-brain barrier 
and its high vascularity, the OVLT must be considered as a 
suitable structure to investigate whether amyloid depositions in 
AD differ quantitatively from normal aging, and to verify whether 
the cerebral amyloid deposits originate from the blood via a 
damaged blood-brain barrier. 
7.2.7 Neuron loss and shrinkage 
At the microscopical level the neocortical atrophy observed in 
AD [22, 121] consists of both cell loss and cell shrinkage [88, 
116]. Cell loss has also been noticed in subcortical structures, 
like the noradrenergic locus coeruleus [78, 120], the serotoner-
gic raphe nuclei [26], the ventral tegmental area [41] and the 
NBMC [6, 103, 106, 125, 128]. The SON and PVN, however, showed 
stability in neuron numbers [55, 126]. In neuroscience research 
on cell loss, emphasis is now being put on: 
1. obtaining total neuron numbers instead of neuron numbers per 
unit volume to avoid bias due to macroscopical volume loss; 
2. measuring neuron sizes to detect possible neuron shrinkage. 
As recent studies report minor reductions in total cell numbers 
combined with major reductions in cell size, these issues are of 
importance. 
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7.2.8 Aim of study 
The present study shows: 
1. quantitative data on NFT, SP and number of neurons showing 
lipofuscin accumulation in the NBMC, the SON and PVN; 
2. semi-quantitative data on GVD and Hirano bodies in the NBMC, 
SON and PVN; 
3. semi-quantitative data on CA in the NBMC, SON and PVN and in 
the OVLT, and on the staining intensity of the lipofuscin; 
7.3 Material and methods 
7.3.1 Material 
For detailed information on the neuropathological diagnosis of 
the cases studied and on the brain structures, the reader is 
referred to Chapter 3, "Material and Methods". Shortly, twelve 
cases of AD were selected, one case of Parkinson's disease (PD), 
and ten nondemented controls. The twelve AD cases could be 
subdivided in five early-onset (first symptoms of the disease 
manifested before 65 years of age) and seven late-onset AD cases. 
Brain regions of interest included the NBMC with the subdivisions 
Chl+Ch2, Ch3, Ch4al, Ch4am, Ch4i and Ch4p [82, 83], the SON and 
the PVN, and the OVLT. Characteristics of the brain material 
used are summarized in Chapter 3, Table 3.1. 
7.3.2 Methods 
All 23 brains were fixed in toto in 4% formaldehyde. After 
embedding in paraffin serial sections with a thickness of 10 or 
20 μιη were cut using a Jung 2050 microtome. Sections were 
stained at regular intervals of 800 μιη throughout the entire 
rostrocaudal extent of the NBMC, SON and PVN. The Kliiver-
Barrera-stained sections and the adjacent Nissl-stained sections 
were used for identification of the NBMC and its subdivisions 
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Chi to Ch4, and for the detection of granulovacuolar degenerati­
on, respectively. The adjacent congored-stain was used in 
fluorescence microscopy for quantification of the NFT, SP and CA 
[97, 98]. Although congored exhibits unspecific binding to 
lipofuscin, red blood cells, and elastic fibers, especially 
within the lamina elastica interna of the arteriole walls [97], 
it was found in our laboratory [70] that the fluorescence 
congored technique [98] was qualitatively and quantitatively 
superior to the polarized congored technique [97], the silver 
impregnation methods [39, 40] and the thioflavine-S fluorescence 
technique [109]. Using the Zeiss combined fluorescence and 
brightfield light microscope, and applying different colour 
filters, the same section could be analyzed with different 
optical techniques, permitting direct comparison of fluorescence 
congored-staining, brightfield microscopic patterns, and 
autofluorescence patterns of lipofuscin, red blood cells and 
elastic fibers. The OVLT was analyzed with both fluorescence 
congored and thioflavine-S. 
Quantitative analysis was carried out by taking 10 samples of 
250x250 μιη2 at a x400 magnification in each SOn and PVN, and in 
each subdivision of the NBMC. This approach resulted in a mean 
density (number/mm7) of all the neuropathological features 
observed: 
1. the NFT, that were subdivided into the neuropil threads [18, 
19], the intraneuronal neurofibrillary tangles and the 
extraneuronally localized ghost tangles; 
2. the SP, that were subdivided into the primitive, mature or 
diffuse, and the burnt-out plaques [131]; 
3. the lipofuscin containing neurons. 
The same samples were also semi-quantitatively analyzed for: 
4. CA, that was subdivided into capillary and arterial CA. 
Scores ranged from absent (0), weakly present (1), to abundant 
CA ( 2 ). 
5. the intensity of the lipofuscin with scores ranging from 
moderate (1) to strong intensity (2). 
Statistical analyses were performed using the distribution-
free, nonparametric Mann-Whitney U-test. 
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7.4 Results 
Fluorescence congored-staining revealed differences in the 
amount of NFT, SP and CA for the subdivisions of the NBMC in AD. 
In age-matched controls NFT, SP and CA were almost completely 
absent. In both the SON and PVN small amounts of neuropil 
threads were present in AD, whereas no amyloid deposits were 
found in age-matched controls. The morphology for each of these 
degenerative changes (Figs. 7a-7f) appeared similar for all 
brain structures. 
The NFT showed three forms : 
neuropil threads ranging in length from 20 to 200 \im (Fig. 7a) 
that were to be sprout out of the tangle (Fig. 7b); 
intraneuronal neurofibrillary degeneration; 
extraneuronal neurofibrillary degeneration or ghost-tangles 
ranging in size from 20-50 цт (Fig. 7c), with a globose shape, 
with wound fibers, reminiscent of a ball of string. 
In AD the neuropil threads and ghost-tangles were most 
frequently observed in the NBMC, and virtually absent in the SON 
and PVN (Table 7.1). 
The SP were distinguished into: 
primitive plaques; 
mature plaques with a central amyloid core (Fig. 7d); 
burnt-out plaques (Fig. 7e), 
The primitive plaques were most frequently present, but 
numerically outnumbered by NFT (Tables 7.1 and 7.2). Enormous 
amounts of NFT could be demonstrated in the NBMC. Both the 
number of neuropil threads and ghost-tangles increased in 
rostrocaudal direction (from Chl+Ch2 to Ch4p), and at the same 
time the ratio neuropil-threads/ghost-tangles decreased from 1.5 
to 0.5. As in age-matched controls almost solely neuropil 
threads and hardly any ghost-tangles are found (ratio about 4:1), 
this finding may suggest that neurofibrillary degeneration 
starts with the formation of neuropil threads. This hypothesis 
is supported by the frequently observed phenomenon that one such 
neuropil thread is connected with the ghost-tangle. 
A rostrocaudal increase (from Chl+Ch2 to Ch4p) in SP could be 
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Fig. 7a long neuropil thread (see arrows) (x400) 
b neuropil thread sprouting out of tangles (arrows) (x400) 
с cluster of ghost tangles (x400) 
d mature plaque with central amyloid core (arrow) (x400) 
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Fig. 7e burnt-out plaque (arrow) (x400) 
f congophilic angiopathy (xlOOO) 
g granulovacuolar degeneration (x400) 
h neuronophagia (xlOOO) 
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pointed out too (Table 7.2), whereas the CA (Fig. 7f) was evenly 
distributed throughout the subdivisions of the NBMC in AD (Table 
7.3). The increase of degenerative changes (NFT and SP) in 
rostrocaudal direction, is in agreement with cell counts in the 
NBMC, showing stability of cell number in the anteriorly located 
Chl+Ch2 region and significant cell loss in the posteriorly 
located Ch4p [125]. 
No differences could be detected in the percentage of 
lipofuscin containing neurons nor in the intensity of lipofuscin-
staining between age-matched controls and AD. 
No differences between left and right hemispheres could be 
detected for either of the degenerative changes. 
No Hirano bodies were found in the NBMC, the SON and PVN in 
age-matched controls and AD. 
The general aspect of NBMC neurons in old age showed dissolu-
tion of the Nissl substance and vacuolization of the 
neurons did regularly occur, sometimes showing the aspect of 
typical granulovacuolar degeneration (GVD) (Fig. 7g). The 
latter was invariantly present in AD, especially in the Ch4 
region of the NBMC. Occasionally, neurons showing GVD, contained 
also neurofibrillary degeneration with the congophilic threads 
twisting around the vacuoles as a loosely wound ball of string. 
The vacuolized enlarged neurons were sometimes surrounded by 
microglia: neuronophagia (Fig. 7h). 
Concerning the OVLT no differences in CA between normal aging 
and AD were found in both the congored and the thioflavine-S-
staining. Perivascular amyloid depositions were almost absent in 
both conditions (Table 7.4). 
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TABLE 7 . 1 
Numbers of n e u r o f i b r i l l a r y t a n g l e s i n d i f f e r e n t bra in s t r u c t u r e s 
in normal aging and Alzhe imer 's d i s e a s e A - B 
N e u r o f i b r i l l a r y t a n g l e s 
neuropil threads intraneuronal tangles ghost-tangles total 
Normal aging 
L R L R L R L R 
- Chl+Ch2 
-Ch3 
- Ch4an 
- Qi4al 
- 0i4i 
- αι4ρ 
- - - ( L R 1-
(n=8) 
1.2 + 0.8 
2.4 + 1.3 
1.0 + 0.7 
1.4 + 0.6 
1.2 + 0.7 
4.0 + 1.0 
(n=8) 
2.0 + 1.0 
1.6 + 0.7 
1.4 + 0.6 
1.2 + 0.6 
2.8 + 1.2 
4.6 + 1.1 
(Jt=8) 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
(n=8) 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
(n=8) 
0.2 + 0.2 
0.2 + 0.2 
0.4 + 0.3 
0.4 + 0.3 
0.6 + 0.3 
0.4 + 0.3 
(IP8) 
1.0 + 0.5 
0.4 + 0.3 
0.4 + 0.3 
0.4 + 0.3 
0.4 + 0.3 
1.4 + 0.6 
(n=8) 
1.4 + 0.8 
2.6 + 1.4 
1.4 + 0.9 
1.8 + 0.8 
1.8 + 0.9 
4.4 + 1.1 
(n=8) 
3.0 + 1.3 
2.0 + 0.9 
1.8 + 0.8 
2.0 + 0.8 
3.2 + 1.4 
6.0 + 1.6 
- SON (n=7;n=8) 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 
- PVN (n=5;n=5) 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 
A l z h e i m e r ' s d i s e a s e 
(n=7) (n=10) (n=7) (n=10) (lt=7) (n=10) (n=7) (n=10) 
Structure--
- Chl+Ch2 
-Ch3 
- ai4am 
- Oi4al 
- Qi4i 
- Ch4p 
- - - ( L R) 
30.6 + 3.3= 29.7+ 3.5' 
35.7 + 3.2 ' 30.6 + 4.5' 
35.7+ 4.9= 24.8 + 4.6' 
44.1 + 4.9= 28.8 + 4.8 3 
38.9 + 6.I 2 27.5 + 5.4' 
40.9 + 3.5= 33.3 + 4.2 ' 
7.6 + 1.9= 
2.1 + 0.8 1 
5.7 + 1.2= 
5.5 + 2.3= 
5.3 + 1.7= 
7.3 + 2.5= 
._. 
3.4 + 0.8= 
0.5 + 0.3 
3.2 + l . l 1 
5.3 + 1.5= 
5.3 + 2.Ô1 
6.6 + 1.4' 
23.6 + 3.5= 20.6 + 3 .0 ' 
15.8 + 2.5= 14.7 + 3 .2 ' 
37.4 + 6.0= 25.8 + 7 .2 ' 
50.5 +10.3= 40.8 + 9 .4' 
56.7 +12.1' 41.8 + 7 .3 ' 
65.6 +10.1= 67.2 +12.5' 
61.7 + 4.3= 
53.6 + 3.2= 
78.8 + 6.2= 
100.1 +10.5= 
100.9 +11.0= 
113.8 + 9.2= 
53.8 + 3.7' 
45.8 + 4.7' 
53.8 + 6.1' 
74.9 + 9.0' 
74.6 + 6.1' 
107.1 +10.3' 
- SON (n=8;n=ll) 0.1 + 0.1 0.0 + 0.0 0/0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.1 + 0.1 0.0 + 0.0 
- PVN (n=5;n=6) 0.4 + 0.2 0.5 + 0.3 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.4 + 0.2 0.5 + 0.3 
L, left hemisphere; R, right hemisphere; 
A
, the number of NFT is expressed as number/mm2; 
B
, data are mean of the number, n, cases + standard error of the mean (SEM); 
1
, p<0.05; 2, p<0.01; 3, p<0.001, according to Mann-Whitney U-test. 
139 
TABLE 7. 2 
Numbers of s en i l e plaques in different brain structures 
in Alzheimer's disease Ä'-B 
Senile plaques 
primitive plaques nature plaques burnt-out plaques total 
L R L R L R L R 
S t r u c t u r e — 
- ail+Ch2 
-Ch3 
- ai4am 
- 0 i 4 a l 
- 0l4i 
- ai4p 
(n=7) 
0.9 + 0.5 
0.5 + 0.5 
1.4 + 0.5 
2.1 + 0.81 
1.4 + 0.6 
2.3 + 0.61 
( L R ) 
(n=10) 
0.8 + 0.4 
0.8 + 0.4 
0.5 + 0.2 
1.1 + 0.4 
1.6 + 0.6 
1.6 + 0.6 
(n=7) 
0.2 + 0.2 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
(n=10) 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.2 + 0.2 
0.8 + 0.8 
(n=7) 
1.1 + 1.1 
0.0 + 0.0 
0.7 + 0.7 
0.7 + 0.5 
0.2 + 0.2 
0.2 + 0.2 
(n=10) 
0.2 + 0.2 
0.0 + 0.0 
0.8 + 0.6 
1.6 + 1.3 
0.3 + 0.2 
0.5 + 0.2 
(n=7) 
2.3 + 1.5 
0.5 + 0.5 
2.1 + 0.8 
2.8 + 0.8 
1.6 + 0.6 
2.5 + 0.6 
(n=10) 
1.0 + 0.4 
0.8 + 0.4 
1.3 + 0.6 
2.7+ 1.3 
2.1 + 0.6 
2.9 + 0.6 
- SON (n=8;n=ll) 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 
- PVN (n=5;n=6) 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 
Data on numbers of SP in different brain structures in normal aging are not 
shown, because no SP were sampled. 
L, left hemisphere; R, right hemisphere; A, the number of SP is expressed as 
number/mm2; B, data are mean of the cases + standard error of the mean (SEM); 
i
, p<0.05; *, p<0.01; -*, p<0.001, according to Mann-Whitney U-test. 
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TABLE 7.3 
Congophilic angiopathy and lipofuscin in different brain 
structures in normal aging and Alzheimer's disease A - s 
N o r m a l 
- 011+0)2 
-Ch3 
- Qi4am 
- Ch4al 
- Ch4i 
- 0i4p 
- - - ( L 
- SON (n=7 
- PVN (n=5 
C o n g o p h i l i c 
capillaries 
a g i n g 
й )-
n=8) 
n=5) 
L 
(n=8) 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.1 + 0.1 
0.2 + 0.1 
0.0 + 0.0 
0.0 + 0.0 
R 
(n=8) 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.1 + 0.1 
0.1 + 0.1 
0.0 + 0.0 
0.0 + 0.0 
a n g i o p a t h y 
arterioles 
L 
(It=8) 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.1 + 0.1 
0.0 + 0.0 
0.0 + 0.0 
R 
(n=8) 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0,0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
0.0 + 0.0 
% of all 
L 
<n=8) 
82.5 + 2.7 
67.3 + 2.4 
84.3 + 1.6 
81.2 + 2.0 
B9.0 + 2.9 
86.5 + 2.9 
79.8 + 3.2 
75.3 + 2.1 
L i p o f u s c i n 
neurons 
R 
(n=8) 
78.8 + 3.0 
64.4 + 2.7 
84.4 + 2.2 
87.5 + 1.8 
89.3 + 2.0 
88.2 + 2.3 
80.4 + 3.1 
78.6 + 3.0 
lipofuscin intensity 
L 
(n=8) 
1.3 + 0.1 
1.0 + 0.1 
1.2 + 0.1 
1.2 + 0.1 
1.4 + 0.1 
1.3 + 0.1 
1.0 J; 0.1 
1.0 + 0.1 
R 
(η=β) 
1.3 + 0.1 
1.0 + 0.1 
1.2 + 0.1 
1.3 + 0.1 
1.4 + 0.1 
1.4 + 0.1 
1.0 + 0.1 
1.0 + 0.1 
Alzheimer's disease 
(n=7) |it=10) 
Structure 
- aü+Ch2 
- Ch3 
- 0143111 
- Oi4al 
- Oi4i 
- αι4ρ 
- - -( L R )-
(n=7) ln=10) (n=7) (n=10) (n=7) (n=10) 
1.5 + 0 . 1 2 1.4 + 0 . 1 3 0.7 + 0 . 1 2 1.0 + 0 . 1 3 81.3 + 3.3 84.4 + 3.6 1.3 + 0.2 
1.4 + 0 . 1 2 1.1 + 0 . 1 3 1.1 + 0 . 1 2 0.3 + 0 . 1 1 68.9 + 2.8 75.0 + 2.7 1.0 + 0.1 
1.5 + 0 . 1 2 1.1 + 0 . Ρ 0.7 + 0 Л 2 0.9 + 0 . 1 3 82.0 + 2.2 89.2 + 2.3 1.2 + 0.1 
1.6 + 0 . 1 2 1.3 + 0 . 1 3 0.8 + 0 . 1 2 0.9 + 0 . 1 3 74.0 + 3.1 85.9 + 2.6 1.0 + 0.1 
1.3 + 0 . 1 2 1.2 + 0 . 1 3 1.1 + 0 . 1 2 1.4 + 0 . 2 3 83.0 + 3.1 84.7 + 2.8 1.2 + 0.1 
1.5 + 0 . 1 2 1.4 + 0 . 1 3 0.8 + 0 . 1 2 0.9 + 0 . 2 3 82.4 + 2.3 78.3 + 2.5 1.2 + 0.1 
1.3 + 0.1 
1.0 + 0.1 
1.2 + 0.1 
1.2 + 0.1 
1.2 + 0.1 
1.2 + 0.1 
SON (η=β;η=11) 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 74.0 + 3.1 79.8 + 2.6 1.0 + 0.1 1.0 + 0.1 
PVN (n=5;n=6) 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 78.2 + 2.5 82.5 + 1.9 1.0 + 0.1 1.0 + 0.1 
L, left hemisphere; R, right hemisphere; л, semi-quantitative data for CA: (0) 
absent, (1) weaJcly, (2) strongly present, and for lipofuscin intensity: (1) 
moderate, (2) strong intensity; B, data are mean of η cases + (SEM); 
1
, p<0.05; 2, p<0.01; J, p<0.001, according to Mann-Whitney U-test. 
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TABLE 7.4 
Congophilic angiopathy in the Organum vasculosum of the lamina 
tenninalis in age-matched controls and Alzheimer's disease A- D 
congored thioflavine-S 
Normal aging (n=10) 0.1+0.0 0.0+0.0 
Alzheimer's disease (n=ll) 0.2+0.0 0.1+0.1 
л
, semi-quantitative data on CA in the OVLT: (0) absent, (1) weakly, (2) 
strongly present; 
B
, data are mean of the number, n, cases + standard error of the mean (SEM). 
7.5 Discussion 
Our results on NFT, SP and CA in AD, confirm previous studies 
[7, 59, 60, 99, 106]. The presence of numerous NFT and few SP is 
also in agreement with these reports. However, the finding of 
many neuropil threads in the NBMC in AD and its presence already 
in normal aging, as well as the proposed pathogenic relationship 
to ghost-tangles, has not yet been reported in literature. This 
may be due to the use of fluorescence [98] instead of the common 
polarized light technique of the congored-staining, because 
neuropil threads are not biréfringent in polarized light 
microscopy [Vogels, unpublished observations]. The length of the 
neuropil threads (20-200 μιη) is suggestive for an axonal rather 
than for a dendritic localization. Their presence in normal 
aging, outnumbering the few ghost-tangles, suggests the represen­
tation of the first stage of neurofibrillary tangle degeneration. 
This concept of axonal retrograde degeneration of the NBMC is in 
accordance with the hypothesis that NFT are largely confined to 
subcortical nuclei projecting to the severely affected neocortex 
in AD [91]. It also corresponds to the secondary cell shrinkage 
in the NBMC [125]. 
The results on the small number of SP are conflicting. On 
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the one hand they are in agreement with a recent study, using 
immunohistochemically antibodies to the ß-protein and revealing 
almost no plaques in the NBMC [89], on the other hand, two 
studies report SP in similar amounts as NFT [7, 60]. The 
discrepancy in SP number may be explained by the different 
staining methods. From our results no relationship between the 
different types of SP can be detected [131]. 
The presence and amounts of CA in the NBMC confirms previous 
studies [7, 59]. It can not be ruled out that the CA increases 
the diffusion barrier of the vessel walls, and influences the 
degeneration of the neurons of the NBMC, since neurons as large 
as those in the NBMC may be especially vulnerable to decreased 
oxygen and glucose supply. However, the same may be true for the 
neocortex where the cholinergic axons terminate. Due to 
diffusion barriers a decrease in the supply of nerve growth 
factor in the neocortex may result in retrograde degeneration of 
the NBMC neurons [5, 51]. 
The virtual absence of CA in the OVLT, a region devoid of an 
intact blood-brain barrier, in both normal aging and AD, suggests 
a nonhaematogeneous origin of the CA-amyloid. Consequently, due 
to the insolubility of the amyloid, the precursor of ß-protein 
must be produced on the spot and the metabolism of ß-protein 
precursor may modified by altered proteolytic processing (e.g. 
the production of the serine protease inhibitor «x-antichymo-
trypsin in the pericytes [1]) resulting in the deposition of the 
ß-protein amyloid fibrils. 
The presence of granulovacuolar degeneration (GVD) has 
already been reported for the NBMC [60, 128]. However, the 
ubiquity of GVD in NBMC neurons is prominent, and its possible 
relation to the formation of the NFT may reflect a certain stage 
of degeneration of the NBMC-neurons. 
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CHAPTER 8 
GALANIN-LIKE IMMUNOREACTIVITY WITHIN CH2 NEURONS IN THE VERTICAL 
LIMB NUCLEUS OF THE DIAGONAL BAND OF BROCA IN AGING AND 
ALZHEIMER'S DISEASE 
O.J.M. Vogels, К. Renkawek- C.A.J. Broere, 
H.J. ter Laak and F. van Workum. 
Acta Neuropathologica 1989;78:90-5 
8.1 Abstract 
The neuropeptide galanin is known to inhibit the evoked 
release of acetylcholine in ventral hippocampus of the rat. Co-
localization of this peptide with choline acetyitransferase in 
neurons of the cholinergic septal nuclei has been demonstrated in 
rat and nonhuman primate. The severe deficiency of the choliner­
gic hippocampal projection system arising mainly from the 
vertical limb nucleus of the diagonal band of Broca also referred 
to as Ch2 region, is a constant finding in Alzheimer's disease, a 
disorder which is neuropathologically characterized by the 
appearance of senile plaques, neurofibrillary tangles and 
congophilic angiopathy in neo- and archicortical structures. In 
the present study for the first time galanin immunoreactivity in 
the human Ch2 region is morphologically investigated and related 
to the severity of hippocampal plaques and neurofibrillary 
tangles in Alzheimer's disease. An inverse relationship between 
decreasing galanin immunoreactivity in the Ch2 region and 
increasing amounts of senile plaques and neurofibrillary tangles 
in the hippocampus can be indicated. Considering the cholinergic 
deficiency in Alzheimer's disease as a secondary phenomenon to 
primary cortical and hippocampal lesions, and realizing the 
inhibitory effect of galanin upon acetylcholine release in 
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hippocampus, this preliminary study suggests, that a decreased 
galanin immunoreactivity in Ch2 in Alzheimer's disease reflects a 
possible negative feedback mechanism to a degenerating choliner-
gic projection system. 
8.2 Introduction 
Galanin is a 29-amino acid peptide, isolated from the porcine 
intestine [27]. Galanin-like immunoreactivity (GA-LI) was found 
to be widely distributed in the animal central nervous system of 
different species [13,15,22,25,29], including human [5,11]. 
This neuropeptide may be of special interest because the presence 
of choline acetyltransferase like immunoreactivity (ChAT-Ll) and 
GA-LI has been shown in the same basal forebrain neurons in rat 
[12] and monkey [13,29]. 
Co-localization of ChAT-LI and GA-LI in a large population of 
cholinergic neurons in the rat vertical limb nucleus of the 
diagonal band of Broca has been demonstrated [12] as well as GA-
LI emerging as faintly labeled puncta within the rat hippocampus 
[14]. 
The existence of a GA-like neuropeptide in putative choliner-
gic somata in the septum-basal forebrain was found to be much 
more pronounced in the owl monkey than in the rat, and within the 
hippocampus and dentate gyrus an extensive network of GA-
immunoreactive (GA-IR) fibers could be demonstrated, closely 
resembling the distribution of putative cholinergic fibers [13]. 
This more extensive distribution of GA-like peptide in the 
cholinergic system of the monkey as compared to the rat may 
reflect an increased importance of this peptide in co-transmissi-
on processes in higher animals, and raises the possibility of a 
modulatory role for GA-like peptide(s) on functions associated 
with the hippocampus such as memory and learning. Recently it 
was demonstrated that one of the effects of galanin involves 
inhibition of the evoked release of acetylcholine in the rat 
ventral hippocampus [7]. 
The cholinergic nature of the projection from the vertical 
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limb nucleus of the diagonal band of Broca, better referred to as 
the Ch2 region [17], to the hippocampal formation is now well 
established in rat [2,23,30] and monkey [10,16]. 
Degeneration of the cholinergic system is the most consistent-
ly found abnormality in Alzheimer's disease (AD), that is 
characterized by memory impairment and intellectual decline 
[3,6]. Moreover, in AD the degree of dementia correlates with 
both the number of senile plaques and neurofibrillary tangles in 
neocortex and hippocampus [4] as well as with the deficiency of 
the acetylcholine synthetizing enzyme ChAT [19]. 
Therefore it is relevant to analyze to what degree GA-LI is 
present in the cholinergic system in normal brain and also 
whether or not GA-LI-content is changed in AD, senile dementia of 
the Alzheimer type (SDAT) and other dementing disorders. 
Very recently GA-LI has been described in the cholinergic 
nucleus basalis of Meynert [5] also known as the Ch4 region, 
which has cholinergic projections to neocortex and amygdala [17]. 
It was claimed that GA-LI increases in AD and in Parkinson's 
disease accompanied with dementia. 
The present preliminary study describes the existence and 
changes of GA-LI in the Ch2 region (vertical limb nucleus of the 
diagonal band of Broca, which has cholinergic projections to the 
hippocampus) of two human control brains, two Alzheimer's 
diseased brains and one senile atrophy brain. 
8.3 Material and methods 
Two brains from clinically diagnosed Alzheimer's disease 
patients (case 1 and 2) were selected. The neuropathological 
diagnosis was performed on paraffin embedded sections stained for 
Nissl, Bodian, Yamamoto Bielschowsky, and fluorescence congored 
[20,21] and thioflavine-S. These two Alzheimer cases differed in 
duration and severity of illness: case 1 had a duration-time of 8 
years and showed clinically advanced aphaso-apraxo-agnostic 
symptoms; case 2 lasted for 4 years with less severe dysfunctio-
ning. 
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In case 1 neurofibrillary tangles (NFT) were abundantly 
present in neocortex and hippocampus, especially in the subiculum 
area; the latter region was also interspersed with neuritic 
plaques as was the whole neocortex. Case 2 showed less NFT in 
the hippocampus and there was a predominance of small immature 
plaques in moderate numbers only. One case of familial frontal 
lobe dementia clinically imposing as Pick's disease (case 3) 
could not be neuropathologically confirmed as such, but was 
diagnosed as senile atrophy (SA): general atrophy of the 
hippocampus and whole neocortex was present especially in frontal 
and temporal lobes, showing severe loss of neurons; however, 
senile plaques and NFT were absent. Autopsy revealed no clues 
for extracranial causes of dementia. The two control cases (case 
4 and 5) showed clinically and neuropathologically no evidence of 
neurological or psychiatric symptoms (Table 8.1). 
Tissue blocks containing the vertical limb nucleus of the 
diagonal band of Broca (Ch2 region) were obtained and fixed 24 h 
in formaldehyde sublimate (case 2,3 and 4) or formaldehyde (case 
1 and 5). After dehydration the slices were embedded in ralwax 
and sections with a thickness of 8 microns were cut using a Jung 
2050 microtome. The sections were incubated with GA antiserum 
(Cambridge Research Biochemicals, Cambridge, UK) in a dilution of 
1:500 for 48 h at room temperature. Staining was performed using 
the avidin-biotin-peroxidase complex technique (ABC)[9] according 
to the manufacture instructions (Vector). Immunoreactivity was 
demonstrated by 0.05% DAB - 0.01% H 20 2 to which 0.01 M imidazole 
was added [26]. Sections were counterstained with haematoxylin. 
With regard to the specificity of the GA antiserum, control 
experiments were carried out by using a non-immune serum, and by 
preadsorbing GA antiserum with an excess of purified GA-peptide 
(Cambridge Research Biochemicals). 
Sections were investigated at a 200x, 400x and lOOOx magnifi­
cation. In each case GA-LI was evaluated on ten randomly chosen 
testfields of 250x250 цт2. Three quantitative and three 
qualitative criteria were used for this purpose: 
mean total neuron number per mm2; all neurons regardless of 
size and staining properties were counted at a 400x magnifica-
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TABLE 8.1 
brain material 
case number 
sex 
age (y) 
duration illness (y) 
postmortem delay (h) 
fixation 
clinical diagnosis 
neuropathological diagnosis 
SP and Ni Τ neocortex 
SP and NIT hippocampus 
1 
F 
85 
8 
4 
Fa 
AD 
AD 
++++ 
++++ 
2 
M 
64 
4 
3 
FaS 
AD 
AD 
+ 
++ 
3 
M 
73 
8.5 
3 
FaS 
Pick 
SA 
-
-
4 
F 
41 
24 
FaS 
Ν 
Ν 
-
-
5 
Μ 
46 
9 
Fa 
Ν 
Ν 
-
-
Characteristics of brain material: gender, age, duration time of illness, 
postmortem delay, fixation, clinical and neuropathological diagnosis, and the 
amount of neocortical and hippocampal senile plaques and neurofibrillary 
tangles. F, female; M, male; y, year; h, hour; Fa, formaldehyde; FaS, 
formaldehyde sublimate; AD, Alzheimer's disease; SA, senile atrophy; N, 
normal; SP, senile plaque; NFT, neurofibrillary tangle; ++++, numerous; ++, 
moderate; +, few; -, occasional or absent. 
tion; 
mean GA-IR neuron number per mm 2 at 400x magnification; 
percentage GA-IR neuron number of total neuron number ; 
estimation of amount of GA-IR granules per GA-IR neuron; 
estimation of staining intensity of GA-IR granules; 
description of neuron processes. 
Data concerning the percentage GA-IR neuron number of total 
neuron number were statistically analyzed using the 2-sided 
Wilcoxon test. 
8.4 Results 
Using the quantitative and qualitative criteria described 
above, the following results were obtained: Table 8.2. 
157 
The control brains (case 4 and 5) exhibited extensive GA-LI in 
the cytoplasm of over 80% of all large and small Ch2 neurons 
(Figs. la and lb). An almost uniform distribution of many 
small, intensively stained granules was present throughout the 
entire cytoplasm (Fig. 8.2a). However, at the very periphery of 
the cytoplasm an increased density of granules gave the impressi-
on of GA-LI on the outside surface of the soma as well. Some 
fusiform neurons showed a very dense, evenly intensive immunore-
activity, resembling the GA-1 type interneurons as described by 
Chan-Palay [5]. GA-IR neuronal processes were traced along a 
small distance, but were sometimes prominently present (Fig. 
8.1a). In contrast to the control brains, the AD-cases showed 
less GA-LI (Fig. 8.1c). GA-LI was most decreased in the advanced 
AD-case (case 1), in which only 53% of all Ch2 neurons exhibited 
GA-LI with low amounts of weakly stained granules per neuron. 
Applying the 2-sided Wilcoxon test, this decrease in percentage 
GA-IR neurons in case l proved to be significant at the 0.01 
level compared to both control cases 4 and 5, and at the 0.05 
level compared to cases 2 and 3. All other comparisons between 
the cases 2-5 demonstrated no significant differences. Especial-
ly the non-GA-IR neurons appeared to be shrunken and showed 
hardly any visible processes. Only the larger neurons showed low 
amounts of weakly stained granules mainly located at the 
periphery of the cytoplasm, and sometimes GA-IR dots over the 
soma surface could be pointed out (Fig. 8.2b). 
In the AD-case with less pronounced neuropathological cortical 
changes (case 2) the number of GA-IR neurons (78%) equaled that 
of the control brains, however the amount of GA-IR granules per 
neuron was clearly less in comparison with the control brains, 
but still more prominent than in the advanced AD-case (Fig. 
8.2c). The difference in clinical severity between the two AD-
cases, is also reflected in the numbers of senile plaques and 
neurofibrillary tangles in neocortex and hippocampus (Table 8.1.) 
Neuronal processes were hardly visible in both AD-cases. The 
fusiform GA-l type interneurons were still present, but less 
easily detectable because of decrease in number as well as in 
staining intensity. 
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Fig. 8.1a+b Extensive galanin-like immunoreactivity (GA-LI) in the vertical 
limb nucleus of the diagonal band of Broca in normal aging (top 
left and right). 
с Strongly decreased GA-LI in advanced form of Alzheimer's disease 
(bottom left). 
d Absence of GA-LI in control case with excess of galanin peptide 
in antiserum (bottom right). 
Magnification: a,c,d 280x; b 28x 
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Fig. 8.2a 
b 
с 
d 
Galanin-like immunoreactivity (GA-LI) in the vertical limb 
nucleus of the diagonal band of Broca: extensive in normal aging 
(top left). 
Strongly decreased GA-LI in advanced form of AD (top right). 
Decreased GA-LI in mild form of AD (bottom left). 
Extensive GA-LI in senile atrophy (bottom right). 
Magnification: 600x 
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TABLE 8.2 
Quantitative and qualitative results 
case number 
neuropathological diagnosis 
mean neuron number/mm7 
mean GA-IR number/mm2 
% GA-IR neurons 
GA-IR granules/neuron 
intensi ty GA granules 
neuron processes: - amount 
- length 
levere 
AD 
98 
53 
54 
+ 
+ 
seldom 
short 
mild 
AD 
102 
80* 
78 
++ 
+/++ 
few 
short 
+long 
SA 
107 
83-
78 
+++ 
++/+++ 
few 
short 
+long 
N 
112 
91" 
81 
+++ 
+++ 
some 
short 
+long 
N 
104 
85" 
82 
+++ 
++/+++ 
some 
short 
+long 
AD, Alzheimer's disease; SA, senile atrophy; N, normal brain; GA-IR, galanin-
like immunoreactive; +, low; ++, moderate; +++, high; *, p<0.05 and **, 
p<0.01 in 2-sided Wilcoxon test as compared to case 1. 
Surpr i s ing ly , case 3, t h a t could be r ead i ly diagnosed 
according to neuropathological c r i t e r i a as s e n i l e atrophy without 
sen i l e plaques or n e u r o f i b r i l l a r y t a n g l e s , showed GA-LI as 
extens ively as compared to the cont ro l cases : almost 80% of a l l 
Ch2 neurons were GA-positive showing numerous in tens ive ly 
s ta ined granules throughout the e n t i r e cytoplasm with an increase 
in densi ty a t the periphery of the c e l l . GA-IR processes were 
comparable to cont ro l b ra ins (Fig. 8 .2d) . 
Another i n t e r e s t i n g finding i s the s t a b i l i t y of mean neuron 
number/mm2 in Ch2 region for a l l 5 cases . 
Regarding to the s p e c i f i c i t y of the GA-antiserum, contro l 
experiments both with a non-immune serum as well as with an 
antiserum preadsorbed with an excess of GA-antigen showed 
completely no immune reac t ion (Fig. 8 . I d ) . 
These r e s u l t s demonstrate the presence of GA-LI in the Ch2 
region of the human bra in . The large pu t a t i ve chol inergic 
neurons show both cytoplasmatic GA-IR granules as well as 
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extracellular GA-IR dots along the cellular surface. This latter 
strongly suggests the possibility of GA-IR axon endings termina-
ting upon the neuronal somata. Smaller fusiform neurons showed 
very dense, evenly intensive GA-LI. In Alzheimer's disease the 
GA-LI decreases: the number of GA-IR neurons diminishes signifi-
cantly and/or the staining intensity decreases as does the amount 
of GA-IR granules per neuron, showing an inverse relationship to 
the numbers of NFT and SP in hippocampus. The senile atrophy 
brain showed GA-LI comparable to the control brains. 
8.5 Discussion 
The study presented here demonstrates the presence of GA-LI 
in the Ch2 region (vertical limb nucleus of the diagonal band of 
Broca) in two human control brains, two Alzheimer's diseased 
brains and one senile atrophy brain. 
In the control brains GA-LI was present in most of the small 
and large putative cholinergic Ch2 neurons showing GA-IR granules 
in the cytoplasma and extracellular GA-IR dots along the outer 
cell membrane. The latter could probably be interpreted as GA-
IR axon endings terminating upon neuronal somata. 
In AD a prominent decrease in both intra- and extracellular 
GA-LI could be demonstrated, however, this decrease was absent in 
the senile atrophy brain that was clinically characterized by 
dementia, but neuropathologically showed no features of Alzhei-
mer's or Pick's disease. 
The Ch2 region is well known to have cholinergic projections 
to the hippocampus [2,10,16,23,30], a limbic structure that is 
functionally involved in memory and learning processes. AD is 
clinically characterized by memory impairment and intellectual 
decline [6]. In AD the degree of dementia correlates with both 
the numbers of senile plaques and neurofibrillary tangles in the 
neocortex and hippocampus [4] as well as with the deficiency of 
the acetylcholine synthetizing enzym ChAT [19]. This cholinergic 
deficiency is most pronounced in the hippocampus [8,24]. 
Co-localization of ChAT- and GA-LI has been described in the 
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Ch2 region of the rat [13,15] and nonhuman primate [13,29]. This 
co-localization was more pronounced in the higher species. 
Recently it was demonstrated that one of the functions of galanin 
involves inhibition of the evoked release of acetylcholine in the 
rat ventral hippocampus in vivo and in vitro [7]; galanin 
therefore acts as an inhibitory modulator of cholinergic 
transmission in the hippocampus. 
The cholinergic basal forebrain system can be subdivided into 
four regions (Chi, Ch2, Ch3 and Ch4) with different projection 
patterns and different amounts of cholinergic neurons [17]. The 
major cholinergic regions are Ch2, that projects to the hippocam-
pus, and Ch4 also known as the nucleus basalis of Meynert, that 
projects to the neocortex and amygdala. 
Degeneration of the cholinergic system in AD is probably due to 
axonal damage as a result of cortical and hippocampal lesions as 
SP and NFT. Recent morphometric studies support this view of 
secondary degeneration: many of the magnocellular cholinergic 
neurons are not completely lost, but persist in a shrunken state 
[1,18,28]. Moreover, in AD a differential involvement of the Ch2 
and Ch4 region can be indicated: in Ch4 secondary cell shrinkage 
occurs as well as primary cell loss to an extent of 20% of all 
cells regardless of size properties; in Ch2 no cell loss could be 
observed, instead a shift from large neurons into shrunken ones 
was prominently present [28]. 
In the present study no cell loss in the Ch2 region was 
present either for all five cases (Table 8.2) and this finding 
strongly supports the hypothesis of secondary degeneration of the 
Ch2 system due to hippocampal lesions. 
Our results suggest an inverse relationship between decreased 
GA-LI in Ch2 in AD and increased numbers of neuropathological 
lesions in the hippocampus; the more severe these lesions, the 
lesser the GA-LI in Ch2 (Table 8.2). Because it has been shown 
that galanin inhibits the evoked release of acetylcholine in the 
hippocampus [7], a decreased GA-LI in Ch2 in AD suggests the 
possibility of a negative feed-back mechanism to a degenerating 
cholinergic system. 
Interestingly, our results indicating a GA-LI decrease in Ch2 
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in AD, are i n c o n s i s t e n t with the r e c e n t l y reported increase in 
GA-LI in Ch4 in AD and Parkinson's d i sease accompanied with 
dementia [ 5 ] . These contrad ic tory r e s u l t s may be due to the 
d i f f e r e n t i a l involvement of Ch2 (only secondary) and Ch4 (both 
primary and secondary degeneration) in AD [28] . Differences in 
f i x a t i o n and immunohistochemical procedures can be an addi t ional 
reason. 
However, t h r e e v a r i a b l e s could have influenced our r e s u l t s : 
age, postmortem delay and di f ferences in f i x a t i o n (Table 8.1). 
Concerning age and postmortem delay, the GA-LI in cases 3, 4, 
and 5 (no presence of hippocampal SP and NFT) were comparable 
although ranging in age from 41 to 73 years and in postmortem 
delay from 3 t o 24 hours (no s i g n i f i c a n t d i f ferences could be 
demonstrated applying the 2-sided Wilcoxon t e s t ) . Difference in 
f i x a t i o n procedure s l i g h t l y favoured the formaldehyde sublimate 
f i x a t i o n , although t h i s impression demands fur ther c l a r i f i c a t i o n 
based on ob ject ive grounds. Although many immunopositive and 
immunonegative neurons are located within surrounding holes , t h i s 
does not suggest neuron shrinkage and as a consequence poss ib le 
nonspecif ic s t a i n i n g , but has t o be considered as t i s s u e 
shrinkage due to f i x a t i o n a r t e f a c t s . 
In conclus ion, our prel iminary r e s u l t s demonstrate a decreased 
GA-LI in Ch2 in Alzheimer's disease p a t i e n t s , but probably not in 
p a t i e n t s with dementia of other o r i g i n . This decrease in GA-LI 
i s inverse ly r e l a t e d t o the numbers of SP and NFT in hippocampus 
in AD. This i s in agreement with the funct ional ef fect of 
g a l a n i n , i n h i b i t i o n of acety lchol ine r e l e a s e in the hippocampus. 
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CHAPTER 9 
CORRELATIONS OF NEURON COUNTS IN BOTH THE NUCLEUS BASALIS OF 
MEYNERT COMPLEX AND HYPOTHALAMUS WITH NEUROPATHOLOGICAL 
DETERMINANTS IN CORTICAL AND SUBCORTICAL STRUCTURES IN 
ALZHEIMER'S DISEASE 
9.1 Introduction 
A variety of neurological conditions, known as "system 
degenerations", involve the selective loss of specific populati-
ons of neurons, frequently at widely separated loci within the 
nervous system. The populations of neurons destroyed by a 
particular disease are often functionally related. For example, 
in amyotrophic lateral sclerosis both upper and lower motor 
neurons are lost, in primary autonomic failure of the Shy-
Drager type both pre-ganglionic and post-ganglionic autonomic 
neurons degenerate, and in olivo-ponto-cerebellar atrophy the 
main pattern of cerebellar connectivity is affected [review: 25]. 
In AD, the limbic and paralimbic regions are most severely 
affected [21]. 
It is now generally accepted, that the functional state of 
neurons depends on both the processes of axonal and transneuronal 
transport for intra- and intercellular communication, and on 
trophic support. In "neurological system degenerations", like 
AD, the processes of axonal and transneuronal transport may 
subserve the transmission from neuron to neuron of a toxic (e.g., 
aluminum [30]) or infectious agent (e.g., herpes simplex virus 
[4]), or alternatively that these diseases may result from the 
failure of normal transport of a trophic agent [1] (e.g. nerve 
growth factor [10]). 
In AD the association areas of the cerebral cortex and the 
amygdala and hippocampus as well are severely affected by SP and 
NFT [8, 21, 24]. The reasons for this apparent vulnerability to 
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SP and NFT formation are not clear though the anatomical linkage 
of these regions to the outside world via the olfactory pathways 
(the corticomedial nuclei of the amygdala and the entorhinal 
cortex of the hippocampus are primary reception areas for 
olfactory information) suggests that any putative agent responsi-
ble for SP and NFT formation might gain access to the brain via 
the olfactory pathways [17, 20]. Moreover, the hippocampus is 
strongly interconnected with the temporal and posterior parietal 
higher order association cortical areas [review: 9]. Subcortical 
cell groups that contain large numbers of NFT, such as the 
cholinergic NBMC, the serotoninergic raphe nuclei and the 
noradrenergic locus coeruleus, all have extensive neocortical 
projections, particularly to the limbic and paralimbic cortex 
[18, 19, 27]. 
Several studies describe significant correlations between 
cortical plaque counts and neuronal cell loss in (different 
subdivisions of) the NBMC [2, 3, 16], substantiating the 
hypothesis of a cholinergic pathogenesis of neuritic plaques in 
AD. However, others report no correlation between neuronal cell 
loss in the NBMC and plaque counts in various corresponding 
projection regions as the hippocampus, frontal and parietal 
cortex, and the parahippocampal gyrus [11, 12]. 
In this chapter two issues are addressed: 1), anatomical 
correlates of the distribution of the pathological changes in 
cortical and subcortical structures are determined in order to 
test the validity "the olfactory pathway hypothesis" for AD [21]; 
2), correlates between the locus coeruleus and its projection 
areas in the hypothalamus (the SON and PVN) are determined, in 
order to trace a possible relationship between decreasing neuron 
numbers in the locus coeruleus [27] and neuronal hypertrophy in 
the hypothalamus [29]. 
9.2 Material and methods 
The subdivisions of the NBMC according to the nomenclature of 
Mesulam (Chl+Ch2, Ch3, Ch4al, Ch4am, Ch4i and Ch4p) [18] and 
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their subsequent major projection areas are correlated [18]: 
- Chl+Ch2 with the hippocampus proper (HIP) and the entorhinal 
cortex (ERC); 
Ch3 with the anterior olfactory nucleus of the olfactory 
bulb (AON); 
Ch4al with area 11 according to Brodmann [5]; 
Ch4am with areas 7 and 23; 
Ch4i with area 8; 
Ch4p with areas 20 and 22, and the hippocampus proper. 
The locus coeruleus (LC) with the SON and PVN in the 
hypothalamus [15]. 
Only structures from the same hemispheres were correlated with 
each other. Unfortunately, no correlates were determined between 
the AON and the hippocampus and/or amygdala due to lack of data 
in identical hemispheres. 
Neuron counts in the subdivisions of the NBMC, and in the 
hippocampus, the AON, the LC, SON and PVN were carried out on 
sections stained for cresyl violet. Only numbers of magnocellu­
lar neurons 037.5 μπι) in the NBMC, the SON and PVN were 
subjected to the correlation analysis, because these numbers 
show the greatest reduction (NBMC) [28] or increase (SON and PVN) 
in AD [29]. SP, NFT and CA were quantitated on sections stained 
for congored fluorescence [23]. The data on structures other 
than the NBMC, the SON and PVN were provided by collaegües [6, 9, 
26, 27]. Statistical analysis was performed using the Pearson's 
correlation test. 
9.3 Results 
The total neuron number of the hippocampus correlates 
significantly (p<0.05) with the number of magnocellular Ch4p 
neurons of the NBMC (r=0.81; p=0.020). A tendency (p<0.10) of a 
correlation (r=0.60; p=0.051) of numbers of magnocellular Ch3 
neurons with total neuron numbers in the AON is found. No other 
correlates are found between neuron numbers of NBMC subdivisions 
and neuron numbers of their respective target structures. 
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TABLE 9.1 
Pearson correlations of magnocellular neuron numbers 
of the NBMC, the SON and PVN with neuropathological determinants 
in cortical and subcortical structures 
origin target nj n 2 Νχ-Ν^ Ν,-SP Ni-NFT Nj-CA 
Chl+Ch2 HIP 4 4 0.49(-) -О.бБС) -0.53(-) n.a 
Chl+Ch2 ERC 4 4 n.a -0.78("*) -0.63(*) n.a 
Ch3 AON 6 5 0.60Г) n.a n.a n.a 
Ch4al area 11 6 4 n.a -0.6ЭІ") -0.34(-) -0.52(-) 
Ch4am area 7 6 6 n.a 
Ch4am area 23 6 6 n.a 
Ch4i area 8 6 3 
Ch4p 
Ch4p 
Ch4p 
LC 
LC 
area 
area 
HIP 
SON 
PVN 
20 
22 
2 
5 
4 
9 
4 
5 
5 
4 
7 
5 
n.a 
-0.77(-") l-0.42(-) -0.51(-
-0.71(***) -0.06(-) -0.55(* 
-О.бІС) -0.02(-) -0.58(* 
n.a -0.93("*") -0.29{-) -0.50(-
n.a -0.70(") -0.22(-) -0.41(-
0.81(**) -0.70(-) -0.87(*") n.a 
-0.66(---) 0.29(-) 0.49(-) n.a 
-О.ЗО(-) 0.59{*) 0.51(-) n.a 
n.a, not available; Пі, number of normal aging hemispheres; n?, number of AD 
hemispheres; N,, number of magnocellular neurons 037.5 μπι) in NBMC, SON and 
PVN; N 2, neuron number in target structure; r, Pearson's correlation; SP, 
senile plaques; NFT, neurofibrillary tangle; CA, congophilic angiopathy; HIP, 
hippocampus; ERC, entorhinal cortex; AON, anterior olfactory nucleus; SON, 
supraoptic nucleus; PVN, paraventricular nucleus; LC, locus coeruleus; 
levels of significance are given in parentheses. -, p>0.10; *, 0.05<p<0.10; 
**, 0.01<p<0.05; ***, p<0.01. 
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The neuron numbers of Chl+Ch2, Ch4al, Ch4am, Ch4am, Ch4p, and 
Ch4p appear to correlate significantly with SP-densities of, 
respectively, the entorhinal cortex (r=-0.78; p=0.020), area 11 
(r=-0.69; p=0.030), area 7 (r=-0.77; p=0.003), area 23 (r=-0.71; 
p=0.009), area 20 (r=-0.93; p=0.003) and area 22 (r=-0.70; 
p=0.020). A tendency (p<0.10) of a correlation of neuron numbers 
of Chl+Ch2, Ch4i and Ch4p with SP-densities of, respectively, the 
hippocampus (r=-0.65; p=0.080), area 8 (r=-0.61; p=0.080) and the 
hippocampus (r=-0.70; p=0.052) is found. 
The Ch4p neuron number correlates significantly with the NFT-
density in the hippocampus (r=-0.87; p=0.005), whereas a tendency 
of a correlation of Chl+Ch2 neuron number with NFT-density of the 
entorhinal cortex is found (r=-0.63; p=0.090). No correlates are 
found between neuron numbers of other NBMC subdivisions and NFT-
densities in their respective target structures. 
No significant correlates between neuron numbers of the NBMC 
subdivisions and CA-densities in their respective target 
structures are found, although a tendency of correlation of 
neuron numbers of Ch4am, Ch4am and Ch4i appears to be present 
with CA-densities of, respectively, area 7 (r=-0.51,· p=0.090), 
area 23 (r=-0.55; p=0.060) and area 8 (r=-0.58; p=0.090). 
Whereas a significant correlation is present between numbers 
of magnocellular neurons in the SON and total neuron numbers of 
the LC (r=-0.66; p=0.005), such a relationship was not found for 
the PVN (Table 9.1). 
9.4 Discussion 
The results give no hard support for the "olfactory pathway 
hypothesis" [20], although a tendency of correlation of AON 
neuron numbers with magnocellular Ch3 neurons is found. 
Moreover, neuron numbers of several subdivisions of the NBMC 
appear to correlate with SP-densities. However, it should be 
noted that only small numbers of identical hemispheres were 
available. 
The results confirm previous studies demonstrating a relati-
171 
onship between cortical plaque formation and loss of magnocellu-
lar neurons in the NBMC [2, 3, 16]. This finding gives no direct 
evidence regarding the nature of the SP or their mode of 
formation. Degeneration of the NBMC occurs also in other 
neurologic disorders but without cortical plaque formation 
[review: 22]. Moreover, it does not solve the controversial 
issue whether the NBMC is primarily or secondarily affected in 
AD, but it only suggests a close linkage between plaque formation 
and loss of cholinergic cortical innervation. In this respect, 
it is noteworthy, that the trophic state of the NBMC neurons 
selectively depends on the availability of nerve growth factor 
(NGF) [10], being produced in the cholinergic target areas, the 
neocortex and hippocampus. These latter two regions show 
tremendous volume reduction and cell loss in AD [6, 7, 9], 
resulting in severe reduction of NGF-production [13] and 
consequently secondary degeneration of the NBMC [28]. This 
selective vulnerability of the hippocampus and neocortex is not 
clear yet. Although this study does not confirm the "olfactory 
pathway hypothesis", it is still a likely candidate for the 
explanation of this selective vulnerability. 
The tendency of a correlation of NBMC magnocellular neurons 
with cortical CA-densities suggests a close linkage between the 
degeneration of the NBMC and cortical CA, the latter known to be 
closely associated to SP-formation [20]. The finding that 
magnocellular NBMC neurons correlate not significantly with NFT-
densities in the neocortex, but significantly with SP-densities 
supports the common view among neuropathologists that the SP has 
to be considered as the main neuropathological finding in AD 
[14]. 
The finding of neuronal hypertrophy in the SON and to a lesser 
extent in the PVN in AD [29], is further supported by the 
significant negative correlation between magnocellular neuron 
numbers in the SON and total neuron numbers in the noradrenergic 
locus coeruleus (LC). Therefore, increased activity of the SON 
and PVN in AD may be related to a reduction of noradrenergic 
innervation of these hypothalamic nuclei. 
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SUMMARY AND CONCLUSIONS 
With respect to the pathogenesis of Alzheimer's disease the 
cholinergic hypothesis (Chapter 1) is a central issue. The 
reported loss of large cholinergic neurons in the nucleus basalis 
of Meynert complex (NBMC, i.e., the nucleus basalis of Meynert, 
the diagonal band of Broca, and the medial septal nucleus) 
correlates significantly with the degree of dementia, the number 
of senile plaques and neurofibrillary tangles in the neocortex 
and hippocampus, and the decreasing amounts of choline acetyl-
transferase in these structures. However, a closer look at the 
pertinent neuropathological and morphometric studies reveals 
several methodological errors especially in the neuroanatomical 
definition of the NBMC and of its ill-defined subdivisions as 
well as in the quantitative and morphometric procedures applied. 
With regard to the neuroanatomical definition of the NBMC and 
its constituting subdivisions, a topographical map is presented 
(Chapter 2) in order to get a clear arrangement of the different 
subdivisions in rostrocaudal direction in relation to its 
surrounding structures. Moreover, the presented review of the 
chemoarchitecture and the hodology of the NBMC suggests, that 
the NBMC is functionally in a position to act as a cholinergic 
relay for transmitting predominantly limbic and paralimbic 
information to the neocortex. Therefore, the NBMC may influence 
complex behaviour (integrated motor or emotional responses, 
learning and memory) according to the prevailing emotional and 
motivational states encoded by the limbic and paralimbic regions 
of the brain (Chapter 2). 
In order to avoid the methodological errors in quantitative 
and morphometric procedures made in previous studies, unbiased 
and efficient sampling procedures have been developed according 
to modern stereological principles (Chapter 3). It is shown 
that in unbiased quantitative morphology the nucleolus is the 
sampling item of first choice in histological sections with a 
minimal thickness of 10 μπ» (Chapter 4). Most morphological 
studies of the NBMC introduced two criteria for neurons to be 
counted: a minimum size criterion (magnocellular neurons, usually 
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larger than 30 μπι) and a subjective staining criterion (hyper-
chromatic neurons showing abundance of Nissl substance). 
However, it was not known whether neuronal loss is restricted to 
magnocellular neurons and whether shrinkage of cells prior to 
death might lead to inaccurate estimations of the loss of 
magnocellular neurons. Moreover, the decreased functional state 
of the NBMC neurons in AD is reflected by dissolution of the 
Nissl substance in the cytoplasm. Therefore, the use of a 
minimum size criterion and a staining criterion make these 
parameters less reliable as markers for the NBMC in AD, as these 
parameters are subjected to the disease process itself. 
Consequently, in the present study neurons are sampled efficient­
ly and in an unbiased way without neuron size or staining 
restrictions. This approach shows that neuron shrinkage rather 
than neuron death in the NBMC in AD is the main neuropathological 
feature. Moreover, a differential involvement of the subdivisi­
ons of the NBMC is found, showing a rostrocaudal increase in 
pathology with the posterior tail of the NBMC being the most 
affected (Chapter 5). This degeneration of the NBMC neurons may 
be related to reduced cortical and hippocampal amounts of nerve 
growth factor, a trophic factor that prevents specifically 
cholinergic neurons from death. 
With regard to the specificity of the degeneration of the 
NBMC, two adjacent hypothalamic structures, i.e., the supraoptic 
and paraventricular nuclei, are also investigated (Chapter 6). 
An unexpected neuronal hypertrophy is found, whereas neuron 
numbers remain constant in AD. This activation of the supraoptic 
and paraventricular nuclei may be secondary to an age-related 
decline in vasopressin binding sites in the kidney and to an age-
related decline in noradrenergic innervation of the hypothalamus 
due to severe cell loss in the locus coeruleus. 
Numbers of senile plaques (SP) and neurofibrillary tangles 
(NFT), as well as the distribution of congophilic angiopathy (CA) 
and lipofuscin in the NBMC are presented in Chapter 7. It is 
demonstrated that a rostrocaudal increase of SP and NFT is 
present, whereas the CA is evenly distributed along the NBMC. No 
major amyloid depositions are detected in the SON and PVN. The 
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lipofuscin accumulation in NBMC neurons in AD does not differ 
from normal aging. No differences in amyloid depositions are 
found in the Organum vasculosum of the lamina terminalis, a 
region devoid of a continuous blood-brain barrier, suggesting a 
cerebral rather than a haematogeneous origin of the amyloid in AD 
(Chapter 7). 
Considering the presumably important role of the noncholiner-
gic interneurons of the NBMC in modulating cholinergic function, 
the neuropeptide galanin is chosen for immunoreactivity studies 
(Chapter 8). Galanin is known to inhibit the evoked release of 
acetylcholine in the rat hippocampus. It is shown, that in AD 
galanin-like immunoreactivity is decreased in the vertical limb 
nucleus of the diagonal band of Broca, that has major cholinergic 
projections to the hippocampus. It is suggested, that this 
decreased galanin-like immunoreactivity reflects a negative 
feedback mechanism to a degenerating cholinergic system. 
In Chapter 9 anatomical correlates of the distribution of 
pathological changes in cortical and subcortical regions in AD 
are presented. No conclusive evidence for "the olfactory 
pathway hypothesis" is found. Significant correlations of 
numbers of magnocellular neurons in the subdivisions of the NBMC 
with SP-densities in their respective cortical projection areas 
are shown, whereas no correlations with NFT-densities are 
demonstrated. 
The two most important findings of the present study may be 
summarized as follows: 
1. Neuronal shrinkage rather than death of NBMC neurons prevails 
in Alzheimer's disease, strongly suggesting a secondary 
degeneration of the NBMC due to deficits of cortical nerve 
growth factor. 
2. Neuronal hypertrophy occurs in the SON and PVN in AD, indica-
ting a reserve capacity and/or plasticity of functional neuro-
nal circuits. 
Both findings may implicate future therapeutic possibilities 
either by neurotrophic factors or by "reserve capacity stimula-
tors" c.q. "plasticity-enhancers". 
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SAMENVATTING EN CONCLUSIES 
Gedurende de laatste tien jaar heeft het internationale 
onderzoek naar dementie een enorme vlucht genomen. Reden 
hiervoor is de stijging van het aantal dementie-pati enten 
tengevolge van het toenemend aantal ouderen in de samenleving. 
In Nederland zijn momenteel naar schatting ongeveer 240.000 
personen lijdende aan enigerlei vorm van dementie. Bij ruim 
70.000 van hen is er sprake van een zo ernstige vorm van ziekte 
dat volledige handelingsonbekwaamheid en hulpbehoevendheid 
bestaat. In 50% van het dementieel syndroom betreft het de 
ziekte van Alzheimer (ZA). De Pathogenese van ZA is tot op heden 
onbekend. Een van de meest gangbare hypothesen betreft de 
cholinerge hypothese, die beschreven wordt in Hoofdstuk 1. De 
cholinerge hypothese postuleert een verband tussen verminderde 
cholinerge activiteit en een afname van het cognitief functione-
ren. Deze verminderde cholinerge activiteit komt tot uiting in 
een afname van het aantal grootcellige, cholinerge neuronen in 
het nucleus basalis van Meynert complex (NBMC). Dit celverlies 
correleert significant met de mate van dementie, de hoeveelheid 
seniele plaques en neurofibrillaire degeneratie (dit zijn de 
neuropathologische kenmerken van ZA) in de hersenschors en de 
hippocampus, en met de verminderde hoeveelheid van het acetylcho-
line synthetiserende enzym choline acetyltransferase in deze 
hersenstrukturen. Echter, een nauwkeurige analyse van de 
literatuur aangaande de cholinerge hypothese laat meerdere 
methodologische fouten zien, met name met betrekking tot zowel de 
neuroanatomische afgrenzing en indeling van het NBMC, als ook tot 
de kwantitatieve en morfometrische methoden ter bepaling van het 
celaantal. 
In Hoofdstuk 2 wordt een nauwkeurige neuroanatomische 
beschrijving gegeven van het NBMC en de subdivisies van het NBMC. 
De atlas laat de verscheidene subdivisies van het NBMC in 
rostrocaudale richting zien in relatie met omgevende hersen-
strukturen. Tevens wordt een literatuuroverzicht van de chemo-
architectuur en de zenuwverbindingen van het NBMC gegeven. 
Hieruit mag men afleiden, dat het NBMC functioneel in staat is 'om 
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voornamelijk limbische en paralimbische informatie (emotie en 
motivatie) door te schakelen naar de hersenschors en hippocampus. 
Daardoor kan het NBMC complexe gedragingen beïnvloeden (geïnte-
greerde emotionele en motorische reakties, het leervermogen en 
geheugen) afhankelijk van de bestaande emotionele en motivatione-
le uitgangssituatie die gestuurd wordt door de limbische en 
paralimbische hersenstrukturen. 
Om fouten in kwantitatieve en morfometrische methoden ter 
bepaling van het celaantal van het NBMC te voorkomen, wordt in 
Hoofdstuk 3 een aanname-vrije en efficiente bemonsteringsmethode 
beschreven die in overeenstemming is met de huidige stereoJo-
gische inzichten. 
In Hoofdstuk 4 blijkt, dat wanneer het kernlichaampje in de 
celkern van neuronen (zenuwcellen) gekozen wordt om te bemonste-
ren, er in principe voldaan is aan de stereologische eisen van 
een aanname-vrije, kwantitificatie methode, mits de dikte van de 
histologische coupe niet minder wordt dan 10 micron. 
In de introductie van Hoofdstuk 5 wordt beschreven, dat 
eerdere kwantificatie-onderzoeken van het celaantal van het NBMC 
twee aannames gebruikten: alleen grootcellige neuronen werden 
geteld, én deze grootcellige neuronen dienden veel Nissl-korrels 
te bevatten. Het was echter niet bekend of celverlies zich 
beperkte tot de grootcellige neuronen of dat celkrimping 
voorafging aan het beschreven celverlies. Bovendien werd 
voorbijgegaan aan het feit dat door het ziekteproces zelf de 
Nissl-korrels verdwenen. Door de toepassing van dit celgrootte-
en korrel-criterium zijn deze celtellingen van het NBMC in feite 
onbetrouwbaar, omdat beide criteria door het ziekteproces zelf 
beïnvloed kunnen worden. Daarom worden in het huidige onderzoek 
(Hoofdstuk 5) alle neuronen, welke een kernlichaampje bevatten, 
bemonsterd. Deze aanname-vrije benadering laat zien dat 
celkrimping van NBMC neuronen het belangrijkste neuropathologi-
sche kenmerk is en waarschijnlijk voorafgaat aan celdood, die 
eveneens maar in veel geringere mate dan tot nu toe werd 
aangenomen, optreedt. Tevens blijkt, dat de subdivisies van het 
NBMC in verschillende mate aangedaan zijn: er bestaat een 
rostrocaudale toename van de pathologie. Er wordt gesuggereerd 
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dat de krimping van de NBMC neuronen veroorzaakt wordt door een 
tekort aan het "nerve growth factor", een zenuwgroei-factor, die 
geproduceerd wordt in de hersenschors en de hippocampus. 
Dierexperimenteel werk heeft namelijk laten zien, dat het "nerve 
growth factor" de dood van specifiek de cholinerge NBMC neuronen 
kan voorkomen. 
Om zeker te zijn van de specificiteit van de pathologie in het 
NBMC in ZA, worden in Hoofdstuk 6 de resultaten van celtellingen 
van twee andere naburige zenuwcelgebieden beschreven, te weten 
de nucleus supraopticus (SON) en de nucleus paraventricularis 
(PVN). In ZA blijft het celaantal constant, en worden de 
neuronen niet kleiner (zoals de NBMC neuronen) maar juist groter. 
Deze aktivatie van de SON en PVN neuronen kan verklaard worden 
door een aan de leeftijd gerelateerd tekort aan nier-receptoren 
voor het hormoon Vasopressine dat deze neuronen aanmaken. Tevens 
wordt gesuggereerd, dat ernstig celveriies in de locus coeruleus 
(een zenuwcelgebied in de hersenstam, dat in verbinding staat met 
de SON en de PVN) eveneens deze aktivatie van de SON en PVN 
neuronen kan veroorzaken. 
In Hoofdstuk 7 worden gegevens gepresenteerd over de neuropa-
thologische afwijkingen, die naast celkrimping en -verlies in het 
NBMC optreden bij ZA: de seniele plaques, de neurofibrillaire 
degeneratie en de congofiele angiopathie (deze drie afwijkingen 
bestaan alle uit amyloid). Opnieuw wordt er een rostrocaudale 
toename van seniele plaques en neurofibrillaire degeneratie 
vastgesteld, terwijl de congofiele angiopathie gelijkelijk 
verdeeld is over de diverse subdivisies van het NBMC. In de SON 
en PVN worden behoudens de celzwelling geen neuropathologische 
afwijkingen vastgesteld. Er wordt geen verschil in hoeveelheid 
lipofuscine, een afvalprodukt van de stofwisseling, tussen 
normale veroudering en ZA waargenomen in het NBMC, de SON en PVN. 
In het Organum vasculosum van de lamina terminalis, een klein 
gebiedje dat geen intacte bloed-hersenen barrière bezit, is er 
geen verschil in congofiele angiopathie tussen normale veroude-
ring en ZA gevonden. Deze bevinding suggereert dat het amyloid 
niet afkomstig is uit de bloedbaan, maar in de hersenen zelf 
aangemaakt wordt. 
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In Hoofdstuk 8 wordt de waarschijnlijk belangrijke rol van 
schakelneuronen in het NBMC nader belicht. Deze schakelneuronen 
zijn mogelijk in staat de funktie van de cholinerge neuronen te 
beïnvloeden. Een type schakelneuron produceert galanine, 
waarvoor de cholinerge cellen receptoren bevatten. Galanine kan 
in de rat de afgifte van acetylcholine in de hippocampus remmen. 
Het blijkt dat bij ZA de hoeveelheid galanine verlaagd is in die 
cholinerge neuronen die juist met de hippocampus in verbinding 
staan. 
In Hoofdstuk 9 worden significante correlaties aangetoond 
tussen het verlies van grootcellige, cholinerge neuronen in de 
diverse subdivisies van het NBMC en aantallen seniele plaques in 
de respectievelijke hersenschorsvelden, waarmee de subdivisies 
van het NBMC verbindingen onderhouden. Dergelijke significante 
correlaties voor de neurofibrillaire degeneratie en de congofiele 
angiopathie worden niet gevonden. 
De twee belangrijkste bevindingen van dit onderzoek laten zich 
als volgt samenvatten: 
1. Celkrimping van NBMC neuronen is de belangrijkste neuropatho-
logische afwijking bij ZA, en gaat waarschijnlijk vooraf aan 
celdood. Dit proces van celkrimping suggereert een secundaire 
degeneratie van het NBMC tengevolge van primaire tekorten aan 
"nerve growth factor" in de hersenschors en hippocampus. 
2. De celzwelling van de SON en PVN neuronen duidt op een 
plasticiteit en reserve-capaciteit van deze neuronen in het 
bijzonder en misschien van alle neuronen in het algemeen. 
Beide bevindingen impliceren toekomstige mogelijkheden voor de 
ontwikkeling van nieuwe farmaca, welke mogelijk werkzaam zijn 
kunnen blijken bij meer dan alleen de ziekte van Alzheimer. 
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STELLINGEN 
I 
"Do more l e s s well" i s het be l ang r i j k s t e s te reo log ische pr inc ipe 
van elk kwant i t a t i e f onderzoek. 
dit proefschrift, hoofdstukken 3, 4, 5, 6 en 7 
Gundersen HJG and Osterby R. J Microsc 1981;121:65-73 
I I 
Niet het c e l v e r l i e s , maar de celschrompeling vormt de be langr i jk -
s t e neuropathologische determinant binnen het nucleus b a s a l i s 
Meynert complex b i j de z iekte van Alzheimer. 
dit proefschrift, hoofdstuk 5 
Pearson RCA, et al . Brain Res 1983;289:375-9 
I I I 
Bij normale veroudering en in v e r s t e r k t e mate b i j de z iek te van 
Alzheimer t r e e d t hyper t rof ie van neuronen van de nucleus 
supraopt icus en nucleus p a r a v e n t r i c u l a r i s op. 
dit proefschrift, hoofdstuk 6 
Fliers E, et al . Brain Res 1985;342:45-53 
IV 
De subkernen van het nucleus b a s a l i s Meynert complex z i jn n i e t in 
ge l i j ke mate aangedaan b i j de z iek te van Alzheimer: er bes t aa t 
een ros t rocaudale toename van de celschrompeling, het c e l v e r l i e s , 
de s en i e l e plaques en n e u r o f i b r i l l a i r e degenera t i e , en p a r a l l e l 
hieraan een rost rocaudale afname van de gen-expressie van 
receptoren voor "nerve growth f ac to r " . 
dit proefschrift, hoofdstuk 7 
Higgins GA and ïtifson EJ. Exp Neurol 1989;106:222-36 
V 
Er z i jn aanwijzigingen dat de bloed-hersen b a r r i è r e n i e t 
wezenlijk aangedaan i s b i j de z iek te van Alzheimer. 
dit proefschrift, hoofdstuk 7 
Rozanuller JM, et al . Neurobiol Aging 1988;9:383-91 
VI 
Het nucleus b a s a l i s Meynert complex i s secundair aangedaan b i j de 
z iek te van Alzheimer. 
dit proefschrift, hoofdstukken 5, 7 en 9 
VII 
Er ontbreekt een r a t i o n e l e bas i s voor therapieën a l s a c e t y l c h o l i -
ne precursors en ace ty l cho l ine -e s t e r a se remmers b i j de z iek te van 
Alzheimer. 
dit proefschrift, hoofdstukken 5, 7 en 9 
VIII 
De ziekte van Alzheimer dient niet opgevat te worden als een 
versneld verouderingsproces. 
IX 
In het onderzoek naar het atherogeen gedrag van low-density 
l ipopro te ins (LDL) dienen de LDL-subfracties a fzonder l i jk 
betrokken t e worden. 
Swinkels DW. Thesis Nijmegen 1989 
X 
Het dominante gen voor schizofrenie i s n i e t gelinked met de regio 
q l l - 1 3 op chromosoom 5. 
Sherrington R, et al . Nature 1988;336:164-7 
Detera-Wadleigh SD, et a l . Nature 1989;340:391-3 
X I 
Het gebruik van de standaard fout van het gemiddelde, is een 
standaard fout van de gemiddelde onderzoeker, en kan beter 
vervangen worden door de variatie-coëfficiënt. 
XII 
Door de ont-aarding van Carnaval krijgt dit oorspronkelijk 
katholieke feest ongemerkt weer een religieus tintje. 
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